0001499717 false 280338 280338
0001499717 2022-01-02 2022-10-01 0001499717 2022-01-01 0001499717
2021-01-02 0001499717 us-gaap:SeriesEPreferredStockMember
2022-01-01 0001499717 us-gaap:SeriesEPreferredStockMember
2021-01-02 0001499717 STAF:SeriesEOnePreferredStockMember
2022-01-01 0001499717 STAF:SeriesEOnePreferredStockMember
2021-01-02 0001499717 2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
2022-01-01 0001499717 STAF:SeriesJPreferredStockMember 2022-10-01
0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
STAF:SeriesJPreferredStockMember 2022-01-01 0001499717
STAF:SeriesJPreferredStockMember 2022-01-01 0001499717 2021-01-03
2022-01-01 0001499717 2019-12-29 2021-01-02 0001499717
us-gaap:SeriesAPreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:SeriesAPreferredStockMember 2019-12-29
2021-01-02 0001499717 us-gaap:SeriesEPreferredStockMember
2021-01-03 2022-01-01 0001499717
us-gaap:SeriesEPreferredStockMember 2019-12-29 2021-01-02
0001499717 STAF:SeriesEOnePreferredStockMember 2021-01-03
2022-01-01 0001499717 STAF:SeriesEOnePreferredStockMember
2019-12-29 2021-01-02 0001499717
us-gaap:SeriesGPreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:SeriesGPreferredStockMember 2019-12-29
2021-01-02 0001499717 STAF:SeriesGOnePreferredStockMember
2021-01-03 2022-01-01 0001499717
STAF:SeriesGOnePreferredStockMember 2019-12-29 2021-01-02
0001499717 2022-07-03 2022-10-01 0001499717 2021-07-04 2021-10-02
0001499717 2021-01-03 2021-10-02 0001499717
us-gaap:SeriesEPreferredStockMember 2022-07-03 2022-10-01
0001499717 us-gaap:SeriesEPreferredStockMember 2021-07-04
2021-10-02 0001499717 us-gaap:SeriesEPreferredStockMember
2022-01-02 2022-10-01 0001499717
us-gaap:SeriesEPreferredStockMember 2021-01-03 2021-10-02
0001499717 STAF:SeriesEOnePreferredStockMember 2022-07-03
2022-10-01 0001499717 STAF:SeriesEOnePreferredStockMember
2021-07-04 2021-10-02 0001499717
STAF:SeriesEOnePreferredStockMember 2022-01-02 2022-10-01
0001499717 STAF:SeriesEOnePreferredStockMember 2021-01-03
2021-10-02 0001499717 us-gaap:SeriesGPreferredStockMember
2022-07-03 2022-10-01 0001499717
us-gaap:SeriesGPreferredStockMember 2021-07-04 2021-10-02
0001499717 us-gaap:SeriesGPreferredStockMember 2022-01-02
2022-10-01 0001499717 us-gaap:SeriesGPreferredStockMember
2021-01-03 2021-10-02 0001499717
STAF:SeriesGOnePreferredStockMember 2022-07-03 2022-10-01
0001499717 STAF:SeriesGOnePreferredStockMember 2021-07-04
2021-10-02 0001499717 STAF:SeriesGOnePreferredStockMember
2022-01-02 2022-10-01 0001499717
STAF:SeriesGOnePreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:PreferredStockMember
STAF:SeriesEOnePreferredStockMember 2019-12-28 0001499717
us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember
2019-12-28 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesEPreferredStockMember 2019-12-28 0001499717
us-gaap:CommonStockMember 2019-12-28 0001499717
us-gaap:AdditionalPaidInCapitalMember 2019-12-28 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-28
0001499717 us-gaap:RetainedEarningsMember 2019-12-28 0001499717
2019-12-28 0001499717 us-gaap:PreferredStockMember
STAF:SeriesEOnePreferredStockMember 2021-01-02 0001499717
us-gaap:PreferredStockMember STAF:SeriesGOnePreferredStockMember
2021-01-02 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2021-01-02 0001499717
us-gaap:PreferredStockMember us-gaap:SeriesEPreferredStockMember
2021-01-02 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2021-01-02 0001499717
us-gaap:CommonStockMember 2021-01-02 0001499717
us-gaap:AdditionalPaidInCapitalMember 2021-01-02 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-02
0001499717 us-gaap:RetainedEarningsMember 2021-01-02 0001499717
us-gaap:PreferredStockMember STAF:SeriesGOnePreferredStockMember
2021-07-03 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2021-07-03 0001499717
us-gaap:CommonStockMember 2021-07-03 0001499717
us-gaap:AdditionalPaidInCapitalMember 2021-07-03 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-03
0001499717 us-gaap:RetainedEarningsMember 2021-07-03 0001499717
2021-07-03 0001499717 us-gaap:PreferredStockMember
STAF:SeriesJPreferredStockMember 2022-07-02 0001499717
us-gaap:CommonStockMember 2022-07-02 0001499717
us-gaap:AdditionalPaidInCapitalMember 2022-07-02 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-02
0001499717 us-gaap:RetainedEarningsMember 2022-07-02 0001499717
2022-07-02 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:PreferredStockMember STAF:SeriesJPreferredStockMember
2022-01-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:CommonStockMember 2022-01-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01
0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:RetainedEarningsMember 2022-01-01 0001499717
us-gaap:PreferredStockMember STAF:SeriesEOnePreferredStockMember
2019-12-29 2021-01-02 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2019-12-29 2021-01-02
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesEPreferredStockMember 2019-12-29 2021-01-02
0001499717 us-gaap:CommonStockMember 2019-12-29 2021-01-02
0001499717 us-gaap:AdditionalPaidInCapitalMember 2019-12-29
2021-01-02 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29
2021-01-02 0001499717 us-gaap:RetainedEarningsMember 2019-12-29
2021-01-02 0001499717 us-gaap:PreferredStockMember
STAF:SeriesEOnePreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:PreferredStockMember
STAF:SeriesGOnePreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesEPreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:CommonStockMember 2021-01-03 2022-01-01
0001499717 us-gaap:AdditionalPaidInCapitalMember 2021-01-03
2022-01-01 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03
2022-01-01 0001499717 us-gaap:RetainedEarningsMember 2021-01-03
2022-01-01 0001499717 us-gaap:PreferredStockMember
STAF:SeriesEOnePreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:PreferredStockMember
STAF:SeriesGOnePreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesEPreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:CommonStockMember 2021-01-03 2021-10-02
0001499717 us-gaap:AdditionalPaidInCapitalMember 2021-01-03
2021-10-02 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-03
2021-10-02 0001499717 us-gaap:RetainedEarningsMember 2021-01-03
2021-10-02 0001499717 us-gaap:PreferredStockMember
STAF:SeriesGOnePreferredStockMember 2021-07-04 2021-10-02
0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2021-07-04 2021-10-02
0001499717 us-gaap:CommonStockMember 2021-07-04 2021-10-02
0001499717 us-gaap:AdditionalPaidInCapitalMember 2021-07-04
2021-10-02 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-04
2021-10-02 0001499717 us-gaap:RetainedEarningsMember 2021-07-04
2021-10-02 0001499717 us-gaap:PreferredStockMember
STAF:SeriesJPreferredStockMember 2022-07-03 2022-10-01 0001499717
us-gaap:CommonStockMember 2022-07-03 2022-10-01 0001499717
us-gaap:AdditionalPaidInCapitalMember 2022-07-03 2022-10-01
0001499717 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-07-03 2022-10-01 0001499717 us-gaap:RetainedEarningsMember
2022-07-03 2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:PreferredStockMember STAF:SeriesJPreferredStockMember
2022-01-02 2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:CommonStockMember 2022-01-02 2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:AdditionalPaidInCapitalMember 2022-01-02 2022-10-01
0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02
2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
us-gaap:RetainedEarningsMember 2022-01-02 2022-10-01 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
2022-01-02 2022-10-01 0001499717 us-gaap:CommonStockMember
2022-01-02 2022-10-01 0001499717 us-gaap:PreferredStockMember
STAF:SeriesEOnePreferredStockMember 2022-01-01 0001499717
us-gaap:PreferredStockMember STAF:SeriesGOnePreferredStockMember
2022-01-01 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember 2022-01-01 0001499717
us-gaap:PreferredStockMember us-gaap:SeriesEPreferredStockMember
2022-01-01 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesFPreferredStockMember 2022-01-01 0001499717
us-gaap:CommonStockMember 2022-01-01 0001499717
us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01
0001499717 us-gaap:RetainedEarningsMember 2022-01-01 0001499717
us-gaap:PreferredStockMember STAF:SeriesEOnePreferredStockMember
2021-10-02 0001499717 us-gaap:PreferredStockMember
STAF:SeriesGOnePreferredStockMember 2021-10-02 0001499717
us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember
2021-10-02 0001499717 us-gaap:PreferredStockMember
us-gaap:SeriesEPreferredStockMember 2021-10-02 0001499717
us-gaap:PreferredStockMember us-gaap:SeriesFPreferredStockMember
2021-10-02 0001499717 us-gaap:CommonStockMember 2021-10-02
0001499717 us-gaap:AdditionalPaidInCapitalMember 2021-10-02
0001499717 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-02 0001499717 us-gaap:RetainedEarningsMember 2021-10-02
0001499717 2021-10-02 0001499717 us-gaap:PreferredStockMember
STAF:SeriesJPreferredStockMember 2022-10-01 0001499717
us-gaap:CommonStockMember 2022-10-01 0001499717
us-gaap:AdditionalPaidInCapitalMember 2022-10-01 0001499717
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01
0001499717 us-gaap:RetainedEarningsMember 2022-10-01 0001499717
us-gaap:SubsequentEventMember 2022-03-31 0001499717
STAF:TwoThousandTwentyJacksonNoteMember 2021-01-03 2022-01-01
0001499717 STAF:TwoThousandTwentyJacksonNoteMember
STAF:MidcapFundingXTrustMember 2022-01-01 0001499717
STAF:TwoThousandTwentyJacksonNoteMember
STAF:MidcapFundingXTrustMember 2021-01-03 2022-01-01 0001499717
STAF:MayTwelveNoteMember STAF:MonroeStaffingServicesLLCMember
2020-05-12 0001499717 STAF:MayTwelveNoteMember
STAF:AffinityBankMember 2021-05-25 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember 2021-05-24
2021-05-25 0001499717 STAF:KeyResourcesIncMember 2020-05-20
0001499717 STAF:LighthousePlacementServicesLLCMember 2020-05-20
0001499717 STAF:StaffingGeorgiaLLCMember 2020-05-20 0001499717
STAF:MayTwentyNoteMember 2020-05-20 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:KeyResourcesIncMember 2021-07-14 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:LighthousePlacementServicesLLCMember 2021-07-14 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:Staffing360GeorgiaLLCMember 2021-07-14 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:KeyResourcesIncMember 2021-07-13 2021-07-14 0001499717
STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:LighthousePlacementServicesLLCMember 2021-07-13 2021-07-14
0001499717 STAF:MayTwelveNoteMember STAF:AffinityBankMember
STAF:Staffing360GeorgiaLLCMember 2021-07-13 2021-07-14 0001499717
STAF:PaycheckProtectionProgramLoanDeferralOneMember 2020-03-26
2020-03-27 0001499717
STAF:PaycheckProtectionProgramLoanDeferralTwoMember 2020-03-26
2020-03-27 0001499717 STAF:FirstPRORecruitmentLLCMember 2020-09-23
2020-09-24 0001499717 STAF:FirstPRORecruitmentLLCMember
STAF:PaycheckProtectionProgramLoansMember 2020-09-24 0001499717
us-gaap:SeriesEPreferredStockMember 2020-09-27 2020-09-28
0001499717 STAF:ForgivenessOfPPPLoanMember 2021-07-22 0001499717
STAF:TemporaryContractorRevenueMember 2021-01-03 2022-01-01
0001499717 STAF:PermanentPlacementRevenueMember 2021-01-03
2022-01-01 0001499717 STAF:TemporaryContractorRevenueMember
2019-12-29 2021-01-02 0001499717
STAF:PermanentPlacementRevenueMember 2019-12-29 2021-01-02
0001499717 2022-06-22 2022-06-24 0001499717
us-gaap:SubsequentEventMember 2022-11-21 0001499717
STAF:PromissoryNoteMember
STAF:ThirdAmendedAndRestatedNotePurchaseAgreementMember
us-gaap:SubsequentEventMember 2022-10-27 0001499717
STAF:ThirdAmendedAndRestatedNotePurchaseAgreementMember
STAF:MidcapFinancialTrustMember us-gaap:SubsequentEventMember
2022-10-27 0001499717 STAF:StaffingUKReportingUnitMember 2021-10-03
2022-01-01 0001499717 STAF:TemporaryContractorRevenueMember
2022-07-03 2022-10-01 0001499717
STAF:PermanentPlacementRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:TemporaryContractorRevenueMember 2021-07-04
2021-10-02 0001499717 STAF:PermanentPlacementRevenueMember
2021-07-04 2021-10-02 0001499717
STAF:TemporaryContractorRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:PermanentPlacementRevenueMember 2022-01-02
2022-10-01 0001499717 STAF:TemporaryContractorRevenueMember
2021-01-03 2021-10-02 0001499717
STAF:PermanentPlacementRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:KeyResourcesIncMember 2019-12-28 0001499717
STAF:KeyResourcesIncMember 2019-12-29 2021-01-02 0001499717
STAF:KeyResourcesIncMember 2021-01-02 0001499717
STAF:KeyResourcesIncMember 2021-01-03 2022-01-01 0001499717
STAF:KeyResourcesIncMember 2022-01-01 0001499717
STAF:ComputersMember srt:MinimumMember 2021-01-03 2022-01-01
0001499717 STAF:ComputersMember srt:MaximumMember 2021-01-03
2022-01-01 0001499717 us-gaap:ComputerEquipmentMember
srt:MinimumMember 2021-01-03 2022-01-01 0001499717
us-gaap:ComputerEquipmentMember srt:MaximumMember 2021-01-03
2022-01-01 0001499717 STAF:NetworkEquipmentMember srt:MinimumMember
2021-01-03 2022-01-01 0001499717 STAF:NetworkEquipmentMember
srt:MaximumMember 2021-01-03 2022-01-01 0001499717
us-gaap:SoftwareDevelopmentMember srt:MinimumMember 2021-01-03
2022-01-01 0001499717 us-gaap:SoftwareDevelopmentMember
srt:MaximumMember 2021-01-03 2022-01-01 0001499717
us-gaap:OfficeEquipmentMember srt:MinimumMember 2021-01-03
2022-01-01 0001499717 us-gaap:OfficeEquipmentMember
srt:MaximumMember 2021-01-03 2022-01-01 0001499717
us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2021-01-03
2022-01-01 0001499717 us-gaap:FurnitureAndFixturesMember
srt:MaximumMember 2021-01-03 2022-01-01 0001499717
us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2021-01-03
2022-01-01 0001499717 us-gaap:LeaseholdImprovementsMember
srt:MaximumMember 2021-01-03 2022-01-01 0001499717
us-gaap:SeriesAPreferredStockMember 2022-07-03 2022-10-01
0001499717 us-gaap:SeriesAPreferredStockMember 2021-07-04
2021-10-02 0001499717 us-gaap:SeriesAPreferredStockMember
2022-01-02 2022-10-01 0001499717
us-gaap:SeriesAPreferredStockMember 2021-01-03 2021-10-02
0001499717 STAF:ComputerSoftwareMember 2022-01-01 0001499717
STAF:ComputerSoftwareMember 2021-01-02 0001499717
us-gaap:OfficeEquipmentMember 2022-01-01 0001499717
us-gaap:OfficeEquipmentMember 2021-01-02 0001499717
us-gaap:ComputerEquipmentMember 2022-01-01 0001499717
us-gaap:ComputerEquipmentMember 2021-01-02 0001499717
us-gaap:FurnitureAndFixturesMember 2022-01-01 0001499717
us-gaap:FurnitureAndFixturesMember 2021-01-02 0001499717
us-gaap:LeaseholdImprovementsMember 2022-01-01 0001499717
us-gaap:LeaseholdImprovementsMember 2021-01-02 0001499717
us-gaap:TradeNamesMember 2022-01-01 0001499717
STAF:NonCompeteMember 2022-01-01 0001499717
us-gaap:CustomerRelationshipsMember 2022-01-01 0001499717
us-gaap:TradeNamesMember 2021-01-02 0001499717
STAF:NonCompeteMember 2021-01-02 0001499717
us-gaap:CustomerRelationshipsMember 2021-01-02 0001499717
STAF:FirstPRORecruitmentLLCMember 2020-09-24 0001499717
STAF:ProfessionalStaffingMember country:US 2022-01-01 0001499717
STAF:ProfessionalStaffingMember country:US 2021-01-02 0001499717
STAF:CommercialStaffingMember country:US 2022-01-01 0001499717
STAF:CommercialStaffingMember country:US 2021-01-02 0001499717
STAF:ProfessionalStaffingMember country:GB 2022-01-01 0001499717
STAF:ProfessionalStaffingMember country:GB 2021-01-02 0001499717
STAF:FirstProReportingUnitMember 2021-01-03 2022-01-01 0001499717
2022-05-18 0001499717 STAF:MidcapFinancialTrustMember 2017-09-15
0001499717 STAF:MidcapFinancialTrustMember 2017-09-13 2017-09-15
0001499717 STAF:MidcapFinancialTrustMember 2022-01-01 0001499717
STAF:MidcapFinancialTrustMember 2021-01-02 0001499717
STAF:HSBCInvoiceFinanceUKLtdMember STAF:NewFacilityMember
2018-02-07 2018-02-08 0001499717 STAF:HSBCInvoiceFinanceUKLtdMember
STAF:NewFacilityMember 2018-06-26 2018-06-28 0001499717
STAF:HSBCInvoiceFinanceUKLtdMember STAF:NewFacilityMember
2019-07-01 2019-07-31 0001499717 STAF:MidcapFinancialTrustMember
2022-10-01 0001499717 STAF:WhiteOakCommercialFinanceLLCMember
2022-10-01 0001499717 STAF:WhiteOakCommercialFinanceLLCMember
2022-01-02 2022-10-01 0001499717
STAF:WhiteOakCommercialFinanceLLCMember
us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-02 2022-10-01
0001499717 STAF:WhiteOakCommercialFinanceLLCMember
us-gaap:InterestRateFloorMember 2022-01-02 2022-10-01 0001499717
STAF:WhiteOakCommercialFinanceLLCMember
us-gaap:InterestRateFloorMember 2021-12-30 2021-12-31 0001499717
STAF:HSBCInvoiceFinanceUKLtdMember STAF:NewFacilityMember
2018-02-08 0001499717 STAF:ASUTwoThousandAndSixteenSixteenMember
2022-01-02 2022-10-01 0001499717
STAF:ASUTwoThousandAndSixteenSixteenMember 2021-01-03 2021-10-02
0001499717 STAF:JacksonInvestmentGroupRelatedPartyMember 2022-01-01
0001499717 STAF:JacksonInvestmentGroupRelatedPartyMember 2021-01-02
0001499717 STAF:PaycheckProtectionProgramLoansMember 2022-01-01
0001499717 STAF:PaycheckProtectionProgramLoansMember 2021-01-02
0001499717 STAF:HSBCTermLoanMember 2022-01-01 0001499717
STAF:HSBCTermLoanMember 2021-01-02 0001499717
STAF:JacksonInvestmentGroupRelatedPartyMember 2022-10-01 0001499717
us-gaap:SeriesHPreferredStockMember 2022-10-01 0001499717
us-gaap:SeriesHPreferredStockMember 2022-01-01 0001499717
STAF:HSBCTermLoanMember 2022-10-01 0001499717
STAF:NoteAgreementMember STAF:TwoThousandSeventeenJacksonNoteMember
2017-09-15 0001499717 STAF:NoteAgreementMember
STAF:TwoThousandSeventeenJacksonNoteMember 2017-09-13 2017-09-15
0001499717 STAF:AmendedAgreementMember STAF:JacksonNoteMember
2018-08-27 0001499717 STAF:AmendedAgreementMember
STAF:JacksonNoteMember 2018-08-26 2018-08-27 0001499717
STAF:JacksonInvestmentGroupLLCMember STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2019-08-29 0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2019-08-28 2019-08-29 0001499717
STAF:JacksonInvestmentGroupLLCMember STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2019-12-29 2021-01-02 0001499717
STAF:JacksonInvestmentGroupLLCMember STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2019-12-31 0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember 2020-10-26 0001499717
STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember 2020-10-24 2020-10-26
0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:AmendedNotePurchaseAgreementMember 2020-10-26 0001499717
STAF:JacksonNoteMember 2020-10-26 0001499717
STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
srt:MinimumMember 2020-10-26 0001499717
STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
srt:MaximumMember 2020-10-26 0001499717
STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember 2020-10-24
2020-10-26 0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember 2021-01-03 2022-01-01
0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember srt:MinimumMember
2022-01-01 0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember srt:MaximumMember
2022-01-01 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember 2022-01-01
0001499717 STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:DebtExchangeAgreementMember 2022-01-01 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:AmendedAndRestatedWarrantAgreementMember 2022-01-01 0001499717
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:DebtExchangeAgreementMember 2021-01-03 2022-01-01 0001499717
STAF:SecuritiesPurchaseAgreementMember 2021-01-01 2021-01-04
0001499717 STAF:SecuritiesPurchaseAgreementMember 2021-01-04
0001499717 STAF:SecuritiesPurchaseAgreementMember
us-gaap:SeriesEPreferredStockMember 2021-01-01 2021-01-04
0001499717 STAF:SecuritiesPurchaseAgreementMember
us-gaap:SeriesEPreferredStockMember 2021-01-04 0001499717
STAF:SecuritiesPurchaseAgreementMember STAF:JacksonNoteMember
2021-01-04 0001499717 STAF:JacksonNoteMember
us-gaap:SeriesEPreferredStockMember 2021-02-04 2021-02-05
0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
2021-04-20 2021-04-21 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SecondAmendedAndRestatedTwelvePercentageSeniorSecuredNoteMember
2021-04-20 2021-04-21 0001499717
STAF:TwelvePercentageSeniorSecuredNoteMember 2021-07-19 2021-07-20
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember
STAF:SeriesGConvertiblePreferredStockMember 2021-07-05 2021-07-21
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember
STAF:SeriesGOnePreferredStockMember 2021-07-05 2021-07-21
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember 2021-07-21
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember
STAF:SeriesGConvertiblePreferredStockMember 2021-07-21 0001499717
STAF:TwelvePercentageSeniorSecuredNoteMember
STAF:SeriesGOnePreferredStockMember 2021-07-21 0001499717
STAF:TwelvePercentageSeniorSecuredNoteMember 2021-07-05 2021-07-21
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember
STAF:NotePurchaseAgreementMember 2021-07-05 2021-07-21 0001499717
STAF:TwelvePercentageSeniorSecuredNoteMember 2021-08-04 2021-08-05
0001499717 STAF:NovemberTwoThousandTwentyOnePrivatePlacementMember
2021-10-01 2021-10-28 0001499717
STAF:NovemberTwoThousandTwentyOnePrivatePlacementMember
STAF:JacksonNoteMember 2021-10-01 2021-10-28 0001499717
STAF:NovemberTwoThousandTwentyOnePrivatePlacementMember
STAF:JacksonNoteMember 2021-10-28 0001499717
STAF:MonroeStaffingServicesLLCMember STAF:MayTwelveNoteMember
2020-05-12 0001499717 STAF:MonroeStaffingServicesLLCMember
STAF:MayTwelveNoteMember 2021-01-03 2022-01-01 0001499717
STAF:AffinityBankMember STAF:MayTwelveNoteMember 2021-05-24
2021-05-25 0001499717 STAF:PrincipalMember 2021-01-03 2022-01-01
0001499717 STAF:InterestMember 2021-01-03 2022-01-01 0001499717
STAF:MayTwentyNoteMember 2021-01-03 2022-01-01 0001499717
STAF:KeyResourcesIncMember STAF:MayTwentyNoteMember
STAF:AffinityBankMember 2021-07-12 2021-07-14 0001499717
STAF:LighthousePlacementServicesLLCMember STAF:MayTwentyNoteMember
STAF:AffinityBankMember 2021-07-12 2021-07-14 0001499717
STAF:StaffingThreeHundredAndSixtyGeorgiaLLCMember
STAF:MayTwentyNoteMember STAF:AffinityBankMember 2021-07-12
2021-07-14 0001499717 STAF:DebtExchangeAgreementMember
us-gaap:SeriesEPreferredStockMember 2018-11-14 2018-11-15
0001499717 STAF:DebtExchangeAgreementMember 2018-11-15 0001499717
STAF:DebtExchangeAgreementMember
us-gaap:SeriesEPreferredStockMember 2018-11-15 0001499717
STAF:AmendedNotePurchaseAgreementMember
STAF:SeriesEOnePreferredStockMember 2020-10-24 2020-10-26
0001499717 STAF:AmendedNotePurchaseAgreementMember
us-gaap:SeriesEPreferredStockMember 2020-10-24 2020-10-26
0001499717 STAF:JacksonInvestmentGroupLLCTermLoanNoteThreeMember
2022-01-01 0001499717 STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCTermLoanNoteThreeMember
STAF:DebtExchangeAgreementMember 2022-01-01 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteThreeMember
STAF:AmendedAndRestatedWarrantAgreementMember 2022-01-01 0001499717
STAF:SeriesEOnePreferredStockMember 2020-10-31 0001499717
STAF:SeriesEOnePreferredStockMember
STAF:AmendedNotePurchaseAgreementMember 2020-10-31 0001499717
STAF:SeriesEOnePreferredStockMember
STAF:AmendedNotePurchaseAgreementMember 2020-10-29 2020-10-31
0001499717 us-gaap:SeriesEPreferredStockMember 2020-10-29
2020-10-31 0001499717 us-gaap:SeriesEPreferredStockMember
2020-10-31 0001499717 STAF:SeriesEOnePreferredStockMember
STAF:AmendedNotePurchaseAgreementMember srt:MinimumMember
2020-10-31 0001499717 STAF:SeriesEOnePreferredStockMember
STAF:AmendedNotePurchaseAgreementMember srt:MaximumMember
2020-10-31 0001499717 us-gaap:SeriesGPreferredStockMember
2021-07-22 0001499717 STAF:LimitedConsentAndWaiverMember 2021-02-04
2021-02-05 0001499717 STAF:ExchangeAgreementMember
STAF:JacksonInvestmentGroupLLCMember
STAF:SeriesEConvertiblePreferredStockMember 2021-05-05 2021-05-06
0001499717 STAF:ExchangeAgreementMember
STAF:JacksonInvestmentGroupLLCMember
STAF:SeriesEOneConvertiblePreferredStockMember 2021-05-05
2021-05-06 0001499717 us-gaap:SeriesGPreferredStockMember
2021-07-19 2021-07-20 0001499717
STAF:SeriesGOnePreferredStockMember 2021-07-19 2021-07-20
0001499717 STAF:HSBCBankMember 2020-05-14 2020-05-15 0001499717
STAF:HSBCBankMember 2020-05-15 0001499717
STAF:NotePurchaseAgreementMember
STAF:TwoThousandSeventeenJacksonNoteMember 2017-09-15 0001499717
STAF:TwoThousandSeventeenJacksonNoteMember 2017-09-15 0001499717
STAF:TwoThousandSeventeenJacksonNoteMember 2017-09-13 2017-09-15
0001499717 STAF:TwoThousandSeventeenJacksonNoteMember 2018-12-30
2019-12-28 0001499717
STAF:AmendedAndRestatedNotePurchaseAgreementMember
STAF:JacksonNoteMember 2018-12-30 2019-12-28 0001499717
STAF:AmendedAndRestatedNotePurchaseAgreementMember
STAF:JacksonNoteMember 2017-09-13 2017-09-15 0001499717
STAF:JacksonInvestmentGroupLLCMember STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2022-01-02 2022-04-02 0001499717
STAF:JacksonInvestmentGroupLLCMember STAF:SeniorSecuredNoteMember
STAF:FourthOmnibusAmendmentAndReaffirmationAgreementMember
2019-12-29 2020-05-28 0001499717
STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember srt:MinimumMember
2021-10-02 0001499717 STAF:JacksonInvestmentGroupLLCMember
STAF:SeniorSecuredTwelvePercentagePromissoryNoteMember
STAF:AmendedNotePurchaseAgreementMember srt:MaximumMember
2021-10-02 0001499717 2022-01-02 2022-04-02 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember 2021-10-02
0001499717 STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:DebtExchangeAgreementMember 2021-10-02 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:AmendedAndRestatedWarrantAgreementMember 2021-10-02 0001499717
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:DebtExchangeAgreementMember 2022-01-02 2022-04-02 0001499717
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:AmendedAndRestatedWarrantAgreementMember 2021-01-31 0001499717
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCTermLoanNoteTwoMember
STAF:DebtExchangeAgreementMember 2020-01-31 2021-01-31 0001499717
STAF:SecuritiesPurchaseAgreementMember 2021-01-03 2021-01-04
0001499717 STAF:SecuritiesPurchaseAgreementMember
us-gaap:SeriesEPreferredStockMember 2021-01-03 2021-01-04
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember 2021-10-26
2021-10-28 0001499717
STAF:ThirdAmendedAndRestatedNotePurchaseAgreementMember
STAF:JacksonInvestmentGroupLLCMember us-gaap:SubsequentEventMember
2022-10-27 0001499717 STAF:SeriesEOnePreferredStockMember
2021-10-31 0001499717 STAF:SeriesEOnePreferredStockMember
2021-10-02 0001499717 us-gaap:SeriesEPreferredStockMember
2021-10-02 0001499717 us-gaap:SeriesEPreferredStockMember
2021-05-01 2021-05-02 0001499717 STAF:HSBCBankMember 2022-07-02
0001499717 us-gaap:SeriesHPreferredStockMember STAF:HeadwayMember
2022-05-18 0001499717 us-gaap:SeriesHPreferredStockMember
2022-05-18 0001499717 us-gaap:SeriesHPreferredStockMember
us-gaap:CommonStockMember 2022-05-18 0001499717
us-gaap:SeriesHPreferredStockMember 2022-05-01 2022-05-18
0001499717 us-gaap:SeriesHPreferredStockMember 2022-07-02
0001499717 us-gaap:SeriesHPreferredStockMember 2022-05-17
2022-05-18 0001499717 us-gaap:AccountingStandardsUpdate201811Member
2022-01-01 0001499717 us-gaap:AccountingStandardsUpdate201811Member
2021-01-01 0001499717 STAF:NewLeaseAgreementMember 2021-09-30
0001499717 us-gaap:AccountingStandardsUpdate201811Member 2022-10-01
0001499717 us-gaap:AccountingStandardsUpdate201811Member 2021-01-02
0001499717 2022-04-30 0001499717 2022-05-31 0001499717
us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-03
2022-01-01 0001499717
us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-03
2022-10-01 0001499717 STAF:EquityRaiseMember 2019-12-29 2021-01-02
0001499717 STAF:EquityRaiseMember srt:MinimumMember 2021-01-02
0001499717 STAF:EquityRaiseMember srt:MaximumMember 2021-01-02
0001499717 STAF:BoardAndCommitteeMember 2019-12-29 2021-01-02
0001499717 STAF:BoardAndCommitteeMember srt:MinimumMember
2021-01-02 0001499717 STAF:BoardAndCommitteeMember
srt:MaximumMember 2021-01-02 0001499717
STAF:LongTermIncentivePlanMember 2019-12-29 2021-01-02 0001499717
STAF:LongTermIncentivePlanMember srt:MinimumMember 2021-01-02
0001499717 STAF:LongTermIncentivePlanMember srt:MaximumMember
2021-01-02 0001499717 STAF:ConsultantsMember 2019-12-29 2021-01-02
0001499717 STAF:ConsultantsMember srt:MinimumMember 2021-01-02
0001499717 STAF:ConsultantsMember srt:MaximumMember 2021-01-02
0001499717 STAF:EmployeesMember 2019-12-29 2021-01-02 0001499717
STAF:EmployeesMember srt:MinimumMember 2021-01-02 0001499717
STAF:EmployeesMember srt:MaximumMember 2021-01-02 0001499717
STAF:ConversionOfSeriesFMember 2019-12-29 2021-01-02 0001499717
STAF:ConversionOfSeriesFMember srt:MinimumMember 2021-01-02
0001499717 STAF:ConversionOfSeriesFMember srt:MaximumMember
2021-01-02 0001499717 STAF:ConversionOfSeriesAMember 2019-12-29
2021-01-02 0001499717 STAF:ConversionOfSeriesAMember
srt:MinimumMember 2021-01-02 0001499717
STAF:ConversionOfSeriesAMember srt:MaximumMember 2021-01-02
0001499717 STAF:EquityRaiseMember 2021-01-03 2022-01-01 0001499717
STAF:EquityRaiseMember srt:MinimumMember 2022-01-01 0001499717
STAF:EquityRaiseMember srt:MaximumMember 2022-01-01 0001499717
STAF:ConsultantsMember 2021-01-03 2022-01-01 0001499717
STAF:ConsultantsMember srt:MinimumMember 2022-01-01 0001499717
STAF:ConsultantsMember srt:MaximumMember 2022-01-01 0001499717
STAF:ConversionOfSeriesAMember 2021-01-03 2022-01-01 0001499717
STAF:ConversionOfSeriesAMember srt:MinimumMember 2022-01-01
0001499717 STAF:ConversionOfSeriesAMember srt:MaximumMember
2022-01-01 0001499717 STAF:BoardAndCommitteeMember 2021-01-03
2022-01-01 0001499717 STAF:BoardAndCommitteeMember
srt:MinimumMember 2022-01-01 0001499717
STAF:BoardAndCommitteeMember srt:MaximumMember 2022-01-01
0001499717 STAF:JacksonInvestmentGroupLLCMember 2021-01-03
2022-01-01 0001499717 STAF:JacksonInvestmentGroupLLCMember
srt:MinimumMember 2022-01-01 0001499717
STAF:JacksonInvestmentGroupLLCMember srt:MaximumMember 2022-01-01
0001499717 STAF:EquityRaiseMember 2022-01-02 2022-10-01 0001499717
STAF:EquityRaiseMember srt:MinimumMember 2022-10-01 0001499717
STAF:EquityRaiseMember srt:MaximumMember 2022-10-01 0001499717
STAF:BoardAndCommitteeMembersMember 2022-01-02 2022-10-01
0001499717 STAF:BoardAndCommitteeMembersMember srt:MinimumMember
2022-10-01 0001499717 STAF:BoardAndCommitteeMembersMember
srt:MaximumMember 2022-10-01 0001499717 STAF:ConsultantMember
2022-01-02 2022-10-01 0001499717 STAF:ConsultantMember
srt:MinimumMember 2022-10-01 0001499717 STAF:ConsultantMember
srt:MaximumMember 2022-10-01 0001499717 STAF:EquityRaiseMember
2021-01-03 2021-10-02 0001499717 STAF:EquityRaiseMember
srt:MinimumMember 2021-10-02 0001499717 STAF:EquityRaiseMember
srt:MaximumMember 2021-10-02 0001499717
STAF:ConversionOfSeriesFPreferredStockMember 2021-01-03 2021-10-02
0001499717 STAF:ConversionOfSeriesFPreferredStockMember
srt:MinimumMember 2021-10-02 0001499717
STAF:ConversionOfSeriesFPreferredStockMember srt:MaximumMember
2021-10-02 0001499717 STAF:ConsultantMember 2022-01-03 2022-10-02
0001499717 STAF:ConsultantMember srt:MinimumMember 2022-10-02
0001499717 STAF:BoardAndCommitteeMembersMember srt:MaximumMember
2022-10-02 0001499717 STAF:ConversionOfSeriesAPreferredStockMember
2021-01-03 2021-10-02 0001499717
STAF:ConversionOfSeriesAPreferredStockMember srt:MinimumMember
2021-10-02 0001499717 STAF:ConversionOfSeriesAPreferredStockMember
srt:MaximumMember 2021-10-02 0001499717 STAF:EmployeesMember
2021-01-03 2021-10-02 0001499717 STAF:EmployeesMember
srt:MinimumMember 2021-10-02 0001499717 STAF:EmployeesMember
srt:MaximumMember 2021-10-02 0001499717
STAF:BoardAndCommitteeMembersMember 2021-01-03 2021-10-02
0001499717 STAF:BoardAndCommitteeMembersMember srt:MinimumMember
2021-10-02 0001499717 STAF:BoardAndCommitteeMembersMember
srt:MaximumMember 2021-10-02 0001499717
STAF:LongTermIncentivePlanMember 2021-01-03 2021-10-02 0001499717
STAF:LongTermIncentivePlanMember srt:MinimumMember 2021-10-02
0001499717 2021-12-27 0001499717 2021-12-26 0001499717
STAF:PublicOfferingMember 2021-02-08 2021-02-09 0001499717
STAF:PublicOfferingMember 2021-02-09 0001499717
us-gaap:CommonStockMember STAF:PublicOfferingMember 2021-02-11
2021-02-12 0001499717 STAF:PublicOfferingMember
STAF:PreFundedWarrantsMember 2021-02-11 2021-02-12 0001499717
STAF:PublicOfferingMember STAF:PreFundedWarrantsMember 2021-02-12
0001499717 STAF:PublicOfferingMember 2021-02-04 2021-02-05
0001499717 STAF:PublicOfferingMember STAF:JacksonNoteMember
us-gaap:SeriesEPreferredStockMember 2021-02-04 2021-02-05
0001499717 STAF:PublicOfferingMember
us-gaap:SeriesEPreferredStockMember 2021-02-04 2021-02-05
0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:CertainInstitutionalAndAccreditedInvestorsMember
STAF:SeriesFConvertiblePreferredStockMember 2021-04-20 2021-04-21
0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:CertainInstitutionalAndAccreditedInvestorsMember
STAF:SeriesFConvertiblePreferredStockMember 2021-04-21 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:CertainInstitutionalAndAccreditedInvestorsMember 2021-04-21
0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SeriesFPreferredStocksMember 2021-04-20 2021-04-21 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SeriesFPreferredStocksMember 2021-04-21 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SeriesFPreferredStocksMember 2021-06-29 2021-06-30 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SecondAmendedAndRestatedTwelvePercentageSeniorSecuredNoteMember
2021-04-20 2021-04-21 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
us-gaap:SeriesFPreferredStockMember 2021-04-20 2021-04-21
0001499717 STAF:SeriesFPreferredStocksMember 2021-04-21 0001499717
us-gaap:SeriesFPreferredStockMember 2022-01-01 0001499717
STAF:ExchangeAgreementMember STAF:JacksonInvestmentGroupLLCMember
us-gaap:SeriesGPreferredStockMember 2021-05-05 2021-05-06
0001499717 STAF:ExchangeAgreementMember
STAF:JacksonInvestmentGroupLLCMember
STAF:SeriesGConvertiblePreferredStockMember 2021-05-05 2021-05-06
0001499717 STAF:RegisteredDirectOfferingMember
STAF:SecuritiesPurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-07-19 2021-07-20 0001499717
STAF:RegisteredDirectOfferingMember
STAF:SecuritiesPurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-07-20 0001499717
STAF:RegisteredDirectOfferingMember 2021-07-19 2021-07-20
0001499717 STAF:TwelvePercentageSeniorSecuredNoteMember 2021-07-20
0001499717 STAF:EngagementLetterMember
STAF:HCWainwrightAndCompanyLLCMember 2020-12-21 0001499717
STAF:EngagementLetterMember STAF:HCWainwrightAndCompanyLLCMember
2020-12-19 2020-12-21 0001499717 2021-07-16 2021-07-22 0001499717
us-gaap:SeriesGPreferredStockMember 2021-07-19 2021-07-21
0001499717 STAF:SeriesG1PreferredStockMember 2021-07-19 2021-07-21
0001499717 us-gaap:SeriesGPreferredStockMember 2021-07-21
0001499717 STAF:SeriesGOnePreferredStockMember 2021-07-21
0001499717 STAF:RegisteredDirectOfferingMember
STAF:FirstAugustTwoThousandTwentyOneSecuritiesPurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-08-04 2021-08-05 0001499717
STAF:RegisteredDirectOfferingMember
STAF:FirstAugustTwoThousandTwentyOneSecuritiesPurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-08-05 0001499717
STAF:EngagementLetterMember STAF:HCWainwrightAndCompanyLLCMember
2020-08-04 2020-08-05 0001499717 STAF:EngagementLetterMember
STAF:HCWainwrightAndCompanyLLCMember 2021-08-04 2021-08-05
0001499717 STAF:EngagementLetterMember
STAF:HCWainwrightAndCompanyLLCMember 2021-08-05 0001499717
STAF:EngagementLetterMember STAF:HCWainwrightAndCompanyLLCMember
2021-08-09 0001499717
STAF:AugustTwoThousandTwentyOneOfferingsMember 2021-08-08
2021-08-09 0001499717
STAF:AugustTwoThousandTwentyOnePurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-08-21 2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOnePurchaseAgreementMember
STAF:InstitutionalInvestorsMember 2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOneOfferingsMember
STAF:InstitutionalInvestorsMember 2021-08-21 2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOneWarrantsMember
STAF:InstitutionalInvestorsMember 2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOneOfferingsMember 2021-08-21
2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOneWainwrightWarrantsMember 2021-08-22
0001499717 STAF:EngagementLetterMember
STAF:HCWainwrightAndCompanyLLCMember 2021-08-22 0001499717
STAF:AugustTwoThousandTwentyOneWarrantsMember 2021-08-22 0001499717
STAF:SecuritiesPurchaseAgreementMember 2021-10-27 2021-10-28
0001499717 STAF:SecuritiesPurchaseAgreementMember 2021-10-28
0001499717 STAF:SecuritiesPurchaseAgreementMember
us-gaap:WarrantMember 2021-10-28 0001499717
STAF:SecuritiesPurchaseAgreementMember STAF:PrefundedWarrantMember
2021-10-28 0001499717 STAF:SecuritiesPurchaseAgreementMember
us-gaap:PrivatePlacementMember 2021-10-27 2021-10-28 0001499717
STAF:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember
us-gaap:PrivatePlacementMember 2021-10-27 2021-10-28 0001499717
STAF:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember
us-gaap:PrivatePlacementMember 2021-10-28 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SecondAmendedAndRestatedTwelvePercentageSeniorSecuredNoteMember
2021-01-03 2021-10-02 0001499717 STAF:RestrictedStocksMember
2021-01-03 2022-01-01 0001499717 STAF:RestrictedStocksMember
2019-12-29 2021-01-02 0001499717 STAF:DesignatedSharesMember
us-gaap:SeriesAPreferredStockMember 2015-05-29 0001499717
STAF:SeriesAPreferredStockRelatedPartyMember 2017-06-15 0001499717
STAF:SeriesAPreferredStockRelatedPartyMember 2017-06-14 2017-06-15
0001499717 STAF:SeriesAPreferredStockRelatedPartyMember 2021-01-03
2021-10-02 0001499717 STAF:SeriesAPreferredStockRelatedPartyMember
2021-01-02 0001499717 STAF:SeriesAPreferredStockRelatedPartyMember
2019-12-29 2021-01-02 0001499717
us-gaap:SeriesAPreferredStockMember 2015-05-29 0001499717
STAF:ConversionOfSeriesAMember 2020-01-20 2020-01-21 0001499717
us-gaap:SeriesAPreferredStockMember 2021-01-08 0001499717
us-gaap:SeriesEPreferredStockMember srt:MaximumMember 2019-12-29
2021-01-02 0001499717 2019-01-21 2019-01-22 0001499717
STAF:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember
2019-02-07 2019-02-08 0001499717
STAF:UnderwrittenPublicOfferingMember us-gaap:CommonStockMember
2019-02-08 0001499717 us-gaap:SeriesEPreferredStockMember
2020-10-22 2020-10-23 0001499717
us-gaap:SeriesEPreferredStockMember srt:MaximumMember 2020-10-22
2020-10-23 0001499717 us-gaap:SeriesEPreferredStockMember
srt:MinimumMember 2020-10-22 2020-10-23 0001499717
STAF:SeriesEOnePreferredStocksMember 2020-10-23 0001499717
STAF:SeriesEPreferredStocksMember 2020-10-23 0001499717
us-gaap:SeriesEPreferredStockMember 2020-09-28 0001499717
STAF:SeriesEConvertiblePreferredStockMember 2021-05-06 0001499717
STAF:SeriesEOneConvertiblePreferredStockMember 2021-05-06
0001499717 STAF:SeriesEConvertiblePreferredStockMember 2022-01-01
0001499717 STAF:SeriesEOneonvertiblePreferredStockMember 2022-01-01
0001499717 STAF:SeriesGConvertiblePreferredStockMember 2021-07-19
2021-07-21 0001499717
STAF:SeriesGOneConvertiblePreferredStockMember 2021-07-19
2021-07-21 0001499717
STAF:SeriesGConvertiblePreferredStockAndSeriesGOneConvertiblePreferredStockMember
2021-07-19 2021-07-21 0001499717
STAF:SeriesGConvertiblePreferredStockMember
STAF:JacksonInvestmentGroupLLCMember 2021-07-19 2021-07-21
0001499717 STAF:SeriesGOneConvertiblePreferredStockMember
STAF:JacksonInvestmentGroupLLCMember 2021-07-19 2021-07-21
0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2020-12-29 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2020-12-25 2020-12-29 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2020-12-31 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2020-12-27 2020-12-31 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-02-09 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-02-08 2021-02-09 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-04-21 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-04-18 2021-04-21 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-07-20 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-07-19 2021-07-20 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-08-05 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-08-04 2021-08-05 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-08-22 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-08-21 2021-08-22 0001499717 STAF:UnderwritingAgreementMember
STAF:HCWainwrightAndCoLLCMember 2021-10-28 0001499717
STAF:UnderwritingAgreementMember STAF:HCWainwrightAndCoLLCMember
2021-10-27 2021-10-28 0001499717 STAF:EquityIncentivePlanMember
2014-01-28 0001499717 STAF:EquityIncentivePlanMember 2014-01-27
2014-01-28 0001499717 STAF:EquityIncentivePlanMember 2018-12-30
2019-12-28 0001499717
STAF:TwoThousandFifteenOmnibusIncentivePlanMember 2019-12-28
0001499717 STAF:TwoThousandFifteenOmnibusIncentivePlanMember
2018-12-30 2019-12-28 0001499717
STAF:TwoThousandFifteenOmnibusIncentivePlanMember 2019-12-29
2021-01-02 0001499717 STAF:OmnibusIncentivePlanMember 2017-01-26
0001499717 STAF:OmnibusIncentivePlanMember 2018-05-30 0001499717
STAF:OmnibusIncentivePlanMember 2019-12-29 2021-01-02 0001499717
STAF:OmnibusIncentivePlanMember 2021-01-02 0001499717
STAF:OmnibusIncentivePlanMember 2021-01-03 2022-01-01 0001499717
STAF:OmnibusIncentivePlanMember 2019-12-29 2020-01-02 0001499717
STAF:OmnibusIncentivePlanMember 2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember 2019-01-01
2019-01-31 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember 2021-01-07
2021-01-08 0001499717
STAF:TwoThousandTwentyOmnibusIncentivePlanMember 2021-01-03
2022-01-01 0001499717
STAF:TwoThousandTwentyOmnibusIncentivePlanMember 2019-12-29
2021-01-02 0001499717
STAF:TwoThousandTwentyOmnibusIncentivePlanMember 2020-06-28
2020-06-30 0001499717
STAF:TwoThousandTwentyOmnibusIncentivePlanMember 2022-01-01
0001499717 STAF:TwoThousandTwentyOneOmnibusIncentivePlanMember
2021-10-13 2021-10-14 0001499717
STAF:TwoThousandTwentyOneOmnibusIncentivePlanMember 2021-12-25
2021-12-27 0001499717
STAF:TwoThousandTwentyOneOmnibusIncentivePlanMember 2021-12-27
0001499717 us-gaap:SeriesAPreferredStockMember 2022-01-03
2022-10-02 0001499717 STAF:SeriesJPreferredStockMember 2022-05-03
0001499717 STAF:StockPurchaseAgreementMember
STAF:SeriesJPreferredStockMember 2022-05-02 2022-05-03 0001499717
STAF:SeriesJPreferredStockMember 2022-07-02 0001499717
STAF:SeriesJPreferredStockMember 2022-04-03 2022-07-02 0001499717
STAF:AprilTwentyTwentyOneSecuritiesPurchaseAgreementMember
STAF:SecondAmendedAndRestatedTwelvePercentageSeniorSecuredNoteMember
2022-01-02 2022-10-01 0001499717 STAF:RestrictedStocksMember
2022-07-03 2022-10-01 0001499717 STAF:RestrictedStocksMember
2021-07-04 2021-10-02 0001499717 STAF:RestrictedStocksMember
2022-01-02 2022-10-01 0001499717 STAF:RestrictedStocksMember
2021-01-03 2021-10-02 0001499717
STAF:WarrantPurchaseAgreementMember
STAF:NineExistingParticipatingInvestorsMember 2022-07-07 0001499717
STAF:WarrantPurchaseAgreementMember srt:MinimumMember 2022-07-07
0001499717 STAF:WarrantPurchaseAgreementMember srt:MaximumMember
2022-07-07 0001499717 STAF:WarrantPurchaseAgreementMember
2022-07-06 2022-07-07 0001499717
STAF:AmendedWarrantAgreementsMember 2022-07-07 0001499717
STAF:AmendedWarrantAgreementsMember 2022-07-06 2022-07-07
0001499717 STAF:OmnibusIncentivePlanMember 2022-07-03 2022-10-01
0001499717 STAF:OmnibusIncentivePlanMember 2022-01-02 2022-10-01
0001499717 STAF:OmnibusIncentivePlanMember 2021-07-04 2021-10-02
0001499717 STAF:OmnibusIncentivePlanMember 2021-01-03 2021-10-02
0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
2021-01-02 0001499717
srt:RevisionOfPriorPeriodReclassificationAdjustmentMember
2021-01-03 2022-01-01 0001499717 srt:MinimumMember 2022-01-01
0001499717 srt:MaximumMember 2022-01-01 0001499717
srt:MinimumMember 2022-10-01 0001499717 srt:MaximumMember
2022-10-01 0001499717 STAF:IncentivePlansMember 2019-12-28
0001499717 STAF:IncentivePlansMember 2019-12-29 2021-01-02
0001499717 STAF:IncentivePlansMember 2021-01-02 0001499717
STAF:IncentivePlansMember 2021-01-03 2022-01-01 0001499717
STAF:IncentivePlansMember 2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
srt:MinimumMember 2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-03
2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
srt:MaximumMember 2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-03
2022-01-01 0001499717
STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01
0001499717 STAF:TwoThousandNinteenLongTermIncentivePlanMember
us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-01-03
2022-01-01 0001499717 STAF:TheFloodEmploymentAgreementMember
STAF:MrBrendanFloodMember STAF:GBPPoundMember 2014-01-02 2014-01-03
0001499717 STAF:TheFloodEmploymentAgreementMember
STAF:MrBrendanFloodMember 2014-01-03 0001499717
STAF:TheFloodEmploymentAgreementMember STAF:MrBrendanFloodMember
2014-01-02 2014-01-03 0001499717
STAF:TheFloodEmploymentAgreementMember
us-gaap:SeriesAPreferredStockMember 2015-05-27 2015-05-29
0001499717 STAF:TheFloodEmploymentAgreementMember
us-gaap:SeriesAPreferredStockMember 2021-01-06 2021-01-08
0001499717 STAF:TheFloodEmploymentAgreementMember
STAF:MrBrendanFloodMember 2019-12-29 2020-01-01 0001499717
STAF:TheBarkerEmploymentAgreementMember STAF:AliciaBarkerMember
2018-07-01 2018-07-02 0001499717
STAF:TheBarkerEmploymentAgreementMember STAF:AliciaBarkerMember
2020-12-30 2021-01-02 0001499717
STAF:TheAnwarEmploymentAgreementMember STAF:MrAnwarMember
2020-06-26 2020-06-29 0001499717
STAF:BusinessCombinationEarnoutConsiderationPreponeDateMember
2018-08-27 0001499717
STAF:BusinessCombinationEarnoutConsiderationPreponeDateMember
2019-09-11 0001499717 STAF:KeyResourcesIncMember 2019-09-29
2019-09-30 0001499717
STAF:BusinessCombinationEarnoutConsiderationPreponeDateMember
2020-08-27 0001499717 STAF:KeyResourcesIncMember
STAF:SharePurchaseAgreementMember 2020-02-01 2020-02-29 0001499717
STAF:KeyResourcesIncMember STAF:SharePurchaseAgreementMember
2020-09-23 2020-09-26 0001499717 STAF:LeaseObligationsMember
2022-01-01 0001499717 STAF:LeaseObligationsMember 2021-01-03
2022-01-01 0001499717 STAF:LeaseObligationsMember 2019-12-29
2021-01-02 0001499717 STAF:NewYorkActionMember
STAF:PamelaDWhitakerMember 2021-01-03 2022-01-01 0001499717
2020-02-25 2020-02-26 0001499717
STAF:HeadwayWorkforceSolutionsMember 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember
STAF:ContingentPaymentOneMember 2022-05-17 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember
STAF:ContingentPaymentTwoMember 2022-05-17 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember
STAF:ContingentPaymentThreeMember 2022-05-17 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember
STAF:ContingentPaymentFourMember 2022-05-17 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember
STAF:ContingentPaymentFiveMember 2022-05-17 2022-05-18 0001499717
STAF:HeadwayWorkforceSolutionsMember srt:ScenarioForecastMember
2023-04-01 2023-04-30 0001499717
STAF:HeadwayWorkforceSolutionsMember 2022-05-17 2022-05-18
0001499717 STAF:RetentionBonusMember 2022-10-01 0001499717
STAF:NewYorkActionMember STAF:PamelaDWhitakerMember 2022-01-02
2022-10-01 0001499717 STAF:NewYorkActionMember
STAF:PamelaDWhitakerMember STAF:HeadwayWorkforceSolutionsMember
2022-10-01 0001499717 2022-09-29 2022-09-30 0001499717
STAF:CommercialStaffingUSMember country:US 2021-01-03 2022-01-01
0001499717 STAF:CommercialStaffingUSMember country:US 2019-12-29
2021-01-02 0001499717 STAF:ProfessionalStaffingUSMember country:US
2021-01-03 2022-01-01 0001499717 STAF:ProfessionalStaffingUSMember
country:US 2019-12-29 2021-01-02 0001499717
STAF:ProfessionalStaffingUKMember country:GB 2021-01-03 2022-01-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB 2019-12-29
2021-01-02 0001499717 country:US 2021-01-03 2022-01-01 0001499717
country:US 2019-12-29 2021-01-02 0001499717 country:GB 2021-01-03
2022-01-01 0001499717 country:GB 2019-12-29 2021-01-02 0001499717
country:US 2022-01-01 0001499717 country:US 2021-01-02 0001499717
country:GB 2022-01-01 0001499717 country:GB 2021-01-02 0001499717
STAF:CommercialStaffingUSMember country:US 2022-07-03 2022-10-01
0001499717 STAF:CommercialStaffingUSMember country:US 2021-07-04
2021-10-02 0001499717 STAF:CommercialStaffingUSMember country:US
2022-01-02 2022-10-01 0001499717 STAF:CommercialStaffingUSMember
country:US 2021-01-03 2021-10-02 0001499717
STAF:ProfessionalStaffingUSMember country:US 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUSMember country:US 2021-07-04
2021-10-02 0001499717 STAF:ProfessionalStaffingUSMember country:US
2022-01-02 2022-10-01 0001499717 STAF:ProfessionalStaffingUSMember
country:US 2021-01-03 2021-10-02 0001499717
STAF:ProfessionalStaffingUKMember country:GB 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB 2021-07-04
2021-10-02 0001499717 STAF:ProfessionalStaffingUKMember country:GB
2022-01-02 2022-10-01 0001499717 STAF:ProfessionalStaffingUKMember
country:GB 2021-01-03 2021-10-02 0001499717
STAF:CommercialStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:PermanentPlacementRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:PermanentPlacementRevenueMember 2022-07-03
2022-10-01 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:TemporaryContractorRevenueMember 2022-07-03 2022-10-01
0001499717 STAF:TemporaryContractorRevenueMember 2022-07-03
2022-10-01 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:PermanentPlacementRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:PermanentPlacementRevenueMember 2021-07-04
2021-10-02 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:TemporaryContractorRevenueMember 2021-07-04 2021-10-02
0001499717 STAF:TemporaryContractorRevenueMember 2021-07-04
2021-10-02 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:PermanentPlacementRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:PermanentPlacementRevenueMember 2022-01-02
2022-10-01 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:TemporaryContractorRevenueMember 2022-01-02 2022-10-01
0001499717 STAF:TemporaryContractorRevenueMember 2022-01-02
2022-10-01 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:PermanentPlacementRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:PermanentPlacementRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:PermanentPlacementRevenueMember 2021-01-03
2021-10-02 0001499717 STAF:CommercialStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:ProfessionalStaffingUSMember country:US
STAF:TemporaryContractorRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:ProfessionalStaffingUKMember country:GB
STAF:TemporaryContractorRevenueMember 2021-01-03 2021-10-02
0001499717 STAF:TemporaryContractorRevenueMember 2021-01-03
2021-10-02 0001499717 country:US 2022-10-01 0001499717 country:GB
2022-10-01 0001499717
STAF:DimitriVillardCorporateGovernanceAndNominatingCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2022-01-01 0001499717
STAF:JeffGroutCompensationCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2022-01-01 0001499717
STAF:NickFlorioAuditCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2022-01-01 0001499717
STAF:VincentCebulaMember STAF:BoardAndCommitteeMember 2021-01-03
2022-01-01 0001499717 STAF:AliciaBarkerMember
STAF:BoardAndCommitteeMember 2021-01-03 2022-01-01 0001499717
STAF:DimitriVillardCorporateGovernanceAndNominatingCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2019-12-29 2021-01-02 0001499717
STAF:JeffGroutCompensationCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2019-12-29 2021-01-02 0001499717
STAF:NickFlorioAuditCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2019-12-29 2021-01-02 0001499717
STAF:AliciaBarkerMember STAF:BoardAndCommitteeMember 2019-12-29
2021-01-02 0001499717
STAF:DimitriVillardCorporateGovernanceAndNominatingCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2022-01-02 2022-10-01 0001499717
STAF:JeffGroutCompensationCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2022-01-02 2022-10-01 0001499717
STAF:NickFlorioAuditCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2022-01-02 2022-10-01 0001499717
STAF:VincentCebulaMember STAF:BoardAndCommitteeMember 2022-01-02
2022-10-01 0001499717 STAF:AliciaBarkerMember
STAF:BoardAndCommitteeMember 2022-01-02 2022-10-01 0001499717
STAF:BoardAndCommitteeMember 2022-01-02 2022-10-01 0001499717
STAF:DimitriVillardCorporateGovernanceAndNominatingCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2021-10-02 0001499717
STAF:JeffGroutCompensationCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2021-10-02 0001499717
STAF:NickFlorioAuditCommitteeChairmanMember
STAF:BoardAndCommitteeMember 2021-01-03 2021-10-02 0001499717
STAF:VincentCebulaMember STAF:BoardAndCommitteeMember 2021-01-03
2021-10-02 0001499717 STAF:AliciaBarkerMember
STAF:BoardAndCommitteeMember 2021-01-03 2021-10-02 0001499717
STAF:BoardAndCommitteeMember 2021-01-03 2021-10-02 0001499717
us-gaap:DomesticCountryMember 2021-01-02 0001499717
us-gaap:DomesticCountryMember 2019-12-28 0001499717
us-gaap:DomesticCountryMember
STAF:ExpirationInTwoThousandAndThirtyTwoMember 2021-01-02
0001499717 us-gaap:DomesticCountryMember 2019-12-29 2021-01-02
0001499717 us-gaap:DomesticCountryMember
STAF:LimitationOnTaxableIncomeMember 2021-01-02 0001499717
us-gaap:StateAndLocalJurisdictionMember 2022-01-01 0001499717
us-gaap:StateAndLocalJurisdictionMember 2021-01-02 0001499717
us-gaap:StateAndLocalJurisdictionMember 2021-01-03 2022-01-01
0001499717 us-gaap:ForeignCountryMember 2022-01-01 0001499717
us-gaap:ForeignCountryMember 2021-01-02 0001499717 2020-01-02
0001499717 us-gaap:SubsequentEventMember 2022-06-22 2022-06-23
0001499717 us-gaap:SubsequentEventMember
STAF:StockPurchaseAgreementMember 2022-04-17 2022-04-18 0001499717
us-gaap:SubsequentEventMember
STAF:SeriesHConvertiblePreferredStockMember
STAF:StockPurchaseAgreementMember 2022-04-17 2022-04-18 0001499717
us-gaap:SubsequentEventMember
STAF:SeriesHConvertiblePreferredStockMember
STAF:StockPurchaseAgreementMember 2022-05-17 2022-05-18 0001499717
us-gaap:SubsequentEventMember
STAF:SeriesHConvertiblePreferredStockMember
STAF:StockPurchaseAgreementMember 2022-05-18 0001499717
us-gaap:SubsequentEventMember STAF:StockPurchaseAgreementMember
2022-05-02 2022-05-03 0001499717
STAF:ThirdAmendedAndRestatedNotePurchaseAgreementMember
STAF:JacksonInvestmentGroupLLCMember us-gaap:SubsequentEventMember
2022-10-25 2022-10-27 0001499717
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCMember us-gaap:SubsequentEventMember
2022-10-25 2022-10-27 0001499717
STAF:AmendedAndRestatedWarrantAgreementMember
STAF:JacksonInvestmentGroupLLCMember us-gaap:SubsequentEventMember
2022-10-27 0001499717 STAF:ExistingWarrantMember
STAF:JacksonInvestmentGroupLLCMember us-gaap:SubsequentEventMember
2022-10-27 0001499717 STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember us-gaap:SubsequentEventMember
2022-10-26 0001499717 STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember us-gaap:SubsequentEventMember
2022-10-27 0001499717 STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember us-gaap:SubsequentEventMember
2022-10-25 2022-10-27 0001499717
STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember STAF:TranchesMember
srt:MaximumMember us-gaap:SubsequentEventMember 2022-10-27
0001499717 STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember STAF:TranchesMember
srt:MinimumMember us-gaap:SubsequentEventMember 2022-10-27
0001499717 STAF:CreditAndSecurityAgreementMember
STAF:MidCapFundingIVTrustMember STAF:TranchesMember
us-gaap:SubsequentEventMember 2022-10-25 2022-10-27 0001499717
STAF:ThirdAmendedAndRestatedNotePurchaseAgreementMember
STAF:JacksonAndMidCapMember us-gaap:SubsequentEventMember
2022-10-25 2022-10-27 0001499717 STAF:StockPurchaseAgreementMember
2022-04-17 2022-04-18 0001499717 STAF:StockPurchaseAgreementMember
STAF:SeriesHConvertiblePreferredStockMember 2022-05-17 2022-05-18
0001499717 STAF:StockPurchaseAgreementMember
STAF:SeriesHConvertiblePreferredStockMember 2022-05-18 0001499717
STAF:StockPurchaseAgreementMember
STAF:SeriesHConvertiblePreferredStockMember 2022-04-17 2022-04-18
0001499717 STAF:StockPurchaseAgreementMember
STAF:SeriesHConvertiblePreferredStockMember
STAF:HeadwayWorkforceSolutionsMember 2022-04-17 2022-04-18
0001499717 STAF:HeadwayWorkforceSolutionsMember 2022-10-01
0001499717 STAF:HeadwayWorkforceSolutionsMember 2022-01-02
2022-10-01 0001499717 STAF:HeadwayWorkforceSolutionsMember
2022-10-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
xbrli:pure iso4217:GBP
As
filed with the Securities and Exchange Commission on January 19,
2023
Registration
No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-1
REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933
STAFFING 360 SOLUTIONS, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
7363 |
|
68-0680859 |
(State
or other jurisdiction
of
incorporation or organization)
|
|
(Primary
Standard Industrial
Classification
Code Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
757
3rd Avenue
27th Floor
New York,
NY
10017
(646)
507-5710
(Address,
including zip code, and telephone number, including area code, of
registrant’s principal executive offices)
Brendan
Flood
Chairman
and Chief Executive Officer
Staffing
360 Solutions, Inc.
757
3rd Avenue, 27th Floor
New
York, New York 10017
(646)
507-5710
(Name,
address, including zip code, and telephone number, including area
code, of agent for service)
Copies to:
Rick
A. Werner, Esq.
Rosebud
Nau, Esq.
Haynes
and Boone, LLP
30
Rockefeller Plaza, 26th Floor
New
York, New York 10112
(212)
659-7300
|
Gregory Sichenzia, Esq.
Sichenzia Ross Ference LLP
1185 Avenue of the Americas
New York, New York 10036
(212) 930-9700
|
Approximate
date of commencement of proposed sale to the public: As soon as
practicable after this registration statement is declared
effective.
If
any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following box: ☒
If
this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same offering.
☐
If
this Form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same offering.
☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer |
☐ |
|
Accelerated
filer |
☐ |
|
|
|
|
|
Non-accelerated filer |
☒ |
|
Smaller
reporting company |
☒ |
|
|
|
|
|
|
|
|
Emerging
growth company |
☐ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The
registrant hereby amends this registration statement on such date
or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states
that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or
until this registration statement shall become effective on such
date as the Commission, acting pursuant to said Section 8(a), may
determine.
The
information in this preliminary prospectus is not complete and may
be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is
effective. This preliminary prospectus is not an offer to sell nor
does it seek an offer to buy these securities in any jurisdiction
where the offer or sale is not permitted.
Subject
to Completion, dated January 19, 2023
Preliminary
Prospectus

Staffing 360 Solutions, Inc.
Up
to
Units,
Each Unit Consisting of One Share of Common Stock and One Common
Warrant to Purchase One Share of Common Stock
Up
to
Pre-Funded
Units, Each Pre-Funded Unit Consisting of One Pre-Funded Warrant to
Purchase One Share of Common Stock and One Common Warrant to
Purchase One Share of Common Stock
Common
Stock Underlying the Pre-Funded Warrants
Common
Stock Underlying the Common Warrants
Placement
Agent Warrants to Purchase up to
Shares
of Common Stock
Shares
of Common Stock Underlying the Placement Agent
Warrants
We
are offering up to
units, each
unit consisting of one share of common stock and one common warrant
to purchase one share of common stock, pursuant to this prospectus.
The offering price of the unit is
$
per unit. The common warrants included in the units will have an
exercise price of $
per
share, will be exercisable immediately upon issuance and will
expire five (5) years from the date of issuance. We are also
offering the shares of our common stock that are issuable from time
to time upon the exercise of the common warrants included in the
units.
We
are also offering to certain purchasers whose purchase of units in
this offering would otherwise result in the purchaser, together
with its affiliates and certain related parties, beneficially
owning more than 4.99% (or, at the election of the purchaser,
9.99%) of our outstanding common stock immediately following the
consummation of this offering, the opportunity to purchase, if any
such purchaser so chooses, pre-funded units, each pre-funded unit
consisting of one pre-funded warrant to purchase one share of
common stock and one common warrant to purchase one share of common
stock, in lieu of units that would otherwise result in such
purchaser’s beneficial ownership exceeding 4.99% (or, at the
election of the purchaser, 9.99%) of our outstanding common stock.
The purchase price of each pre-funded unit will be equal to the
price per unit being sold to the public in this offering, minus
$0.001, and the exercise price of each pre-funded warrant included
in the pre-funded units will be $0.001 per share. The pre-funded
warrants will be exercisable immediately upon issuance and may be
exercised at any time until all of the pre-funded warrants are
exercised in full. Each common warrant included in the pre-funded
units has an exercise price of $_________ per share, will be
exercisable immediately upon issuance and will expire five (5)
years from the date of issuance. For each pre-funded unit we sell,
the number of shares of common stock we are offering will be
decreased on a one-for-one basis. This offering also relates to the
shares of common stock issuable upon the exercise of the pre-funded
warrants and the common warrants included in the pre-funded
units.
The
units and the pre-funded units will not be issued or certificated.
The shares of common stock or pre-funded warrants, as the case may
be, and the common warrants included in the units or the pre-funded
units, can only be purchased together in this offering, but the
securities contained in the units or pre-funded units will be
issued separately and will be immediately separable upon
issuance.
This
offering will terminate on _____, 2023 unless we decide to
terminate the offering (which we may do at any time in our
discretion) prior to that date. We will have one closing for all
the securities purchased in this offering. The combined public
offering price per unit (or pre-funded unit) will be fixed for the
duration of this offering.
We
have engaged H.C. Wainwright & Co., LLC, or the placement agent
or Wainwright, to act as our exclusive placement agent in
connection with this offering. The placement agent has agreed to
use its reasonable best efforts to arrange for the sale of the
securities offered by this prospectus. The placement agent is not
purchasing or selling any of the securities we are offering and the
placement agent is not required to arrange the purchase or sale of
any specific number of securities or dollar amount. We have agreed
to pay to the placement agent the placement agent fees set forth in
the table below, which assumes that we sell all of the securities
offered by this prospectus. There is no arrangement for funds to be
received in escrow, trust or similar arrangement. There is no
minimum offering requirement as a condition of closing of this
offering. We may sell fewer than all of the units and pre-funded
units offered hereby, which may significantly reduce the amount of
proceeds received by us, and investors in this offering will not
receive a refund if we do not sell all of the units and pre-funded
units offered hereby. Because there is no escrow account and no
minimum number of securities or amount of proceeds, investors could
be in a position where they have invested in us, but we have not
raised sufficient proceeds in this offering to adequately fund the
intended uses of the proceeds as described in this prospectus. We
will bear all costs associated with the offering. See “Plan of
Distribution” on page 30 of this prospectus for more information
regarding these arrangements.
Our
common stock is listed on The Nasdaq Capital Market, or Nasdaq,
under the symbol “STAF.” The closing price of our common stock on
Nasdaq on January 18, 2023 was $3.47 per share. The public offering
price per unit or pre-funded unit, as the case may be, will be
determined through negotiation among us, the placement agent and
the investors in the offering based on market conditions at the
time of pricing, and may be at a discount to the current market
price of our common stock. Therefore, the recent market price used
throughout this prospectus may not be indicative of the final
offering price. There is no established trading market for the
pre-funded warrants or the common warrants, and we do not expect a
market to develop. We do not intend to apply for a listing of the
pre-funded warrants or the common warrants on any securities
exchange or other nationally recognized trading system. Without an
active trading market, the liquidity of the pre-funded warrants and
the common warrants will be limited.
Effective
as of 4:05 pm Eastern Time on June 23, 2022, we filed a Certificate
of Amendment to our Amended and Restated Certificate of
Incorporation, or the Certificate of Incorporation, to effect a
reverse stock split of the issued and outstanding shares of our
common stock, at a ratio of 1-for-10, or the 1-for-10 Reverse Stock
Split. All share and per share prices in this prospectus have been
adjusted to reflect the 1-for-10 Reverse Stock Split.
Investing
in our securities involves a high degree of risk. See “Risk
Factors” beginning on page 5 of this prospectus for a discussion of
risks that should be considered in connection with an investment in
our securities.
Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
passed upon the adequacy or the accuracy of this prospectus. Any
representation to the contrary is a criminal
offense.
|
|
Per
Unit(1) |
|
|
Per
Pre-Funded Unit(1) |
|
|
Total |
|
Public offering price |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Placement
agent’s fees(2) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Proceeds
to us, before expenses(3) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
(1)
Based on an assumed offering price of
$ per unit.
The final offering price per unit or pre-funded unit, as the case
may be, will be determined by us, the placement agent and the
investors in this offering and may be at a discount to the market
price of our common stock
(2)
We have agreed to pay the placement agent a management fee of 1.0%
of the aggregate gross proceeds raised in this offering and cash
fee equal to 7.5% of the aggregate gross proceeds raised in this
offering, and to reimburse the placement agent for certain of its
offering-related expenses. In addition, we have agreed to issue the
placement agent or its designees warrants to purchase a number of
shares of common stock equal to 7.5% of the shares of common stock
sold in this offering (including the shares of common stock
issuable upon the exercise of the pre-funded warrants), at an
exercise price of $
per share,
which represents 125% of the public offering price per unit. See
“Plan of Distribution” for a description of the compensation to be
received by the placement agent.
(3)
We estimate the total expenses of this offering payable by us,
excluding the placement agent fee, will be approximately
$ . Because
there is no minimum number of securities or amount of proceeds
required as a condition to closing in this offering, the actual
public offering amount, placement agent fees, and proceeds to us,
if any, are not presently determinable and may be substantially
less than the total maximum offering amounts set forth above. For
more information, see “Plan of Distribution”.
Delivery
of the securities offered hereby is expected to be made on or about
,
2023, subject to satisfaction of customary closing
conditions.
H.C.
Wainwright & Co.
The
date of this prospectus is
,
2023
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
The
registration statement we filed with the Securities and Exchange
Commission (the “SEC”) includes exhibits that provide more detail
of the matters discussed in this prospectus. You should read this
prospectus and the related exhibits filed with the SEC before
making your investment decision. You should rely only on the
information provided in this prospectus. In addition, this
prospectus contains summaries of certain provisions contained in
some of the documents described herein, but reference is made to
the actual documents for complete information.
This
prospectus includes important information about us, the securities
being offered and other information you should know before
investing in our securities. You should not assume that the
information contained in this prospectus is accurate on any date
subsequent to the date set forth on the front cover of this
prospectus, even though this prospectus is delivered or securities
are sold or otherwise disposed of on a later date. It is important
for you to read and consider all information contained in this
prospectus in making your investment decision. All of the summaries
in this prospectus are qualified in their entirety by the actual
documents. Copies of some of the documents referred to herein have
been filed, will be filed or will be incorporated by reference as
exhibits to the registration statement of which this prospectus is
a part, and you may obtain copies of those documents as described
below under the heading “Where You Can Find Additional
Information.”
We
have not, and the placement agent has not, authorized anyone to
provide any information or to make any representations other than
those contained in this prospectus or in any free writing
prospectuses prepared by or on behalf of us or to which we have
referred you. We take no responsibility for, and can provide no
assurance as to the reliability of, any other information that
others may give you. The information contained in this prospectus
or in any applicable free writing prospectus is current only as of
its date, regardless of its time of delivery or any sale of our
securities. Our business, financial condition, results of
operations and prospects may have changed since that
date.
For
investors outside the United States: We have not, and the placement
agent has not, done anything that would permit this offering or
possession or distribution of this prospectus in any jurisdiction
where action for that purpose is required, other than in the United
States. Persons outside the United States who come into possession
of this prospectus must inform themselves about, and observe any
restrictions relating to, the offering of the securities and the
distribution of this prospectus outside the United
States.
Unless
otherwise indicated, information contained in this prospectus
concerning our industry, including our general expectations and
market opportunity, is based on information from our own management
estimates and research, as well as from industry and general
publications and research, surveys and studies conducted by third
parties. Management estimates are derived from publicly available
information, our knowledge of our industry and assumptions based on
such information and knowledge, which we believe to be reasonable.
In addition, assumptions and estimates of our and our industry’s
future performance are necessarily uncertain due to a variety of
factors, including those described in “Risk Factors” beginning on
page 5 of this prospectus. These and other factors could cause our
future performance to differ materially from our assumptions and
estimates.
This
prospectus is an offer to sell only the securities offered hereby,
and only under circumstances and in jurisdictions where it is
lawful to do so. We are not, and the placement agent is not, making
an offer to sell these securities in any state or jurisdiction
where the offer or sale is not permitted.
PROSPECTUS
SUMMARY
This
summary provides an overview of selected information contained
elsewhere and does not contain all of the information you should
consider before investing in our securities. You should carefully
read the prospectus and the registration statement of which this
prospectus is a part in their entirety before investing in our
securities, including the information discussed under “Risk
Factors” in this prospectus and our financial statements and notes
thereto that are included elsewhere in this prospectus. Some of the
statements in this prospectus constitute forward-looking statements
that involve risks and uncertainties. See information set forth
under the section “Special Note Regarding Forward-Looking
Statements.” As used in this prospectus, unless the context
otherwise indicates, the terms “we,” “our,” “us,” or the “Company”
refer to Staffing 360 Solutions, Inc., a Delaware corporation, and
its subsidiaries taken as a whole.
Overview
We
are a high-growth international staffing company engaged in the
acquisition of United States and United Kingdom based staffing
companies. Our services principally consist of providing temporary
contractors, and, to a much lesser extent, the recruitment of
candidates for permanent placement. As part of our consolidation
model, we pursue a broad spectrum of staffing companies supporting
primarily accounting and finance, IT, engineering, administration
and commercial disciplines. Our typical acquisition model is based
on paying consideration in the form of cash, stock, earn-outs
and/or promissory notes. In furthering our business model, we are
regularly in discussions and negotiations with various suitable,
mature acquisition targets. To date, we have completed 11
acquisitions since November 2013.
Recent
Developments
Amended Note Purchase Agreement and Warrant with
Jackson
On
October 27, 2022, we entered into the Third Amended Note Purchase
Agreement (the “Amended Note Purchase Agreement”) with Jackson
Investment Group, LLC (“Jackson”), which amended and restated the
Second Amended and Restated Note Purchase Agreement, dated October
26, 2020, as amended, and issued to Jackson the Third Amended and
Restated Senior Secured 12% Promissory Note (the “Jackson Note”),
with a remaining outstanding principal balance of approximately
$9.0 million.
Under
the terms of the Amended Note Purchase Agreement and the Jackson
Note, we are required to pay interest on the Jackson Note at an
annual rate of 12% and in the event we have not repaid in cash at
least 50% of the outstanding principal balance of the Jackson Note
by October 27, 2023, then interest on the outstanding principal
balance of the Jackson Note shall continue to accrue at 16% per
year of the outstanding principal balance of the Jackson Note until
the Jackson Note is repaid in full. The Amended Note Purchase
Agreement also extended the maturity date of the Jackson Note from
October 28, 2022 to October 14, 2024. On October 27, 2022, in
connection with the Amended Note Purchase Agreement, we issued to
Jackson 100,000 shares of common stock and a warrant to purchase up
to 24,332 shares of common stock at an exercise price of $3.06 per
share, which is exercisable six months from October 27, 2022, and
expires on October 27, 2027.
On
October 27, 2022, in connection with the Amended Note Purchase
Agreement, the Jackson Note and Amendment No. 27 (as defined
below), we, Jackson and MidCap (as defined below) entered into the
Fifth Amendment to Intercreditor Agreement (the “Fifth Amendment”),
which amended the Intercreditor Agreement, dated September 15,
2017, by and between us, Jackson and MidCap, as amended. The Fifth
Amendment, among other things, permits the increase of the credit
commitments under the Credit and Security Agreement as amended by
Amendment No. 27 to $32.5 million. On October 27, 2022, in
connection with the Amended Note Purchase Agreement, we also
entered into an Omnibus Amendment and Reaffirmation Agreement with
Jackson, which, among other things, amended (i) the Amended and
Restated Security Agreement, dated as of September 15, 2017, as
amended, and (ii) the Amended and Restated Pledge Agreement, dated
as of September 15, 2017, as amended, to reflect certain of the
terms as updated and amended by the Amended Note Purchase
Agreement.
Amendment to Credit and Security Agreement with
MidCap
On
October 27, 2022, we entered into Amendment No. 27 and Joinder
Agreement to the Credit and Security Agreement (“Amendment No. 27”)
with MidCap Funding IV Trust as successor by assignment to MidCap
Funding X Trust, dated April 8, 2015 (“MidCap”), which amended the
Credit and Security Agreement, dated April 8, 2015 (as amended, the
“Credit and Security Agreement”). Amendment No. 27, among other
things, (i) increased the revolving loan commitment amount from $25
million to $32.5 million (the “Loan”); (ii) extended the commitment
expiry date from October 27, 2022 to September 6, 2024; and (iii)
modified certain of the financial covenants. Pursuant to Amendment
No. 27, as long as no default or event of default under the Credit
and Security Agreement as amended by Amendment No. 27 exists, upon
our written request and with the prior written consent of the agent
and lenders, the Loan may be increased by up to $10 million in
minimum amounts of $5 million tranches each, for an aggregate loan
commitment amount of $42.5 million.
July 2022 Private Placement
On
July 1, 2022, we entered into a securities purchase agreement with
certain institutional and accredited investors for the issuance and
sale of a private placement of 657,858 shares of common stock or
pre-funded warrants to purchase shares of common stock, and
warrants (the “July 2022 Warrants”) to purchase up to 657,858
shares of common stock, with an exercise price of $5.85 per share.
The July 2022 Warrants are exercisable immediately upon issuance
and have a term of exercise of five and one-half years from the
date of issuance. The combined purchase price for one share (or
pre-funded warrant) and one associated warrant to purchase one
share of common stock was $6.10.
In
connection with the private placement, each investor entered into a
warrant amendment agreement with us (collectively, the “Warrant
Amendment Agreements”) to amend the exercise prices of certain
existing warrants to purchase up to an aggregate of 657,858 shares
of our common stock that were previously issued to the investors,
with exercise prices ranging from $18.50 to $38.00 per share and
expiration dates ranging from July 22, 2026 to November 1, 2026.
The Warrant Amendment Agreements became effective upon the closing
of the private placement and pursuant to the Warrant Amendment
Agreements, the amended warrants have a reduced exercise price of
$5.85 per share and expire five and one-half years following the
closing of the private placement. We intend to use the net proceeds
received from the private placement for general working capital
purposes.
Headway Acquisition
On
April 18, 2022, we entered into a stock purchase agreement (the
“Stock Purchase Agreement”) with Headway Workforce Solutions
(“Headway”), and Chapel Hill Partners, LP, as the representatives
of all the stockholders of Headway, pursuant to which, among other
things, we agreed to purchase all of the issued and outstanding
securities of Headway in exchange for (i) a cash payment of $14,065
and (ii) 9,000,000 shares of our Series H Convertible Preferred
Stock (the “Series H Preferred Stock”), with a value equal to the
Closing Payment, as defined in the Stock Purchase Agreement (the
“Headway Acquisition”). On May 18, 2022, the Headway Acquisition
closed. The purchase price in connection with the Headway
Acquisition was approximately $9,000,000. Pursuant to the Stock
Purchase Agreement and in connection with the closing of the
Headway Acquisition, on May 17, 2022, the Company filed a
certificate of designation with the Secretary of State of Delaware
designating the rights, preferences and limitations of the Series H
Preferred Stock.
Corporate Information
We incorporated in the State of Nevada on December 22, 2009, as
Golden Fork Corporation, and changed our name to Staffing 360
Solutions, Inc., and our trading symbol to “STAF”, on March 16,
2012. On June 15, 2017, we changed our state of domicile to the
State of Delaware. Our principal executive office is located at 757
3rd Avenue, 27th Floor, New York, New York
10017, and our telephone number is (646) 507-5710. Our website is
www.staffing360solutions.com, and the information included in, or
linked to our website is not part of this prospectus. We have
included our website address in this prospectus solely as a textual
reference.
THE
OFFERING
|
Units
offered by us |
|
units,
each unit consisting of one share of common stock and one common
warrant to purchase one share of common stock.
Each
common warrant will have an exercise price of
$ per share, will be
immediately exercisable upon issuance and will expire on the five
(5) year anniversary of the original issuance date. This prospectus
also relates to the offering of the shares of common stock issuable
upon exercise of the common warrants.
|
|
|
|
Pre-funded
units offered by us
|
|
We
are also offering to certain purchasers whose purchase of units in
this offering would otherwise result in the purchaser, together
with its affiliates, beneficially owning more than 4.99% of our
outstanding common stock immediately following the consummation of
this offering, the opportunity to purchase, if such purchasers so
choose, pre-funded units, each pre-funded unit consisting of one
pre-funded warrant to purchase one share of common stock and one
common warrant to purchase one share of common stock, in lieu of
units that would otherwise result in any such purchaser’s
beneficial ownership exceeding 4.99% (or, at the election of the
purchaser, 9.99%) of our outstanding common stock. The purchase
price of each pre-funded unit will equal the price per share at
which the units are being sold to the public in this offering,
minus $0.001, and the exercise price of each pre-funded warrant
will be $0.001 per share. The pre-funded warrants will be
exercisable immediately and may be exercised at any time until all
of the pre-funded warrants are exercised in full. For each
pre-funded unit we sell, the number of units we are offering will
be decreased on a one-for-one basis. This offering also relates to
the shares of common stock issuable upon the exercise of any
pre-funded warrants sold in this offering.
|
Common
stock outstanding before this offering |
|
shares |
|
|
|
Common
stock outstanding after this offering(1) |
|
shares
(assuming the sale of the maximum number of units covered by this
prospectus, no sale of pre-funded units and no exercise of the
common warrants issued in this offering, including the warrants
issued to the placement agent or its designees).
|
Offering
price |
|
The
offering price is
$ per unit and
$ per pre-funded
unit. |
|
|
|
Use
of proceeds |
|
We
currently intend to use 50% of the net proceeds from this offering
to repay a portion of the outstanding obligations under the Jackson
Note.
We
currently intend to use the remaining 50% of the net proceeds from
this offering for working capital purposes.
See
“Use of Proceeds” on page 23.
|
Risk
factors |
|
See
“Risk Factors” beginning on page 5 of this prospectus for a
discussion of the risk factors you should consider carefully when
making an investment decision.
|
Nasdaq
symbol |
|
Our
common stock is listed on Nasdaq under the symbol “STAF”. There is
no established trading market for the common warrants or the
pre-funded warrants, and we do not expect a trading market to
develop. We do not intend to list the common warrants or the
pre-funded warrants on any securities exchange or other trading
market. Without a trading market, the liquidity of the common
warrants and the pre-funded warrants will be extremely
limited. |
|
|
|
(1)
The number of shares of our common stock to be outstanding
immediately after the closing of this offering is based on
2,669,199 shares of common stock outstanding as of January 10, 2023
and, unless otherwise indicated, excludes, as of that
date:
●
51,302 shares
of common stock issuable upon exercise of stock options;
●
2,361,880 shares
of common stock issuable upon the exercise of warrants outstanding
prior to this offering at a weighted average exercise price of
$9.61;
●
210,000 shares
of common stock issuable pursuant to outstanding performance
awards;
●
350,004 shares
of common stock issuable upon conversion of 9,000,000 shares of
Series H Preferred Stock issued and outstanding;
● the
shares of common stock issuable upon the exercise of the common
warrants and the pre-funded warrants to be issued to investors in
this offering an at exercise price of $ per share and $0.001 per
share, respectively; and
● the
shares of common stock issuable upon the exercise of warrants with
an exercise price of $ per share to be issued to the placement
agent or its designees in connection with this offering. See “Plan
of Distribution” on page 30. This prospectus also relates to the
offering of the shares of common stock issuable upon exercise of
the warrants issued to the placement agent or its
designees.
Except
as otherwise indicated, the information in this prospectus assumes:
(i) no sale of the pre-funded units in this offering, which, if
sold, would reduce the number of units that we are offering on an
one-for-one basis; (ii) no exercise of any common warrants issued
in this offering; (iii) no exercise of the warrants to be issued to
the placement agent or its designees in connection with this
offering; and (iv) no exercise of the options or warrants described
above.
|
RISK FACTORS
An
investment in our securities involves certain risks. Before
deciding to invest in our securities, you should consider carefully
the following discussion of risks and uncertainties affecting us
and our securities, together with other information in this
prospectus, including the risks, uncertainties and assumptions
discussed elsewhere in this prospectus. Our business, business
prospects, financial condition or results of operations could be
seriously harmed as a result of these risks, which could cause the
trading price of our common stock to decline, resulting in a loss
of all or part of your investment. Additional risks and
uncertainties not presently known to us or that we currently deem
immaterial also may materially and adversely affect our business,
financial condition and results of operations. Please also read
carefully the section below entitled “Special Note Regarding
Forward-Looking Statements.”
Risk
Factor Summary
Below
is a summary of the principal factors that make an investment in
our common stock speculative or risky. This summary does not
address all of the risks that we face. Additional discussion of the
risks summarized in this risk factor summary, and other risks that
we face, can be found below under the heading “Risk Factors” and
should be carefully considered, together with other information in
this prospectus and our other filings with the SEC, before making
an investment decision regarding our common stock.
|
● |
We
have incurred significant losses since our inception and may
continue to incur losses and thus may never achieve or maintain
profitability; |
|
● |
Our
debt level could negatively impact our financial condition, results
of operations and business prospects; |
|
● |
Our
debt instruments contain covenants that could limit our financing
options and liquidity position, which would limit our ability to
grow our business; |
|
● |
The
Jackson Note is secured by substantially all of our assets that are
not secured by our revolving loan facility with Midcap, and the
terms of the Jackson Note may restrict our current and future
operations. Additionally, Jackson may be able to exert significant
influence over us as our senior secured lender; |
|
● |
We
will need to raise additional capital to meet our business
requirements in the future, which is likely to be challenging,
could be highly dilutive and may cause the market price of our
common stock to decline; |
|
● |
We
have significant working capital needs and if we are unable to
satisfy those needs from cash generated from our operations or
borrowings under our debt instruments, we may not be able to
continue our operations; |
|
● |
The
continuing uncertainty surrounding the implementation of Brexit and
future arrangements between the U.K and the European Union may
impact our U.K. operations; |
|
● |
Our
revenue may be adversely affected by fluctuations in currency
exchange rates; |
|
● |
Our
revenue can vary because our customers can terminate their
relationship with us at any time with limited or no
penalty; |
|
● |
We
operate in an intensely competitive and rapidly changing business
environment, and there is a substantial risk that our services
could become obsolete or uncompetitive; |
|
● |
We
have been and may be exposed to employment-related claims and
losses, including class action lawsuits, which could have a
material adverse effect on our business; |
|
● |
Our
growth of operations could strain our resources and cause our
business to suffer; |
|
● |
Our
strategy of growing through acquisitions may impact our business in
unexpected ways; |
|
● |
A
more active, liquid trading market for our common stock may not
develop, and the price of our common stock may fluctuate
significantly; |
|
● |
Our
strategy of growing through acquisitions may impact our business in
unexpected ways; |
|
● |
We
depend on attracting, integrating, managing, and retaining
qualified personnel; |
|
● |
If we
are unable to retain existing customers or attract new customers,
our business and results of operations could suffer; |
|
● |
We
are dependent upon technology services, and if we experience
damage, service interruptions or failures in our computer and
telecommunications systems, our customer relationships and our
ability to attract new customers may be adversely affected;
and |
|
● |
Our
management has identified a material weakness in our internal
control over financial reporting relating to the lack of a
sufficient complement of competent finance personnel to
appropriately account for, review and disclose the completeness and
accuracy of transactions entered into by the Company. This material
weakness, if not remediated, could result in material misstatements
in our consolidated financial statements. We may be unable to
develop, implement and maintain appropriate internal controls over
financial reporting. If we fail to maintain an effective system of
internal control over financial reporting, we may not be able to
accurately report our financial results and current and potential
stockholders may lose confidence in our financial
reporting. |
|
● |
Our
management has identified a material weakness in our internal
control over our goodwill assessment relating to the lack of a
sufficient process for determining the valuation of goodwill
assets. This material weakness, if not remediated, could result in
material misstatements in our consolidated financial
statements. |
Risks
Relating to Our Organization and Our Financial
Condition
We have incurred significant losses since our inception and may
continue to incur losses and thus may never achieve or maintain
profitability.
We
have incurred substantial losses since our inception, anticipate
that we will continue to incur losses for the foreseeable future
and may not achieve or sustain profitability. Because of the
numerous risks and uncertainties associated with the staffing
industry, we are unable to predict the extent of any future losses
or when we will become profitable, if at all. Expected future
operating losses will have an adverse effect on our cash resources,
stockholders’ equity and working capital. Our negative working
capital and liquidity position combined with the uncertainty
generated by the economic reaction to the COVID-19 pandemic raise
substantial doubt about our ability to continue as a going
concern.
Our
failure to become and remain profitable could depress the value of
our common stock and impair our ability to raise capital, expand
our business, maintain our development efforts, diversify our
portfolio of staffing companies, or continue our operations. A
decline in the value of our common stock could also cause you to
lose all or part of your investment. For more detailed discussion
of the risks related to the COVID-19 pandemic, please see “The
recent COVID-19 pandemic has adversely affected our business and
may continue to adversely affect our business until the pandemic is
resolved” above.
Our
independent registered public accounting firm has included an
explanatory paragraph in its report as of and for the year ended
January 1, 2022 expressing substantial doubt in our ability to
continue as a going concern based on our negative working capital
and liquidity position combined with the uncertainty generated by
the economic reaction to the COVID-19 pandemic. Our consolidated
financial statements do not include any adjustments that might
result from the outcome of this going concern uncertainty and have
been prepared under the assumption that we will continue to operate
as a going concern, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of
business. If we are unable to continue as a going concern, we may
be forced to liquidate our assets which would have an adverse
impact on our business and developmental activities. In such a
scenario, the values we receive for our assets in liquidation or
dissolution could be significantly lower than the values reflected
in our financial statements. The reaction of investors to the
inclusion of a going concern statement by our independent
registered public accounting firm and our potential inability to
continue as a going concern may materially adversely affect our
stock price and our ability to raise new capital or to enter into
strategic alliances.
Our debt level could negatively impact our financial condition,
results of operations and business prospects.
As of
October 1, 2022, our total gross debt was approximately
$18,361,000. Our level of debt could have significant consequences
to our stockholders, including the following:
|
● |
requiring
the dedication of a substantial portion of cash flow from
operations to make payments on debt, thereby reducing the
availability of cash flow for working capital, capital expenditures
and other general business activities; |
|
● |
requiring
a substantial portion of our corporate cash reserves to be held as
a reserve for debt service, limiting our ability to invest in new
growth opportunities; |
|
● |
limiting
the ability to obtain additional financing in the future for
working capital, capital expenditures, acquisitions and general
corporate and other activities; |
|
● |
limiting
the flexibility in planning for, or reacting to, changes in the
business and industry in which we operate; |
|
● |
increasing
our vulnerability to both general and industry-specific adverse
economic conditions including the economic consequences of the
COVID-19 pandemic and its ongoing effects; |
|
● |
putting
us at a competitive disadvantage versus less leveraged competitors;
and |
|
● |
increasing
vulnerability to changes in the prevailing interest
rates. |
Our
ability to make payments of principal and interest, or to refinance
our indebtedness, depends on our future performance, which is
subject to economic, financial, competitive and other factors. We
had negative cash flows from operations for the quarter ended
October 1, 2022, and we may not generate cash flow in the future
sufficient to service our debt because of factors beyond our
control, including but not limited to our ability to expand our
operations. If we are unable to generate sufficient cash flows, we
may be required to adopt one or more alternatives, such as
restructuring debt or obtaining additional equity capital on terms
that may be onerous or highly dilutive. Our ability to refinance
our indebtedness will depend on the capital markets and our
financial condition at such time. We may not be able to engage in
any of these activities or engage in these activities on desirable
terms, which could result in a default on our debt obligations. A
default on our debt obligations could have a material adverse
effect on our business, financial condition and results of
operations and may cause you to lose all or part of your
investment.
Further,
the outstanding Jackson Note due October 14, 2024 contains certain
customary financial covenants, and we have had instances of
non-compliance. Management has historically been able to obtain
from Jackson, waivers of any non-compliance and management expects
to continue to be able to obtain necessary waivers in the event of
future non-compliance; however, there can be no assurance that we
will be able to obtain such waivers, and should Jackson refuse to
provide a waiver in the future, the outstanding debt under the
agreement could become due immediately. Our financing with MidCap
includes customary financial covenants and we have had instances of
non-compliance. We have been able to obtain forbearance of any
non-compliance from MidCap, and management expects to continue to
be able to obtain necessary forbearance in the event of future
non-compliance; however, there can be no assurance that we will be
able to obtain such forbearance, and should MidCap refuse to
provide a forbearance in the future, the outstanding debt under the
agreement could become due immediately, which exceeds our current
cash balance.
Our debt instruments contain covenants that could limit our
financing options and liquidity position, which would limit our
ability to grow our business.
Covenants
in our debt instruments impose operating and financial restrictions
on us. These restrictions prohibit or limit our ability to, among
other things:
|
● |
pay
cash dividends to our stockholders, subject to certain limited
exceptions; |
|
● |
redeem
or repurchase our common stock or other equity; |
|
● |
incur
additional indebtedness; |
|
● |
permit
liens on assets; |
|
● |
make
certain investments (including through the acquisition of stock,
shares, partnership or limited liability company interests, any
loan, advance or capital contribution); |
|
● |
sell,
lease, license, lend or otherwise convey an interest in a material
portion of our assets; |
|
● |
cease
making public filings under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”); and |
|
● |
sell
or otherwise issue shares of our common stock or other capital
stock subject to certain limited exceptions. |
Our
failure to comply with the restrictions in our debt instruments
could result in events of default, which, if not cured or waived,
could result in us being required to repay these borrowings before
their due date. The holders of our debt may require fees and
expenses to be paid or other changes to terms in connection with
waivers or amendments. If we are forced to refinance these
borrowings on less favorable terms, our results of operations and
financial condition could be adversely affected by increased costs
and rates. In addition, these restrictions may limit our ability to
obtain additional financing, withstand downturns in our business or
take advantage of business opportunities.
The Jackson Note is secured by substantially all of our assets that
are not secured by our revolving loan facility with Midcap, and the
terms of the Jackson Note may restrict our current and future
operations. Additionally, Jackson may be able to exert significant
influence over us as our senior secured lender.
The
Jackson Note contains a number of restrictive covenants that impose
significant operating and financial restrictions on us and may
limit our ability to engage in acts that we believe may be in our
long-term best interests. The Jackson Note includes covenants
limiting or restricting, among other things, our ability
to:
|
● |
incur
or guarantee additional indebtedness; |
|
● |
pay
distributions on, redeem or repurchase shares of our capital stock
or redeem or repurchase any of our subordinated debt; |
|
● |
make
certain investments; |
|
● |
sell
assets; |
|
● |
enter
into agreements that restrict distributions or other payments from
our restricted subsidiaries; |
|
● |
incur
or allow the existence of liens; |
|
● |
consolidate,
merge or transfer all or substantially all of our assets;
and |
|
● |
engage
in transactions with affiliates. |
In
addition, the Jackson Note contains financial covenants including,
among other things, a fixed charge coverage ratio, minimum
liquidity requirements and total leverage ratio. A breach of any of
these financial covenants could result in a default under the
Jackson Note. If any such default occurs, Jackson may elect to
declare all outstanding borrowings, together with accrued interest
and other amounts payable thereunder, to be immediately due and
payable. In addition, following an event of default under the
Jackson Note, Jackson will have the right to proceed against the
collateral granted to it to secure the debt, which includes our
available cash. If the debt under the Jackson Note was to be
accelerated, we cannot assure you that our assets would be
sufficient to repay in full our debt.
We review the recoverability of goodwill and other indefinite lived
intangible assets annually as of the first day of our fiscal fourth
quarter, and whenever events or circumstances indicate that the
carrying value of a reporting unit, including goodwill, or an
indefinite lived intangible asset may not be
recoverable.
To
evaluate goodwill and other indefinite lived intangible assets for
impairment, we may use qualitative assessments to determine whether
it is more likely than not that the fair value of a reporting unit,
including goodwill, or an indefinite lived intangible asset is less
than its carrying amount. The qualitative assessments require
assumptions to be made regarding multiple factors, including the
current operating environment, historical and future financial
performance and industry and market conditions. If an initial
qualitative assessment identifies that it is more likely than not
that the carrying value of a reporting unit exceeds its estimated
fair value, additional quantitative testing is performed.
Alternatively, we may elect to bypass the qualitative assessment
and instead perform a quantitative impairment test to calculate the
fair value of the reporting unit in comparison to its associated
carrying value.
The
quantitative impairment tests require us to make an estimate of the
fair value of our reporting units. An impairment could be recorded
as a result of changes in assumptions, estimates or circumstances,
some of which are beyond our control. Because a number of factors
may influence determinations of fair value of goodwill, we are
unable to predict whether impairments of goodwill will occur in the
future, and there can be no assurance that continued conditions
will not result in future impairments of goodwill. The future
occurrence of a potential indicator of impairment could include
matters such as (i) a decrease in expected net earnings; (ii)
adverse equity market conditions; (iii) a decline in current market
multiples; (iv) a decline in our common stock price; (v) a
significant adverse change in legal factors or the general business
climate; and (vi) a significant downturn in employment markets in
the United States. Any such impairment would result in us
recognizing a non-cash charge in our consolidated statement of
operations, which could adversely affect our business, results of
operations and financial condition.
We will need to raise additional capital to meet our business
requirements in the future, which is likely to be challenging,
could be highly dilutive and may cause the market price of our
common stock to decline.
As of
October 1, 2022, we had a working capital deficiency of
$13,764,289, an accumulated deficit of $87,577,632 and a net loss
for the nine months ended October 1, 2022 of $3,556,407. We will
need to raise additional capital to pursue growth opportunities,
improve our infrastructure, finance our operations and otherwise
make investments in assets and personnel that will allow us to
remain competitive. Additional capital would be used to accomplish
the following:
|
● |
financing
our current operating expenses; |
|
● |
pursuing
growth opportunities; |
|
● |
making
capital improvements to improve our infrastructure; |
|
● |
hiring
and retaining qualified management and key employees; |
|
● |
responding
to competitive pressures; |
|
● |
complying
with regulatory requirements; and |
|
● |
maintaining
compliance with applicable laws. |
To
the extent that we raise additional capital through the sale of
equity or convertible debt securities, the issuance of those
securities could result in substantial dilution for our current
stockholders. The terms of any securities issued by us in future
capital transactions may be more favorable to new investors, and
may include preferences, superior voting rights and the issuance of
warrants or other derivative securities, which may have a further
dilutive effect on the holders of any of our securities
then-outstanding. We may issue additional shares of our common
stock or securities convertible into or exchangeable or exercisable
for our common stock in connection with hiring or retaining
personnel, option or warrant exercises, future acquisitions or
future placements of our securities for capital-raising or other
business purposes. The issuance of additional securities, whether
equity or debt, by us, or the possibility of such issuance, may
cause the market price of our common stock to decline further and
existing stockholders may not agree with our financing plans or the
terms of such financings.
In
addition, we may incur substantial costs in pursuing future capital
financing, including investment banking fees, legal fees,
accounting fees, securities law compliance fees, printing and
distribution expenses and other costs. We may also be required to
recognize non-cash expenses in connection with certain securities
we issue, such as convertible notes and warrants, which may
adversely impact our financial condition.
Furthermore,
any additional debt or equity financing that we may need may not be
available on terms favorable to us, or at all. If we are unable to
obtain such additional financing on a timely basis, we may have to
curtail our development activities and growth plans and/or be
forced to sell assets, perhaps on unfavorable terms, which would
have a material adverse effect on our business, financial condition
and results of operations, and we ultimately could be forced to
discontinue our operations and liquidate, in which event it is
unlikely that stockholders would receive any distribution on their
shares. Further, we may not be able to continue operating if we do
not generate sufficient revenues from operations needed to stay in
business.
We have significant working capital needs and if we are unable to
satisfy those needs from cash generated from our operations or
borrowings under our debt instruments, we may not be able to
continue our operations.
We
require significant amounts of working capital to operate our
business. We often have high receivables from our customers, and as
a staffing company, we are prone to cash flow imbalances because we
have to fund payroll payments to temporary workers before receiving
payments from clients for our services. Cash flow imbalances also
occur because we must pay temporary workers even when we have not
been paid by our customers. If we experience a significant and
sustained drop in operating profits, or if there are unanticipated
reductions in cash inflows or increases in cash outlays, we may be
subject to cash shortfalls. If such a shortfall were to occur for
even a brief period of time, it may have a significant adverse
effect on our business. In particular, we use working capital to
pay expenses relating to our temporary workers and to satisfy our
workers’ compensation liabilities. As a result, we must maintain
sufficient cash availability to pay temporary workers and fund
related tax liabilities prior to receiving payment from
customers.
In
addition, our operating results tend to be unpredictable from
quarter to quarter. Demand for our services is typically lower
during traditional national vacation periods in the United States
and United Kingdom when customers and candidates are on vacation.
No single quarter is predictive of results of future periods. Any
extended period of time with low operating results or cash flow
imbalances could have a material adverse effect on our business,
financial condition and results of operations.
We
derive working capital for our operations through cash generated by
our operating activities, equity raises, and borrowings under our
debt instruments. If our working capital needs increase in the
future, we may be forced to seek additional sources of capital,
which may not be available on commercially reasonable terms. The
amount we are entitled to borrow under our debt instruments is
calculated monthly based on the aggregate value of certain eligible
trade accounts receivable generated from our operations, which are
affected by financial, business, economic and other factors, as
well as by the daily timing of cash collections and cash outflows.
The aggregate value of our eligible accounts receivable may not be
adequate to allow for borrowings for other corporate purposes, such
as capital expenditures or growth opportunities, which could reduce
our ability to react to changes in the market or industry
conditions.
We face risks associated with litigation and
claims.
We
are a party to certain legal proceedings as further described under
“Legal Proceedings”. In addition, from time to time, we may become
involved in various claims, disputes and legal or regulatory
proceedings that arise in the ordinary course of business and
relate to contractual and other obligations. Due to the
uncertainties of litigation, we can give no assurance that we will
prevail on any claims made against us in any such lawsuit. Also, we
can give no assurance that any other lawsuits or claims brought in
the future will not have an adverse effect on our financial
condition, liquidity or operating results. Adverse outcomes in some
or all of these claims may result in significant monetary damages
that could adversely affect our ability to conduct our
business.
The continuing uncertainty surrounding the implementation of Brexit
and future arrangements between the U.K and the European Union may
impact our U.K. operations.
Pursuant
to a June 2016 referendum, the U.K. left the European Union on
January 31, 2020. Following a transition period, the U.K. and the
European Union signed a Trade and Cooperation Agreement, which came
into full force on May 1, 2021 and set out the foundation of the
economic and legal framework for trade between the U.K. and the
European Union. While we have yet to experience any negative
impacts, there may continue to be economic uncertainty surrounding
the consequences of Brexit and the U.K.’s future arrangements with
the European Union that could adversely impact customer confidence,
resulting in customers reducing their spending budgets on our
services. There has been volatility in currency exchange rate
fluctuations between the U.S. dollar relative to the British pound,
which could continue, as well as market volatility, which
contribute to instability in global financial and foreign exchange
markets, political institutions, and regulatory agencies as
negotiations of trade deals between the U.K. and the European
Union, and also between the U.K. and other countries. These and
other adverse consequences such as reduced consumer spending,
deterioration in economic conditions, loss of key international
employees, volatility in exchange rates, and prohibitive laws and
regulations could have a negative impact on our business, operating
results and financial condition.
Our revenue may be adversely affected by fluctuations in currency
exchange rates.
A
significant portion of our expenditures are derived or spent in
British pounds. However, we report our financial condition and
results of operations in U.S. dollars. As a result, fluctuations
between the U.S. dollar and the British pound will impact the
amount of our revenues and net income. For example, if the British
pound appreciates relative to the U.S. dollar, the fluctuation will
result in a positive impact on the revenues that we report.
However, if the British pound depreciates relative to the U.S.
dollar, which was the case during 2016 and in 2020, there will be a
negative impact on the revenues we report due to such fluctuation.
It is possible that the impact of currency fluctuations will result
in a decrease in reported consolidated sales even though we may
have experienced an increase in sales transacted in the British
pound. Conversely, the impact of currency fluctuations may result
in an increase in reported consolidated sales despite declining
sales transacted in the British pound. The exchange rate from the
U.S. dollar to the British pound has fluctuated substantially in
the past and may continue to do so in the future. Though we may
choose to hedge our exposure to foreign currency exchange rate
changes in the future, there is no guarantee such hedging, if
undertaken, will be successful.
Our revenue can vary because our customers can terminate their
relationship with us at any time with limited or no
penalty.
We
focus on providing mid-level professional and light industrial
personnel on a temporary assignment-by-assignment basis, which
customers can generally terminate at any time or reduce their level
of use when compared with prior periods. To avoid large placement
agency fees, large companies may use in-house personnel staff,
current employee referrals, or human resources consulting companies
to find and hire new personnel. Because placement agencies
typically charge a fee based on a percentage of the first year’s
salary of a new worker, companies with many jobs to fill have a
large financial incentive to avoid agencies.
Our
business is also significantly affected by our customers’ hiring
needs and their views of their future prospects. Our customers may,
on very short notice, terminate, reduce or postpone their
recruiting assignments with us and, therefore, affect demand for
our services. As a result, a significant number of our customers
can terminate their agreements with us at any time, making us
particularly vulnerable to a significant decrease in revenue within
a short period of time that could be difficult to quickly replace.
This could have a material adverse effect on our business,
financial condition and results of operations.
Most
of our contracts do not obligate our customers to utilize a
significant amount of our staffing services and may be cancelled on
limited notice, so our revenue is not guaranteed.
Substantially
all of our revenue is derived from multi-year contracts that are
terminable for convenience. Under our multi-year agreements, we
contract to provide customers with staffing services through work
or service orders at the customers’ request. Under these
agreements, our customers often have little or no obligation to
request our staffing services. In addition, most of our contracts
are cancellable on limited notice, even if we are not in default
under the contract. We may hire employees permanently to meet
anticipated demand for services under these agreements that may
ultimately be delayed or cancelled. We could face a significant
decline in revenues and our business, financial condition or
results of operations could be materially adversely affected
if:
|
● |
we
see a significant decline in the staffing services requested from
us under our service agreements; or |
|
● |
our
customers cancel or defer a significant number of staffing
requests; or our existing customer agreements expire or lapse and
we cannot replace them with similar agreements. |
We could be adversely affected by risks associated with
acquisitions and joint ventures.
We
are engaged in the acquisition of U.S. and U.K. based staffing
companies, and our typical acquisition model is based on paying
consideration in the form of cash, stock, earn-outs and/or
promissory notes. To date, we have completed 11 acquisitions. We
intend to expand our business through acquisitions of complementary
businesses, services or products, subject to our business plans and
management’s ability to identify, acquire and develop suitable
investments or acquisition targets in both new and existing service
categories. In certain circumstances, acceptable investments or
acquisition targets might not be available. Acquisitions involve a
number of risks, including:
|
● |
difficulty
in integrating the operations, technologies, products and personnel
of an acquired business, including consolidating redundant
facilities and infrastructure; |
|
● |
potential
disruption of our ongoing business and the distraction of
management from our day-to-day operations; |
|
● |
difficulty
entering markets in which we have limited or no prior experience
and in which competitors have a stronger market
position; |
|
● |
difficulty
maintaining the quality of services that such acquired companies
have historically provided; potential legal and financial
responsibility for liabilities of acquired businesses; |
|
● |
overpayment
for the acquired company or assets or failure to achieve
anticipated benefits, such as cost savings and revenue
enhancements; |
|
● |
increased
expenses associated with completing an acquisition and amortizing
any acquired intangible assets; |
|
● |
challenges
in implementing uniform standards, accounting policies, customs,
controls, procedures and policies throughout an acquired
business; |
|
● |
failure
to retain, motivate and integrate key management and other
employees of the acquired business; and |
|
● |
loss
of customers and a failure to integrate customer bases. |
Our
business plan for continued growth through acquisitions is subject
to certain inherent risks, including accessing capital resources,
potential cost overruns and possible rejection of our business
model and/or sales methods. Therefore, we provide no assurance that
we will be successful in carrying out our business plan. We
continue to pursue additional debt and equity financing to fund our
business plan. We have no assurance that future financing will be
available to us on acceptable terms or at all.
In
addition, if we incur indebtedness to finance an acquisition, it
may reduce our capacity to borrow additional amounts and require us
to dedicate a greater percentage of our cash flow from operations
to payments on our debt, thereby reducing the cash resources
available to us to fund capital expenditures, pursue other
acquisitions or investments in new business initiatives and meet
general corporate and working capital needs. This increased
indebtedness may also limit our flexibility in planning for, and
reacting to, changes in or challenges relating to our business and
industry. The use of our common stock or other securities
(including those convertible into or exchangeable or exercisable
for our common stock) to finance any such acquisition may also
result in dilution of our existing shareholders.
The
potential risks associated with future acquisitions could disrupt
our ongoing business, result in the loss of key customers or
personnel, increase expenses and otherwise have a material adverse
effect on our business, results of operations and financial
condition.
We could be harmed by improper disclosure or loss of sensitive or
confidential company, employee, associate or customer data,
including personal data.
In
connection with the operation of our business, we store, process
and transmit a large amount of data, including personnel and
payment information, about our employees, customers, associates and
candidates, a portion of which is confidential and/or personally
sensitive. In doing so, we rely on our own technology and systems,
and those of third-party vendors we use for a variety of processes.
We and our third-party vendors have established policies and
procedures to help protect the security and privacy of this
information. Unauthorized disclosure or loss of sensitive or
confidential data may occur through a variety of methods. These
include, but are not limited to, systems failure, employee
negligence, fraud or misappropriation, or unauthorized access to or
through our information systems, whether by our employees or third
parties, including a cyberattack by computer programmers, hackers,
members of organized crime and/or state-sponsored organizations,
who may develop and deploy viruses, worms or other malicious
software programs.
Such
disclosure, loss or breach could harm our reputation and subject us
to government sanctions and liability under our contracts and laws
that protect sensitive or personal data and confidential
information, resulting in increased costs or loss of revenues. It
is possible that security controls over sensitive or confidential
data and other practices we and our third-party vendors follow may
not prevent the improper access to, disclosure of, or loss of such
information. Further, data privacy is subject to frequently
changing rules and regulations, which sometimes conflict among the
various jurisdictions in which we provide services. Any failure or
perceived failure to successfully manage the collection, use,
disclosure, or security of personal information or other privacy
related matters, or any failure to comply with changing regulatory
requirements in this area, could result in legal liability or
impairment to our reputation in the marketplace.
We have been and may be exposed to employment-related claims and
losses, including class action lawsuits, which could have a
material adverse effect on our business.
We
employ people internally and in the workplaces of other businesses.
Many of these individuals have access to customer information
systems and confidential information. The risks of these activities
include possible claims relating to:
|
● |
discrimination
and harassment; |
|
● |
wrongful
termination or denial of employment; |
|
● |
violations
of employment rights related to employment screening or privacy
issues; |
|
● |
classification
of temporary workers; |
|
● |
assignment
of illegal aliens; |
|
● |
violations
of wage and hour requirements; |
|
● |
retroactive
entitlement to temporary worker benefits; |
|
● |
errors
and omissions by our temporary workers; |
|
● |
misuse
of customer proprietary information; |
|
● |
misappropriation
of funds; |
|
● |
damage
to customer facilities due to negligence of temporary workers;
and |
|
● |
criminal
activity. |
We
may incur fines and other losses or negative publicity with respect
to these problems. In addition, these claims may give rise to
litigation, which could be time-consuming and expensive. New
employment and labor laws and regulations may be proposed or
adopted that may increase the potential exposure of employers to
employment-related claims and litigation. There can be no assurance
that the corporate policies we have in place to help reduce our
exposure to these risks will be effective or that we will not
experience losses as a result of these risks. There can also be no
assurance that the insurance policies we have purchased to insure
against certain risks will be adequate or that insurance coverage
will remain available on reasonable terms or be sufficient in
amount or scope of coverage.
Provisions in our corporate charter documents and under Delaware
law could make an acquisition of us more difficult and may prevent
attempts by our stockholders to replace or remove our current
management.
Provisions
in our amended and restated certificate of incorporation, as
amended (the “Certificate of Incorporation”) and our amended and
restated bylaws (the “Bylaws”) may discourage, delay or prevent a
merger, acquisition or other change in control of us that
stockholders may consider favorable, including transactions in
which stockholders might otherwise receive a premium for their
shares. These provisions could also limit the price that investors
might be willing to pay in the future for shares of our common
stock, thereby depressing the market price of our common stock. In
addition, these provisions may frustrate or prevent any attempts by
our stockholders to replace or remove our current management by
making it more difficult for stockholders to replace members of our
Board of Directors (the “Board”). Because our Board is responsible
for appointing the members of our management team, these provisions
could in turn affect any attempt by our stockholders to replace
current members of our management team. Among others, these
provisions include that:
|
● |
our
Board has the exclusive right to expand the size of our Board and
to elect directors to fill a vacancy created by the expansion of
the Board or the resignation, death or removal of a director, which
prevents stockholders from being able to fill vacancies on our
Board; |
|
● |
a
special meeting of stockholders may be called only by a majority of
the Board, the executive chairman or the president, which may delay
the ability of our stockholders to force consideration of a
proposal or to take action, including the removal of
directors; |
|
● |
our
stockholders do not have the right to cumulate votes in the
election of directors, which limits the ability of minority
stockholders to elect director candidates; |
|
● |
our
Board may alter our Bylaws without obtaining stockholder
approval; |
|
● |
stockholders
must provide advance notice and additional disclosures in order to
nominate individuals for election to the Board or to propose
matters that can be acted upon at a stockholders’ meeting, which
may discourage or deter a potential acquiror from conducting a
solicitation of proxies to elect the acquiror’s own slate of
directors or otherwise attempting to obtain control of our company;
and |
|
● |
our
Board is authorized to issue shares of preferred stock and to
determine the terms of those shares, including preferences and
voting rights, without stockholder approval, which could be used to
significantly dilute the ownership of a hostile
acquiror. |
In
addition, the terms of the Jackson Note limit our ability to
consolidate, merge, or transfer all or substantially all of our
assets or to effect a change in control of ownership of our
company. A breach of such restrictions could result in a default
under the Jackson Note, under which Jackson may elect to declare
all outstanding borrowings under the Jackson Note, together with
accrued interest and other amounts payable thereunder, to be
immediately due and payable.
Moreover,
because we are incorporated in Delaware, we are governed by the
provisions of Section 203 of the Delaware General Corporation Law,
which prohibits a person who owns in excess of 15% of our
outstanding voting stock from merging or combining with us for a
period of three years after the date of the transaction in which
the person acquired in excess of 15% of our outstanding voting
stock, unless the merger or combination is approved in a prescribed
manner.
Furthermore,
our Certificate of Incorporation specifies that, unless we consent
in writing to the selection of an alternative forum, a state court
located within the State of Delaware will be the sole and exclusive
forum for most legal actions involving actions brought against us
by stockholders, which may include federal claims and derivative
actions, except that if no state court located within the State of
Delaware has jurisdiction over such claims (including subject
matter jurisdiction), the sole and exclusive forum for such claim
shall be the federal district court for the District of Delaware.
We believe these provisions may benefit us by providing increased
consistency in the application of Delaware law and federal
securities laws by chancellors and judges, as applicable,
particularly experienced in resolving corporate disputes, efficient
administration of cases on a more expedited schedule relative to
other forums and protection against the burdens of multi-forum
litigation. However, these provisions may have the effect of
discouraging lawsuits against our directors and officers. The
enforceability of similar choice of forum provisions in other
companies’ certificates of incorporation has been challenged in
legal proceedings, and it is possible that, in connection with any
applicable action brought against us, a court could find the choice
of forum provisions contained in the Certificate of Incorporation
to be inapplicable or unenforceable in such action. Specifically,
the choice of forum provision in requiring that the state courts of
the State of Delaware be the exclusive forum for certain suits
would (i) not be enforceable with respect to any suits brought to
enforce any liability or duty created by the Exchange Act and (ii)
have uncertain enforceability with respect to claims under the
Securities Act of 1933, as amended (the “Securities Act”). The
choice of forum provision in the Certificate of Incorporation does
not have the effect of causing our stockholders to have waived our
obligation to comply with the federal securities laws and the rules
and regulations thereunder.
Risks
Relating to Our Business and Industry
Our growth of operations could strain our resources and cause our
business to suffer.
While
we plan to continue growing our business organically through
expansion, sales efforts, and strategic acquisitions, while
maintaining tight controls on our expenses and overhead, lean
overhead functions combined with focused growth may place a strain
on our management systems, infrastructure and resources, resulting
in internal control failures, missed opportunities, and staff
attrition which could impact our business and results of
operations.
Our strategy of growing through acquisitions may impact our
business in unexpected ways.
Our
growth strategy involves acquisitions that help us expand our
service offerings and diversify our geographic footprint. We
continuously evaluate acquisition opportunities, but there are no
assurances that we will be able to identify acquisition targets
that complement our strategy and are available at valuation levels
accretive to our business.
Even
if we are successful in acquiring, our acquisitions may subject our
business to risks that may impact our results of operations,
including:
|
● |
inability
to integrate acquired companies effectively and realize anticipated
synergies and benefits from the acquisitions; |
|
● |
diversion
of management’s attention to the integration of the acquired
businesses at the expense of delivering results for the legacy
business; |
|
● |
inability
to appropriately scale critical resources to support the business
of the expanded enterprise and other unforeseen challenges of
operating the acquired business as part of our
operations; |
|
● |
inability
to retain key employees of the acquired businesses and/or inability
of such key employees to be effective as part of our
operations; |
|
● |
impact
of liabilities of the acquired businesses undiscovered or
underestimated as part of the acquisition due
diligence; |
|
● |
failure
to realize anticipated growth opportunities from a combined
business, because existing and potential clients may be unwilling
to consolidate business with a single supplier or to stay with the
acquirer post acquisition; |
|
● |
impacts
of cash on hand and debt incurred to finance acquisitions, thus
reducing liquidity for other significant strategic objectives;
and |
|
● |
internal
controls, disclosure controls, corruption prevention policies,
human resources and other key policies and practices of the
acquired companies may be inadequate or ineffective. |
We operate in an intensely competitive and rapidly changing
business environment, and there is a substantial risk that our
services could become obsolete or uncompetitive.
The
markets for our services are highly competitive. Our markets are
characterized by pressures to provide high levels of service,
incorporate new capabilities and technologies, accelerate job
completion schedules and reduce prices. Furthermore, we face
competition from a number of sources, including other executive
search firms and professional search, staffing and consulting
firms. Several of our competitors have greater financial and
marketing resources than we do. New and existing competitors are
aided by technology, and the market has low barriers to entry.
Furthermore, Internet employment sites expand a company’s ability
to find workers without the help of traditional agencies. Personnel
agencies often work as intermediaries, helping employers accurately
describe job openings and screen candidates. Increasing the use of
sophisticated, automated job description and candidate screening
tools could make many traditional functions of staffing companies
obsolete. Specifically, the increased use of the internet may
attract technology-oriented companies to the professional staffing
industry. Free social networking sites such as LinkedIn and
Facebook are also becoming a common way for recruiters and
employees to connect without the assistance of a staffing
company.
Our
future success will depend largely upon our ability to anticipate
and keep pace with those developments and advances. Current or
future competitors could develop alternative capabilities and
technologies that are more effective, easier to use or more
economical than our services. In addition, we believe that, with
continuing development and increased availability of information
technology, the industries in which we compete may attract new
competitors. If our capabilities and technologies become obsolete
or uncompetitive, our related sales and revenue would decrease. Due
to competition, we may experience reduced margins on our services,
loss of market share, and loss of customers. If we are not able to
compete effectively with current or future competitors as a result
of these and other factors, our business, financial condition and
results of operations could be materially adversely
affected.
Risks
Relating to our Common Stock
We may not meet the continued listing requirements of The Nasdaq
Capital Market, which could result in a delisting of our common
stock.
Our
common stock is listed on Nasdaq. We have in the past, and may in
the future, be unable to comply with certain of the listing
standards that we are required to meet to maintain the listing of
our common shares on Nasdaq. We have in the past received
deficiency letters from the Listing Qualifications Department of
Nasdaq indicating that we did not meet the minimum bid price
requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid
Price Requirement”) or the minimum stockholders’ equity requirement
under Nasdaq Listing Rule 5550(b)(1), which requires listed
companies to maintain stockholders’ equity of at least $2,500,000
(the “Stockholders’ Equity Requirement”).
For
example, on June 3, 2020, we received a letter from the Staff (the
“Staff”) of Nasdaq notifying us that we were no longer in
compliance with the Stockholders’ Equity Requirement for continued
listing on Nasdaq. A hearing before the Nasdaq Hearings Panel (the
“Panel”) was held on January 21, 2021, and we were granted an
extension to regain compliance until February 28, 2021, which was
subsequently further extended to May 31, 2021. On June 28, 2021, we
received a letter from the Staff notifying us that the Panel
determined that we had regained compliance with the Stockholders’
Equity Requirement. The Panel also imposed a panel monitor (the
“Panel Monitor”) under Nasdaq Listing Rule 5815(d)(4)(A) for a
period of one year from the date of the June 28, 2021 letter,
during which period we were expected to remain in compliance with
all of Nasdaq’s continued listing requirements.
On
February 23, 2022, we received a letter from the Staff notifying us
that we were no longer in compliance with the Minimum Bid Price
Requirement, for continued listing on Nasdaq. On April 12, 2022, we
received a letter from Nasdaq notifying us that the Panel
determined to grant our request for continued listing on Nasdaq,
subject to, among other provisions, effecting a reverse stock split
and demonstrating compliance with the Minimum Bid Price
Requirement. On each of April 19, 2022 and May 20, 2022, we
received letters from the Staff notifying us that as we had not yet
filed our Form 10-K for the period ended January 1, 2022 and our
Form 10-Q for the period ended April 2, 2022, each such matter
serving as an additional basis for delisting our securities from
Nasdaq under Nasdaq Listing Rule 5810(c)(2)(A). On May 4, 2022 the
Panel granted us an extension request until July 11, 2022 to
demonstrate compliance with the Minimum Bid Price
Requirement.
On
June 23, 2022, we effected the 1-for-10 Reverse Stock Split, on
June 24, 2022, we filed our Annual Report on Form 10-K for the
fiscal year ended January 1, 2022, and on July 14, 2022, we filed
our Quarterly Report on Form 10-Q for the period ended April 2,
2022. On July 15, 2022, we received a letter from the Staff
informing us that we had regained compliance with the Minimum Bid
Price Requirement and the subsequent delinquency concerns as
described above. The letter additionally informed us that we are in
compliance with the terms of the Panel Monitor. We are now in
compliance with the listing requirements required for continued
listing on Nasdaq. Accordingly, the Panel determined to continue
the listing of our securities on Nasdaq and the aforementioned
matters are now closed.
If
Nasdaq delists our common stock from trading on its exchange for
failure to meet the listing standards, an investor would likely
find it significantly more difficult to dispose of or obtain our
shares, and our ability to raise future capital through the sale of
our shares or issue our shares as consideration in acquisitions
could be severely limited. Additionally, we may not be able to list
our common stock on another national securities exchange, which
could result in our securities being quoted on an over-the-counter
market. If this were to occur, our stockholders could face
significant material adverse consequences, including limited
availability of market quotations for our common stock and reduced
liquidity for the trading of our securities. Delisting could also
have other negative results, including the potential loss of
confidence by employees, the loss of institutional investor
interest and fewer business development opportunities.
A more active, liquid trading market for our common stock may
not develop, and the price of our common stock may fluctuate
significantly.
Historically, the market price of our common stock has fluctuated
over a wide range. There has been relatively limited trading volume
in the market for our common stock, and a more active, liquid
public trading market may not develop or may not be sustained.
Limited liquidity in the trading market for our common stock may
adversely affect a stockholder’s ability to sell its shares of
common stock at the time it wishes to sell them or at a price that
it considers acceptable. If a more active, liquid public trading
market does not develop we may be limited in our ability to raise
capital by selling shares of common stock and our ability to
acquire other companies or assets by using shares of our common
stock as consideration. In addition, if there is a thin trading
market or “float” for our stock, the market price for our common
stock may fluctuate significantly more than the stock market as a
whole. Without a large float, our common stock would be less liquid
than the stock of companies with broader public ownership and, as a
result, the trading prices of our common stock may be more volatile
and it would be harder for a stockholder to liquidate any
investment in our common stock. Furthermore, the stock market is
subject to significant price and volume fluctuations, and the price
of our common stock could fluctuate widely in response to several
factors, including:
|
● |
our quarterly or annual operating results; |
|
● |
changes in our earnings estimates; |
|
● |
investment recommendations by securities analysts following our
business or our industry; |
|
● |
additions or departures of key personnel; |
|
● |
changes in the business, earnings estimates or market
perceptions of our competitors; |
|
● |
our failure to achieve operating results consistent with
securities analysts’ projections; |
|
● |
changes in industry, general market or economic conditions;
and |
|
● |
announcements of legislative or regulatory changes. |
The stock market has experienced extreme price and volume
fluctuations in recent years that have significantly affected the
quoted prices of the securities of many companies, including
companies in the staffing industry. The changes often appear to
occur without regard to specific operating performance. The price
of our common stock could fluctuate based upon factors that have
little or nothing to do with us and these fluctuations could
materially reduce our stock price.
We have suspended our dividends in the past and we may not
pay dividends on our common stock for the foreseeable
future.
We initiated a dividend program in early 2019 under which we
intended to pay a regular quarterly cash dividend of $0.10 per
share to holders of our common stock. The first such dividend was
paid on February 28, 2019 to shareholders of record as of February
15, 2019, but subsequent dividends were suspended by our Board. In
the future, our Board may, without advance notice, determine to
initiate, reduce or suspend our dividends in order to maintain our
financial flexibility and best position us for long-term success.
The declaration and amount of future dividends is at the discretion
of our Board and will depend on our financial condition, results of
operations, cash flows, prospects, industry conditions, capital
requirements and other factors and restrictions our Board deems
relevant. In addition, we are limited in our ability to pay
dividends by certain of our existing agreements. In particular, our
debt agreements only permit us to pay a quarterly cash dividend of
one cent per share of common stock issued and outstanding,
provided, that such cash dividend does not exceed $100 in the
aggregate per fiscal quarter. We may not pay such dividends if any
events of default exist under our debt agreements.
Accordingly, we cannot be certain if we will be able to pay
quarterly cash dividends to holders of our common stock in the
foreseeable future. Consequently, investors must mainly rely on
sales of their common stock after price appreciation, which may
never occur, as the primary way to realize any future gains on
their investment. There is no guarantee that shares of our common
stock will appreciate in value or even maintain the price at which
our stockholders have purchased their shares.
Upon our dissolution, you may not recoup all or any portion
of your investment.
In the event of our liquidation, dissolution or winding-up, our
proceeds and/or assets remaining after giving effect to such
transaction, and the payment of all of our debts and liabilities
will be distributed to the stockholders of common stock on a pro
rata basis. There can be no assurance that we will have available
assets to pay to the holders of common stock, or any amounts, upon
such our liquidation, dissolution or winding-up. In this event, you
could lose some or all of your investment.
General Risk Factors
Global, market and economic conditions may negatively impact
our business, financial condition and share price.
Concerns over inflation, geopolitical issues, the U.S. financial
markets, foreign exchange rates, capital and exchange controls,
unstable global credit markets and financial conditions and the
COVID-19 pandemic, have led to periods of significant economic
instability, declines in consumer confidence and discretionary
spending, diminished expectations for the global economy and
expectations of slower global economic growth going forward, and
increased unemployment rates. Our general business strategy may be
adversely affected by any such economic downturns, volatile
business environments and continued unstable or unpredictable
economic and market conditions. If these conditions deteriorate or
do not improve, it may make any necessary debt or equity financing
more difficult to complete, more costly, and more dilutive. In
addition, there is a risk that one or more of our current or future
service providers and other partners could be negatively affected
by difficult economic times, which could adversely affect our
ability to attain our operating goals on schedule and on budget or
meet our business and financial objectives.
In addition, we face several risks associated with international
business and are subject to global events beyond our control,
including war, public health crises, such as pandemics and
epidemics, trade disputes, economic sanctions, trade wars and their
collateral impacts and other international events. Any of these
changes could have a material adverse effect on our reputation,
business, financial condition or results of operations. There may
be changes to our business if there is instability, disruption or
destruction in a significant geographic region, regardless of
cause, including war, terrorism, riot, civil insurrection or social
unrest; and natural or man-made disasters, including famine, flood,
fire, earthquake, storm or disease. In February 2022, armed
conflict escalated between Russia and Ukraine. The sanctions
announced by the United States and other countries, following
Russia’s invasion of Ukraine against Russia to date include
restrictions on selling or importing goods, services or technology
in or from affected regions and travel bans and asset freezes
impacting connected individuals and political, military, business
and financial organizations in Russia. The United States and other
countries could impose wider sanctions and take other actions
should the conflict further escalate. It is not possible to predict
the broader consequences of this conflict, which could include
further sanctions, embargoes, regional instability, geopolitical
shifts and adverse effects on macroeconomic conditions, currency
exchange rates and financial markets, all of which could impact our
business, financial condition and results of operations.
The COVID-19 pandemic and its ongoing effects has adversely
affected our business and may continue to adversely affect our
business.
In December 2019, a strain of coronavirus was reported to have
surfaced in Wuhan, China, and spread globally. The COVID-19
pandemic has, from time to time, led to government-imposed
quarantines, limitations on business activity and shelter-in-place
mandates to mitigate or contain the virus, and has contributed to
financial market volatility and uncertainty, significant
disruptions in general commercial activity and the global economy,
including in the United States and the United Kingdom where our
operations are based. Much of the independent contractor work we
provide to our clients is performed at the site of our clients. As
a result, we are subject to the plans and approaches of our clients
have made to address the COVID-19 pandemic, such as whether they
support remote working or if they have simply closed their
facilities and furloughed employees. To the extent that our clients
were to decide or are required to close their facilities, or not
permit remote work when they close facilities, we would no longer
generate revenue and profit from that client. In addition, in the
event that our clients’ businesses suffer or close as a result of
the COVID-19 pandemic, we may experience decline in our revenue or
write-off of receivables from such clients. Developments such as
social distancing and shelter-in-place directives have impacted our
ability to deploy our staffing workforce effectively during the
COVID-19 pandemic, thereby impacting contracts with customers in
our commercial staffing and professional staffing business streams,
and may continue to impact our business and results of operations
should such measures be implemented again. While some
government-imposed precautionary measures have been relaxed in
certain countries or states, more strict measures may be put in
place again due to a resurgence in COVID-19 cases or emergence of
new variants of the virus.
Our business was impacted in the years ended January 1, 2022 and
December 31, 2022 by numerous government-mandated lockdown periods
in the United States and United Kingdom. This had a large impact on
the financial results of our numerous business streams, which
differed in their financial recoveries primarily due to the
geographies and industries in which they operate.
The ultimate impact of the COVID-19 pandemic and its ongoing
effects continues to be highly uncertain and subject to future
developments. A continuation or worsening of the levels of market
disruption and volatility seen in the recent past could have an
adverse effect on our ability to access capital and on the market
price of our common stock, and affect our ability to successfully
raise needed capital. If we are unsuccessful in raising capital in
the future, we may need to reduce activities, curtail or cease
operations. The COVID-19 pandemic and its ongoing effects may
continue to disrupt the marketplaces in which we operate, which may
negatively affect our business, results of operations and overall
liquidity, as it has previously.
We depend on attracting, integrating, managing, and retaining
qualified personnel.
Our success is substantially dependent upon our ability to attract,
integrate, manage and retain personnel who possess the skills and
experience necessary to fulfill our customers’ needs. Our ability
to hire and retain qualified personnel could be impaired by any
diminution of our reputation, decrease in compensation levels
relative to our competitors or modifications to our total
compensation philosophy or competitor hiring programs. If we cannot
attract, hire and retain qualified personnel, our business,
financial condition and results of operations may suffer. Our
future success also depends upon our ability to manage the
performance of our personnel. Failure to successfully manage the
performance of our personnel could affect our profitability by
causing operating inefficiencies that could increase operating
expenses and reduce operating income. An overall tightening and
competitive labor market in the U.S. employment market generally,
especially in response to the COVID-19 pandemic, has been observed
in the U.S. A sustained labor shortage or increased turnover rates
within our employee base, caused by the COVID-19 pandemic or as a
result of general macroeconomic factors, could lead to increased
costs, such as increased overtime to meet demand and increased wage
rates to attract and retain employees, and could negatively affect
our ability to efficiently operate and our overall business. If we
are unable to hire and retain employees capable of performing at a
high-level, or if mitigation measures we may take to respond to a
decrease in labor availability have unintended negative effects,
our business could be adversely affected. An overall labor
shortage, lack of skilled labor, increased turnover or labor
inflation caused by the COVID-19 pandemic or as a result of general
macroeconomic factors, could have a material adverse impact on our
operations, results of operations, liquidity or cash flows.
We depend on our ability to attract and retain qualified
temporary workers.
In addition to the members of our own team, our success is
substantially dependent on our ability to recruit and retain
qualified temporary workers who possess the skills and experience
necessary to meet the staffing requirements of our customers. We
are required to continually evaluate our base of available
qualified personnel to keep pace with changing customer needs.
Competition for individuals with proven professional skills is
intense, and demand for these individuals is expected to remain
strong for the foreseeable future. There can be no assurance that
qualified personnel will continue to be available.
If we are unable to retain existing customers or attract new
customers, our business and results of operations could
suffer.
Increasing the growth and profitability of our business is
particularly dependent upon our ability to retain existing
customers and capture additional customers. Our ability to do so is
dependent upon our ability to provide high quality services and
offer competitive prices. If we are unable to execute these tasks
effectively, we may not be able to attract a significant number of
new customers and our existing customer base could decrease, either
or both of which could have an adverse impact on our business and
revenues.
We are dependent upon technology services, and if we
experience damage, service interruptions or failures in our
computer and telecommunications systems, our customer relationships
and our ability to attract new customers may be adversely
affected.
Our business could be interrupted by damage to or disruption of our
computer and telecommunications equipment and software systems, and
we may lose data. Our customers’ businesses may be adversely
affected by any system or equipment failure we experience. As a
result of any of the foregoing, our relationships with our
customers may be impaired, we may lose customers, our ability to
attract new customers may be adversely affected and we could be
exposed to contractual liability. Precautions in place to protect
us from, or minimize the effect of, such events may not be
adequate. If an interruption by damage to or disruption of our
computer and telecommunications equipment and software systems
occurs, we could be liable and the market perception of our
services could be harmed.
Our management has identified a material weakness in our
internal control over financial reporting relating to the lack of a
sufficient complement of competent finance personnel to
appropriately account for, review and disclose the completeness and
accuracy of transactions entered into by the Company. This material
weakness, if not remediated, could result in material misstatements
in our consolidated financial statements. We may be unable to
develop, implement and maintain appropriate internal controls over
financial reporting. If we fail to maintain an effective system of
internal control over financial reporting, we may not be able to
accurately report our financial results and current and potential
stockholders may lose confidence in our financial
reporting.
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, and the
Sarbanes-Oxley Act of 2002 and the SEC rules require that our
management report annually on the effectiveness of our internal
control over financial reporting and our disclosure controls and
procedures. Among other things, our management must conduct an
assessment of our internal control over financial reporting to
allow management to report on the effectiveness of our internal
control over financial reporting, as required by Section 404 of the
Sarbanes-Oxley Act of 2002.
A “material weakness” is a deficiency, or a combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement
of our annual or interim consolidated financial statements will not
be prevented or detected on a timely basis. During the preparation
of our financial statements for the year ended January 1, 2022, we
and our auditors identified a material weakness in our internal
control over financial reporting. We lack a sufficient complement
of competent finance personnel to appropriately account for,
review, and disclose the completeness and accuracy of transactions
entered into by us. In addition, the Company has ineffective design
and operating effectiveness over forecasts used in our annual
goodwill and intangibles evaluation. As part of our remediation
plan, we hired additional employees and external consultants who
have the technical skillset to improve our financial reporting;
implement new policies, procedures and controls; properly review
transactions recorded and classified in the financial statements;
provide effective design and operating effectiveness over
forecasts; and ensure proper accounting and related disclosures for
complex accounting matters when necessary both in the United States
and United Kingdom.
Although we are working to remedy the material weaknesses in our
internal controls over financial reporting discussed above, and
have so far implemented additional controls relating to payroll,
treasury, and accounts payable, there can be no assurance as to
when the remediation plan will be fully developed, when it will be
fully implemented or the aggregate cost of implementation. Until
our remediation plan is fully implemented, our management will
continue to devote significant time and attention to these efforts.
If we do not complete our remediation in a timely fashion, or at
all, or if our remediation plan is inadequate, there will continue
to be an increased risk that we will be unable to timely file
future periodic reports with the SEC and that our future
consolidated financial statements could contain errors that will be
undetected. Further and continued determinations that there are
material weaknesses in the effectiveness of our internal control
over financial reporting relating the above items could also reduce
our ability to obtain financing or could increase the cost of any
financing we obtain and require additional expenditures of both
money and our management’s time to comply with applicable
requirements.
Any failure to implement or maintain required new or improved
controls, or any difficulties we encounter in their implementation,
could result in additional material weaknesses, or could result in
material misstatements in our consolidated financial statements.
These misstatements could result in a restatement of our
consolidated financial statements, cause us to fail to meet our
reporting obligations, reduce our ability to obtain financing or
cause investors to lose confidence in our reported financial
information, leading to a decline in our stock price.
There are inherent limitations in all control systems, and
misstatements due to error or fraud may occur and not be
detected.
The ongoing internal control provisions of Section 404 of the
Sarbanes-Oxley Act of 2002 require us to identify material
weaknesses in internal control over financial reporting, which is a
process to provide reasonable assurance regarding the reliability
of financial reporting for external purposes in accordance with
accounting principles generally accepted in the United States. Our
management, including our Chief Executive Officer and Principal
Financial Officer, does not expect that our internal controls and
disclosure controls will prevent all errors and all fraud. A
control system, no matter how well conceived and operated, can
provide only reasonable, not absolute, assurance that the
objectives of the control system are met. In addition, the design
of a control system must reflect the fact that there are resource
constraints and the benefit of controls must be relative to their
costs. Because of the inherent limitations in all control systems,
no evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, in our business have
been detected. These inherent limitations include the realities
that judgments in decision-making can be faulty and that breakdowns
can occur because of simple errors or mistakes. Further, controls
can be circumvented by individual acts of some persons, by
collusion of two or more persons, or by management override of the
controls. The design of any system of controls is also based in
part upon certain assumptions about the likelihood of future
events, and there can be no assurance that any design will succeed
in achieving our stated goals under all potential future
conditions. Over time, a control may be inadequate because of
changes in conditions, such as growth of our business or increased
transaction volume, or the degree of compliance with the policies
or procedures may deteriorate. Because of inherent limitations in a
cost-effective control system, misstatements due to error or fraud
may occur and not be detected.
In addition, discovery and disclosure of a material weakness could
have a material adverse impact on our financial statements. Such an
occurrence could discourage certain customers or suppliers from
doing business with us, cause downgrades in our future debt ratings
leading to higher borrowing costs and affect how our stock trades.
This could, in turn, negatively affect our ability to access public
debt or equity markets for capital.
Our compliance with complicated regulations concerning
corporate governance and public disclosure has resulted in
additional expenses.
We are faced with expensive, complicated and evolving disclosure,
governance and compliance laws, regulations and standards relating
to corporate governance and public disclosure. In addition, as a
staffing company, we are regulated by the U.S. Department of Labor,
the Equal Employment Opportunity Commission, and often by state
authorities. New or changing laws, regulations and standards are
subject to varying interpretations in many cases due to their lack
of specificity, and their application in practice may evolve over
time as new guidance is provided by regulatory and governing
bodies, which could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing
compliance work.
Our failure to comply with all laws, rules and regulations
applicable to U.S. public companies could subject us or our
management to regulatory scrutiny or sanction, which could harm our
reputation and stock price. Our efforts to comply with evolving
laws, regulations and standards are likely to continue to result in
increased general and administrative expenses and a diversion of
management time and attention from revenue-generating activities to
compliance activities.
The requirements of being a public company place significant
demands on our resources.
As a public company, we incur significant legal, accounting, and
other expenses. In addition, the Sarbanes-Oxley Act of 2002, the
Dodd-Frank Wall Street Reform and Consumer Protection Act, as well
as rules subsequently implemented by the SEC and Nasdaq, have
imposed various requirements on public companies. New laws and
regulations as well as changes to existing laws and regulations
affecting public companies, including the provisions of the
Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and
Consumer Protection Act, and changes in required accounting
practices and rules adopted by the SEC and Nasdaq, would likely
result in increased costs to us as we respond to their
requirements.
Shareholder activism, the current political environment, and the
current high level of government intervention and regulatory reform
may lead to substantial new regulations and disclosure obligations,
which may lead to additional compliance costs and impact the manner
in which we operate our business in ways we cannot currently
anticipate. Our management and other personnel will need to devote
a substantial amount of time to these compliance initiatives.
Moreover, these rules and regulations have increased our legal and
financial compliance costs and will make some activities more time
consuming and costly. For example, these rules and regulations make
it more difficult and more expensive for us to obtain and maintain
director and officer liability insurance and we may be required to
incur substantial costs to maintain our current levels of such
coverage.
Risks Related to This Offering
We have broad discretion in the use of the net proceeds from
this offering and may not use them effectively.
Our management will have broad discretion in the application of the
net proceeds, including for any of the purposes described in the
section of this prospectus entitled “Use of Proceeds”. You will be
relying on the judgment of our management with regard to the use of
these net proceeds, and you will not have the opportunity, as part
of your investment decision, to assess whether the net proceeds are
being used appropriately. The failure by our management to apply
these funds effectively could result in financial losses that could
have a material adverse effect on our business and cause the price
of our securities to decline. Pending the application of these
funds, we may invest the net proceeds from this offering in a
manner that does not produce income or that loses value.
You will experience immediate and substantial dilution in the
net tangible book value of the shares you purchase in this offering
and may experience additional dilution in the future.
Because the effective price per share of common stock included in
the units or issuable upon exercise of the pre-funded warrants
included in the pre-funded units being offered may be substantially
higher than the net tangible book value per share of our common
stock, you may experience substantial dilution to the extent of the
difference between the effective offering price per share of common
stock you pay in this offering and the net tangible book value per
share of our common stock immediately after this offering.
Assuming the sale of [ ]
units at a public offering price of $[ ] per unit, the
closing sale price per share of our common stock on Nasdaq on
[ ], 2023, and assuming no sale of any pre-funded units
in this offering, no exercise of any of the common warrants being
offered in this offering, including the warrants issued to the
placement agent or its designees, and after deducting the placement
agent fees and estimated offering expenses payable by us, you will
incur immediate dilution in as adjusted net tangible book value of
approximately $[ ] per share. As a result of the
dilution to investors purchasing securities in this offering,
investors may receive significantly less than the purchase price
paid in this offering, if anything, in the event of the liquidation
of our company. See the section entitled “Dilution” below for a
more detailed discussion of the dilution you will incur if you
participate in this offering. To the extent shares are issued under
outstanding options and warrants at exercise prices lower than the
public offering price of the units offered in this offering, you
will incur further dilution.
Purchasers who purchase our securities in this offering
pursuant to a securities purchase agreement may have rights not
available to purchasers that purchase without the benefit of a
securities purchase agreement.
In addition to rights and remedies available to all purchasers in
this offering under federal securities and state law, the
purchasers that enter into a securities purchase agreement will
also be able to bring claims for breach of contract against us. The
ability to pursue a claim for breach of contract provides those
investors with the means to enforce the covenants uniquely
available to them under the securities purchase agreement
including: [(i) timely delivery of shares; (ii) agreement to not
enter into variable rate financings for [ ] from
closing, subject to certain exceptions; (iii) agreement to not
enter into any financings for [ ] days from closing; and
(iv) indemnification for breach of contract].
There is no public market for the common warrants or pre-funded
warrants being offered by us in this offering.
There
is no established public trading market for the common warrants or
the pre-funded warrants, and we do not expect a market to develop.
In addition, we do not intend to apply to list the common warrants
or the pre-funded warrants on any national securities exchange or
other nationally recognized trading system. Without an active
market, the liquidity of the common warrants and the pre-funded
warrants will be limited.
The common warrants included in the units and the pre-funded units
are speculative in nature.
The
common warrants represent the right to acquire shares of common
stock at a fixed price. Specifically, commencing on the date of
issuance, holders of the common warrants may acquire the shares of
common stock issuable upon exercise of such warrants at an exercise
price of $
per
share of common stock. Moreover, following this offering, the
market value of the common warrants is uncertain and there can be
no assurance that the market value of the common warrants will
equal or exceed the public offering price. There can be no
assurance that the market price of the shares of common stock will
ever equal or exceed the exercise price of the common warrants, and
consequently, whether it will ever be profitable for holders of
common warrants to exercise the common warrants.
Except as otherwise set forth in the common warrants and
pre-funded warrants, holders of the common warrants
and the pre-funded warrants offered hereby will have no rights as
stockholders with respect to the shares our common stock underlying
the common warrants and the pre-funded warrants until such holders
exercise their common warrants and pre-funded warrants and acquire
our common stock.
Except as otherwise set forth in the common warrants and pre-funded
warrants, until holders of the common warrants and the pre-funded
warrants acquire shares of our common stock upon exercise thereof,
such holders of the common warrants and the pre-funded warrants
will have no rights with respect to the shares of our common stock
underlying such warrants, such as voting rights. Upon exercise of
the common warrants or the pre-funded warrants, as the case may be,
the holder will be entitled to exercise the rights of a common
stockholder only as to matters for which the record date occurs
after the exercise date.
This is a best efforts offering, with no minimum amount of
securities required to be sold, and we may sell fewer than all of
the securities offered hereby.
The
placement agent has agreed to use its reasonable best efforts to
solicit offers to purchase the units and pre-funded units in this
offering. The placement agent has no obligation to buy any of the
securities from us or to arrange for the purchase or sale of any
specific number or dollar amount of the securities. There is no
required minimum number of securities that must be sold as a
condition to completion of this offering. As there is no minimum
offering amount required as a condition to the closing of this
offering, the actual offering amount, placement agent fees and
proceeds to us are not presently determinable and may be
substantially less than the maximum amounts set forth above. We may
sell fewer than all of the securities offered hereby, which may
significantly reduce the amount of proceeds received by us, and
investors in this offering will not receive a refund in the event
that we do not sell all of the units or pre-funded units offered in
this offering.
SPECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS
This prospectus may include “forward-looking statements” within the
meaning of Section 27A of the Securities Act, and Section 21E of
the Exchange Act. Our use of the words “may,” “will,” “would,”
“could,” “should,” “believes,” “estimates,” “projects,”
“potential,” “expects,” “plans,” “seeks,” “intends,” “evaluates,”
“pursues,” “anticipates,” “continues,” “designs,” “impacts,”
“forecasts,” “target,” “outlook,” “initiative,” “objective,”
“designed,” “priorities,” “goal” or the negative of those words or
other similar expressions is intended to identify forward-looking
statements that represent our current judgment about possible
future events. Forward-looking statements should not be read as a
guarantee of future performance or results and will probably not be
accurate indications of when such performance or results will be
achieved. All statements included in this prospectus and in related
comments by our management, other than statements of historical
facts, including without limitation, statements about future events
or financial performance, are forward-looking statements that
involve certain risks and uncertainties. These statements are based
on certain assumptions and analyses made in light of our experience
and perception of historical trends, current conditions and
expected future developments as well as other factors that we
believe are appropriate in the circumstances. Important factors
that could cause actual results to differ materially from these
forward-looking statements include, but are not limited to:
weakness in general economic conditions and levels of capital
spending by customers in the industries we serve; weakness or
volatility in the financial and capital markets, which may result
in the postponement or cancellation of our customers’ capital
projects or the inability of our customers to pay our fees; the
termination of a major customer contract or project; delays or
reductions in U.S. government spending; credit risks associated
with our customers; competitive market pressures; the availability
and cost of qualified labor; our level of success in attracting,
training and retaining qualified management personnel and other
staff employees; changes in tax laws and other government
regulations, including the impact of health care reform laws and
regulations; the possibility of incurring liability for our
business activities, including, but not limited to, the activities
of our temporary employees; our performance on customer contracts;
negative outcome of pending and future claims and litigation;
government policies, legislation or judicial decisions adverse to
our businesses; potential cost overruns and possible rejection of
our business model and/or sales methods; impairment of goodwill;
our ability to access the capital markets by pursuing additional
debt and equity financing to fund our business plan and expenses on
terms acceptable to us or at all; and our ability to comply with
our contractual covenants, including in respect of our debt.
While
these forward-looking statements represent our judgment on what the
future may hold, and we believe these judgments are reasonable,
these statements are not guarantees of any events or financial
results. Whether actual future results and developments will
conform with our expectations and predictions is subject to a
number of risks and uncertainties, including the risks and
uncertainties discussed under the caption “Risk Factors” in this
prospectus and in our Annual Report on Form 10-K for the fiscal
year ended January 1, 2022, as well as any updates to such risks
and uncertainties disclosed in our Quarterly Reports on Form 10-Q
or Current Reports on Form 8-K.
Consequently, all of the forward-looking statements made in this
prospectus are qualified by these cautionary statements and there
can be no assurance that the actual results or developments that we
anticipate will be realized or, even if realized, that they will
have the expected consequences to or effects on us and our
subsidiaries or our businesses or operations. We caution investors
not to place undue reliance on forward-looking statements. We
undertake no obligation to update publicly or otherwise revise any
forward-looking statements, whether as a result of new information,
future events, or other such factors that affect the subject of
these statements, except where we are expressly required to do so
by law.
USE OF PROCEEDS
We
estimate that we will receive net proceeds of approximately $
million from
the sale of the securities offered by us in this offering, assuming
a public offering price of
$ per unit,
the closing price per share of our common stock on Nasdaq on
,
2023, after deducting the placement agent fees and estimated
offering expenses payable by us and assuming no sale of any
pre-funded units offered in this offering. However, because this is
a best efforts offering with no minimum number of securities or
amount of proceeds as a condition to closing, the actual offering
amount, the placement agent’s fees and net proceeds to us are not
presently determinable and may be substantially less than the
maximum amounts set forth on the cover page of this prospectus, and
we may not sell all or any of the securities we are offering. As a
result, we may receive significantly less in net proceeds. In
addition, we may receive proceeds from the exercise of the
placement agent warrants, to the extent such warrants are exercised
for cash, but we will not receive any proceeds from any sale of the
shares underlying the placement agent warrants.
We currently intend to use 50% of the net proceeds from this
offering to repay a portion of the outstanding obligations under
the Jackson Note, due under the Amended Note Purchase Agreement.
The Jackson Note accrues interest at a rate of 12% per year,
provided that if we have not repaid in cash at least 50% of the
outstanding principal balance of the Jackson Note on or before
October 27, 2023, then the interest rate will increase to 16% per
year. The Jackson Note will mature on October 14, 2024.
We
intend to use the remaining 50% of the net proceeds from this
offering for working capital purposes. The amounts and timing of
our use of proceeds will vary depending on a number of factors,
including the amount of cash generated or used by our operations.
As a result, we will retain broad discretion in the allocation of
the net proceeds of this offering.
DILUTION
If
you invest in our securities in this offering, your interest will
be diluted immediately to the extent of the difference between the
public offering price paid by the purchasers of the units sold in
this offering and the as adjusted net tangible book value per
shares of common stock after this offering.
Our
net tangible book value as of October 1, 2022, was approximately
$(24,005,104), or $(9.866) per share of our common stock, based
upon 2,433,199 shares of our common stock outstanding as of that
date. Net tangible book value per share is determined by dividing
our total tangible assets, less total liabilities, by the number of
shares of our common stock outstanding as of October 1, 2022.
Dilution in net tangible book value per share represents the
difference between the amount per share paid by purchasers of units
in this offering and the net tangible book value per share of our
common stock immediately after this offering.
After
giving effect to the issuance and sale of (i) 100,000 shares of our
common stock issued to Jackson pursuant to the Amended Note
Purchase Agreement; and (ii) a warrant to purchase up to an
aggregate of 24,332 shares of common stock at an exercise price of
$3.06 issued to Jackson pursuant to the Amended Note Purchase
Agreement on October 27, 2022, our pro forma net tangible book
value as of October 1, 2022 would have been approximately
$(24,005,104), or $(9.476) per share of common stock (collectively,
the “Pro Forma Adjustments”).
After
giving effect to the sale by us in this offering
of units
in this offering at an assumed public offering price of
$ per unit,
based on the closing sale price of our common stock on Nasdaq on
,
2023, assuming no sale of any pre-funded units in this offering, no
exercise of any of the common warrants being offered in this
offering, including the warrants issued to the placement agent or
its designees, and after deducting the placement agent fees and
estimated offering expenses payable by us, our as adjusted net
tangible book value as of October 1, 2022 would have been
approximately
$ million,
or approximately
$ per
share of common stock. This represents an immediate increase in net
tangible book value of approximately
$ per
share of common stock to our existing security holders and an
immediate dilution in as adjusted net tangible book value of
approximately
$ per
share to purchasers of our securities in this offering, as
illustrated by the following table:
Assumed public offering
price per unit |
|
|
|
|
|
$ |
[ ] |
|
Historical net tangible book value per share as of October 1,
2022 |
|
$ |
(9.866
|
) |
|
|
|
|
Increase in net
tangible book value per share attributable to the Pro Forma
Adjustments |
|
$ |
[
] |
|
|
|
|
|
Pro forma net tangible book value
per share as of October 1, 2022 |
|
$ |
|
|
|
|
|
|
Increase in pro
forma net tangible book value per share attributable to this
offering |
|
$ |
|
|
|
|
|
|
Pro forma as
adjusted net tangible book value per share as of October 1, 2022
after giving effect to this offering |
|
|
|
|
|
$ |
[ ] |
|
Dilution in pro forma as adjusted net
tangible book value per share to investors participating in this
offering |
|
|
|
|
|
$ |
[
] |
|
A
$0.10 increase in the assumed public offering price of $
per unit
would increase our as adjusted net tangible book value after this
offering by $
million, or $
per share,
and the dilution per share to investors purchasing securities in
this offering would be approximately $
per share,
assuming that the maximum number of units, as set forth on the
cover page of this prospectus, remains the same and after deducting
the placement agent fees and estimated offering expenses payable by
us. Similarly, a $0.10 decrease in the assumed public offering
price of $
per unit
would decrease our as adjusted net tangible book value after this
offering by $
million, or
$ per share,
and the dilution per share to investors purchasing securities in
this offering would be $
per share,
assuming that the maximum number of units offered by us, as set
forth on the cover page of this prospectus, remains the same and
after deducting the placement agent fees and estimated offering
expenses payable by us.
We
may also increase or decrease the number of units we are offering
from the assumed maximum number of units set forth above. An
increase of 100,000 units from the assumed maximum number of units
set forth on the cover page of this prospectus would increase our
as adjusted net tangible book value after this offering by $
million, or
$ per share,
and the dilution per share to investors purchasing securities in
this offering would be approximately $
per share,
assuming that the assumed public offering price remains the same
and after deducting the placement agent fees and estimated offering
expenses payable by us. Similarly, a decrease of 100,000 units from
the assumed maximum number units stock set forth on the cover page
of this prospectus would decrease our as adjusted net tangible book
value after this offering by $
million, or $
per share,
and the dilution per share to investors purchasing securities in
this offering would be approximately $
per share,
assuming that the assumed public offering price remains the same
and after deducting the placement agent fees and estimated offering
expenses payable by us.
The
information discussed above is illustrative only and will adjust
based on the actual public offering price, the actual number of
units that we offer in this offering, and other terms of this
offering determined at pricing. The foregoing discussion and table
assumes no sale of pre-funded units, which if sold, would reduce
the number of units that we are offering on a one-for-one basis and
does not take into account further dilution to investors in this
offering that could occur upon the exercise of outstanding options
and warrants having a per share exercise price less than the public
offering price per unit in this offering.
The
discussion and table above are based on 2,433,199 shares of common
stock outstanding as of October 1, 2022, which excludes, unless
otherwise indicated, as of that date:
|
● |
51,302
shares
of common stock issuable upon exercise of stock
options; |
|
● |
2,361,880
shares
of common stock issuable upon the exercise of warrants outstanding
prior to this offering at a weighted average exercise price of
$9.61; |
|
● |
210,000
shares
of common stock issuable pursuant to outstanding performance
awards; |
|
● |
350,004
shares of common stock issuable upon conversion of 9,000,000 shares
of Series H Preferred Stock issued and outstanding; |
|
● |
the
shares of common stock issuable upon the exercise of the common
warrants and the pre-funded warrants to be issued to investors in
this offering an at exercise price of
$ per share
and $0.001 per share, respectively; and |
|
● |
the
shares of common stock issuable upon the exercise of warrants with
an exercise price of $ per
share to be issued to the placement agent or its designees in
connection with this offering. See “Plan of Distribution” on page
30. This prospectus also relates to the offering of the shares of
common stock issuable upon exercise of the warrants issued to the
placement agent or its designees. |
To
the extent that options or warrants outstanding as of October 1,
2022 have been or may be exercised or we issue other shares,
investors purchasing securities in this offering may experience
further dilution. In addition, we may seek to raise additional
capital in the future through the sale of equity or convertible
debt securities. To the extent we raise additional capital through
the sale of equity or convertible debt securities, the issuance of
such securities could result in further dilution to our
stockholders.
DESCRIPTION
OF SECURITIES WE ARE OFFERING
We
are offering (i) units, each unit consisting of one share of our
common stock and one warrant to purchase one share of common stock
and (ii) pre-funded units, each pre-funded unit consisting of one
pre-funded warrant to purchase one share of common stock and one
common warrant to purchase one share of common stock. For each
pre-funded unit we sell, the number of units we are offering will
be decreased on a one-for-one basis.
Each
share of common stock and common warrant included in each unit will
be immediately separable upon issuance and will be issued
separately, and each pre-funded warrant to purchase one share of
common stock and the common warrant included in each pre-funded
unit will be immediately separable upon issuance and will be issued
separately. The units and pre-funded units will not be issued or
certificated. We are also registering the shares of common stock
included in the units, the common warrants included in the units
and the pre-funded units, and the shares of common stock issuable
from time to time upon the exercise of the pre-funded warrants
included in pre-funded units.
Authorized
Capital Stock
We
have authorized 220,000,000 shares of capital stock, of which
200,000,000 are shares of common stock and 20,000,000 are shares of
“blank check” preferred stock. On January 10, 2023, there were
2,669,199 shares of common stock issued and outstanding. We
currently have 1,663,008 shares of preferred stock designated as
Series A Preferred Stock, 200,000 shares of preferred stock
designated as Series B Preferred Stock, 2,000,000 shares of
preferred stock designated as Series C Preferred Stock, 13,000
shares of preferred stock designated as Series E Convertible
Preferred Stock, 6,500 shares of preferred stock designated as
Series E-1 Convertible Preferred Stock, 4,698 shares of preferred
stock designated as Series F Convertible Preferred Stock, 13,000
shares of preferred stock designated as Series G Preferred
Convertible Stock, 6,500 shares of preferred stock designated as
Series G-1 Convertible Preferred Stock, 9,000,000 shares of
preferred stock designated as Series H Preferred Stock, and 40,000
shares of preferred stock designated as Series J Preferred Stock.
On December 28, 2022, there were no shares of the Series A
Preferred Stock, Series B Preferred Stock, Series C Preferred
Stock, Series E Convertible Preferred Stock, Series E-1 Convertible
Preferred Stock, Series F Convertible Preferred Stock, Series G
Convertible Preferred Stock, Series G-1 Convertible Preferred Stock
and Series J Preferred Stock issued and outstanding and 9,000,000
shares of Series H Preferred Stock issued and
outstanding.
The Series H Preferred Stock issued has a stated value equal to
$1.00 per share (the “Stated Value”) and is convertible into an
aggregate of 350,004 shares of common stock at a conversion price
of $2.5714 per share, subject to certain ownership limitations. The
Series H Preferred Stock may be redeemed by us through a cash
payment at a per share price equal to the Stated Value (including,
for the avoidance of doubt, all PIK Dividends accredited thereto,
as defined in the Certificate of Designation), plus all accrued but
unpaid dividends thereon (the “Redemption Price”), at any time on
or after the date of issuance. Upon the third anniversary of the
date of issuance, we shall redeem all of the shares of the Series H
Preferred Stock at the Redemption Price, subject to certain
provisions in the Limited Consent to the Second Amended and
Restated Note Purchase Agreement, dated April 18, 2022, by and
between us and Jackson. The Series H Preferred Stock carries
quarterly dividend rights of cash dividends accruing (i) at an
annual rate per share equal to 12% from the date of issuance and
(ii) at an annual rate per share of 15%, if we have not redeemed
all outstanding shares of Series H Preferred Stock after the third
anniversary from the date of issuance.
Subject to certain beneficial ownership limitations, the Series H
Preferred Stock shall vote on an “as converted” basis on all
matters submitted to the holders of our common stock for approval.
In addition, as long as any shares of the Series H Preferred Stock
are outstanding, we shall not, without the affirmative vote of the
holders of a majority of the then outstanding shares of the Series
H Preferred Stock, (a) alter or change adversely the powers,
preferences or rights given to the Series H Preferred Stock, (b)
amend our certificate of incorporation or other charter documents
in any manner that adversely affects any rights of the holders of
the Series H Preferred Stock, or (c) increase the number of
authorized shares of the Series H Preferred Stock, or (d) enter
into any agreement with respect to any of the foregoing.
The
authorized and unissued shares of common stock and the authorized
and undesignated shares of preferred stock are available for
issuance without further action by our stockholders, unless such
action is required by applicable law or the rules of any stock
exchange on which our securities may be listed. Unless approval of
our stockholders is so required, our Board does not intend to seek
stockholder approval for the issuance and sale of our common stock
or preferred stock.
Common
Stock
The following is a summary of the material terms and provisions of
the shares of common stock that are being offered hereby. This
summary is subject to and qualified in its entirety by our
Certificate of Incorporation, any certificates of designation for
our preferred stock, and our Bylaws, as may be amended from time to
time, which are filed as exhibits to the registration statement of
which this prospectus forms a part.
Pursuant to our Certificate of Incorporation, the members of the
Board are divided into three classes, designated Class I, Class II
and Non-Classified. Class I or Class II directors shall be elected
to hold office for a two-year term and until such directors’
respective successors shall be duly elected and qualified. Each
member of the Board who is not assigned to either Class I or Class
II, including such member’s respective successors shall be
designated “Non-Classified Directors”, and shall, at each annual
meeting of stockholders, be elected to serve for a term of one year
and until such director’s successor shall be duly elected and
qualified.
Our
common stock is entitled to one vote for each share held on all
matters submitted to a vote of the stockholders, including the
election of directors, and does not have cumulative voting rights.
Accordingly, the holders of a majority of the shares of our common
stock entitled to vote in any election of directors can elect all
of the directors standing for election.
Subject
to preferences that may be applicable to any then-outstanding
preferred stock, the holders of common stock are entitled to
receive dividends, if any, as may be declared from time to time by
our Board out of legally available funds. At our Board’s
discretion, we paid a quarterly cash dividend of $0.01 per share to
holders of our common stock on each of February 28, 2019 and May
30, 2019. We are limited in our ability to pay dividends by certain
of our existing agreements. In particular, our debt agreements only
permit us to pay a quarterly cash dividend of one cent per share of
common stock issued and outstanding, provided, that such cash
dividend does not exceed $100,000 in the aggregate per fiscal
quarter. We may not pay such dividends if any events of default
exist under our debt agreements.
In
the event of our liquidation, dissolution or winding-up, holders of
our common stock will be entitled to share ratably in the net
assets legally available for distribution to stockholders after the
payment of all of our debts and other liabilities, subject to the
satisfaction of any liquidation preference granted to the holders
of any outstanding shares of preferred stock. Holders of our common
stock have no preemptive, conversion or subscription rights, and
there are no redemption or sinking fund provisions applicable to
our common stock. The rights, preferences and privileges of the
holders of our common stock are subject to, and may be adversely
affected by, the rights of the holders of shares of any series of
our preferred stock that are outstanding or that we may designate
and issue in the future.
Our common stock is listed on Nasdaq under the symbol “STAF.” The
transfer agent and registrar for our common stock is Securities
Transfer Corporation. The transfer agent’s address 2901 N. Dallas
Parkway, Suite 380, Plano, Texas 75093.
As of
January 17, 2023, we had 551 holders of record of our shares of
common stock.
Common
Warrants
The
following summary of certain terms and provisions of the common
warrants included in the units and pre-funded units that are being
offered hereby is not complete and is subject to, and qualified in
its entirety by, the provisions of the common warrant, the form of
which will be filed as an exhibit to the registration statement of
which this prospectus forms a part. Prospective investors should
carefully review the terms and provisions of the form of common
warrant for a complete description of the terms and conditions of
the common warrants.
Duration,
Exercise Price and Form
Each
common warrant included in the units and pre-funded units will have
an exercise price equal to
$ per share. The common
warrants will be immediately exercisable and may be exercised until
the five-year anniversary of the original issuance date. The
exercise price and number of shares of common stock issuable upon
exercise is subject to appropriate adjustment in the event of stock
dividends, stock splits, reorganizations or similar events
affecting our common stock and the exercise price. The common
warrants will be issued separately from the common stock or the
pre-funded warrants, as the case may be, and may be transferred
separately immediately thereafter. The common warrants will be
issued in certificated form only.
Exercisability
The
common warrants will be exercisable, at the option of each holder,
in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of
our common stock purchased upon such exercise (except in the case
of a cashless exercise as discussed below). A holder (together with
its affiliates) may not exercise any portion of such holder’s
warrants to the extent that the holder would own more than 4.99% of
the outstanding common stock (or at the election of a holder prior
to the date of issuance, 9.99%) immediately after exercise, except
that upon at least 61 days’ prior notice from the holder to us, the
holder may increase the amount of ownership of outstanding stock
after exercising the holder’s warrants up to 9.99% of the number of
shares of our common stock outstanding immediately after giving
effect to the exercise, as such percentage ownership is determined
in accordance with the terms of the common warrants.
Cashless
Exercise
If at the time of exercise there is no effective registration
statement registering, or the prospectus contained therein is not
available for the issuance of the underlying shares to the holder,
in lieu of making the cash payment otherwise contemplated to be
made to us upon such exercise in payment of the aggregate exercise
price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of common
stock determined according to a formula set forth in the common
warrant.
Fundamental
Transactions
In
the event of a fundamental transaction, as described in the common
warrants and generally including any reorganization,
recapitalization or reclassification of our common stock, the sale,
transfer or other disposition of all or substantially all of our
properties or assets, our consolidation or merger with or into
another person, the acquisition of more than 50% of our outstanding
common stock, or any person or group becoming the beneficial owner
of 50% of the voting power represented by our outstanding common
stock, the holders of the common warrants will be entitled to
receive upon exercise of the common warrants the kind and amount of
securities, cash or other property that the holders would have
received had they exercised the common warrants immediately prior
to such fundamental transaction. In addition, in certain
circumstances, upon a fundamental transaction, the holder of a
common warrant will have the right to require us to repurchase its
common warrants at the Black-Scholes value; provided, however,
that, if the fundamental transaction is not within our control,
including not approved by our Board, then the holder will only be
entitled to receive the same type or form of consideration (and in
the same proportion), at the Black-Scholes value of the unexercised
portion of the common warrant that is being offered and paid to the
holders of our common stock in connection with the fundamental
transaction.
Transferability
Subject
to applicable laws, a common warrant may be transferred at the
option of the holder upon surrender of the common warrant to us
together with the appropriate instruments of transfer.
Fractional
Shares
No
fractional shares of common stock will be issued upon the exercise
of the common warrants. Rather, the number of shares of common
stock to be issued will, at our election, either be rounded up to
the nearest whole number or we will pay a cash adjustment in
respect of such final fraction in an amount equal to such fraction
multiplied by the exercise price.
Trading
Market
There
is no established trading market for the common warrants, and we do
not expect a market to develop. We do not intend to apply for a
listing of the common warrants on any securities exchange or other
nationally recognized trading system. Without an active trading
market, the liquidity of the common warrants will be limited. The
common stock issuable upon exercise of the common warrants is
currently listed on Nasdaq.
Rights
as a Stockholder
Except
as otherwise provided in the common warrants or by virtue of the
holders’ ownership of shares of common stock, the holders of the
common warrants do not have the rights or privileges of holders of
our shares of common stock, including any voting rights, until such
common warrant holders exercise their common warrants.
Pre-Funded
Warrants
The
following summary of certain terms and provisions of the pre-funded
warrants included in the pre-funded units that are being offered
hereby is not complete and is subject to, and qualified in its
entirety by, the provisions of the pre-funded warrant, the form of
which will be filed as an exhibit to the registration statement of
which this prospectus forms a part. Prospective investors should
carefully review the terms and provisions of the form of pre-funded
warrant for a complete description of the terms and conditions of
the pre-funded warrants.
Duration,
Exercise Price and Form
The
pre-funded warrants offered hereby will have an exercise price of
$0.001 per share. The pre-funded warrants will be immediately
exercisable and may be exercised at any time after their original
issuance until such pre-funded warrants are exercised in full. The
exercise price and number of shares of common stock issuable upon
exercise are subject to appropriate adjustment in the event of
share dividends, share splits, reorganizations or similar events
affecting our shares of common stock. The pre-funded warrants will
be issued separately from the common warrants included in the
pre-funded units and may be transferred separately immediately
thereafter. The pre-funded warrants will be issued in certificated
form only.
Exercisability
The
pre-funded warrants will be exercisable, at the option of each
holder, in whole or in part, by delivering to us a duly executed
exercise notice accompanied by payment in full for the number of
shares of our common stock purchased upon such exercise (except in
the case of a cashless exercise as discussed below). A holder
(together with its affiliates) may not exercise any portion of the
pre-funded warrant to the extent that the holder would own more
than 4.99% (or at the election of a holder prior to the date of
issuance, 9.99%) of the outstanding common stock immediately after
exercise; provided, however, that upon notice to us, the holder may
increase or decrease such beneficial ownership limitation, provided
that in no event shall the beneficial ownership limitation exceed
9.99% and any increase in the beneficial ownership limitation will
not be effective until 61 days following notice of such increase
from the holder to us.
Cashless
Exercise
At
the time a holder exercises its pre-funded warrants, in lieu of
making the cash payment otherwise contemplated to be made to us
upon such exercise in payment of the aggregate exercise price, the
holder may elect instead to receive upon such exercise (either in
whole or in part) the net number of shares of common stock
determined according to a formula set forth in the pre-funded
warrant.
Fundamental
Transactions
In
the event of a fundamental transaction, as described in the
pre-funded warrants and generally including any reorganization,
recapitalization or reclassification of our common stock, the sale,
transfer or other disposition of all or substantially all of our
properties or assets, our consolidation or merger with or into
another person, the acquisition of more than 50% of our outstanding
common stock, or any person or group becoming the beneficial owner
of 50% of the voting power represented by our outstanding common
stock, the holders of the pre-funded warrants will be entitled to
receive upon exercise of the pre-funded warrants the kind and
amount of securities, cash or other property that the holders would
have received had they exercised the pre-funded warrants
immediately prior to such fundamental transaction.
Transferability
Subject
to applicable laws, a pre-funded warrant may be transferred at the
option of the holder upon surrender of the pre-funded warrant to us
together with the appropriate instruments of transfer.
Fractional
Shares
No
fractional shares of common stock will be issued upon the exercise
of the pre-funded warrants. Rather, the number of shares of common
stock to be issued will, at our election, either be rounded up to
the nearest whole number or we will pay a cash adjustment in
respect of such final fraction in an amount equal to such fraction
multiplied by the exercise price.
Trading
Market
There
is no established trading market for the pre-funded warrants, and
we do not expect a market to develop. We do not intend to apply for
a listing of the pre-funded warrants on any securities exchange or
other nationally recognized trading system. Without an active
trading market, the liquidity of the pre-funded warrants will be
limited. The common stock issuable upon exercise of the pre-funded
warrants is currently listed on Nasdaq.
Rights
as a Stockholder
Except
as otherwise provided in the pre-funded warrants or by virtue of
the holders’ ownership of shares of common stock, the holders of
pre-funded warrants do not have the rights or privileges of holders
of our shares of common stock, including any voting rights, until
such pre-funded warrant holders exercise their warrants.
PLAN OF DISTRIBUTION
We
have engaged H.C. Wainwright & Co., LLC, or the placement
agent, to act as our exclusive placement agent to solicit offers to
purchase the shares of our common stock, pre-funded warrants and
common warrants offered by this prospectus. The placement agent is
not purchasing or selling any such securities, nor is it required
to arrange for the purchase and sale of any specific number or
dollar amount of such securities, other than to use its “reasonable
best efforts” to arrange for the sale of such securities by us.
Therefore, we may not sell all of the shares of common stock,
pre-funded warrants and common warrants being offered. The terms of
this offering were subject to market conditions and negotiations
between us, the placement agent and prospective investors. The
placement agent will have no authority to bind us by virtue of the
engagement letter. This is a best efforts offering and there is no
minimum offering amount required as a condition to the closing of
this offering. The placement agent may retain sub-agents and
selected dealers in connection with this offering. Investors
purchasing securities offered hereby will have the option to
execute a securities purchase agreement with us. In addition to
rights and remedies available to all purchasers in this offering
under federal securities and state law, the purchasers which enter
into a securities purchase agreement will also be able to bring
claims of breach of contract against us. The ability to pursue a
claim for breach of contract is material to larger purchasers in
this offering as a means to enforce the following covenants
uniquely available to them under the securities purchase agreement:
(i) a covenant to not enter into variable rate financings for a
period of one year following the closing of the offering, subject
to an exception; and (ii) a covenant to not enter into any equity
financings for thirty (30) days from closing of the offering,
subject to certain exceptions.
The
nature of the representations, warranties and covenants in the
securities purchase agreements shall include:
|
● |
standard
issuer representations and warranties on matters such as
organization, qualification, authorization, no conflict, no
governmental filings required, current in SEC filings, no
litigation, labor or other compliance issues, environmental,
intellectual property and title matters and compliance with various
laws such as the Foreign Corrupt Practices Act; and |
|
|
|
|
● |
covenants
regarding matters such as registration of warrant shares, no
integration with other offerings, filing of an 8-K to disclose
entering into these securities purchase agreements, no shareholder
rights plans, no material nonpublic information, use of proceeds,
indemnification of purchasers, reservation and listing of common
stock, and no subsequent equity sales for thirty (30)
days. |
Delivery
of the shares of common shares, pre-funded warrants and common
warrants offered hereby is expected to occur on or about
___________, 2023, subject to satisfaction of certain customary
closing conditions.
We
have agreed to pay the placement agent (i) a cash fee equal to 7.5%
of the aggregate gross proceeds of this offering; (ii) a management
fee of 1.0% of the aggregate gross proceeds of this offering; (iii)
$25,000 for non-accountable expenses; (iv) up to $100,000 for the
placement agent’s legal expenses; and (v) up to $15,950 for the
clearing expenses of the placement agent in connection with this
offering.
We
estimate the total expenses of this offering paid or payable by us
will be approximately
$ . After
deducting the fees due to the placement agent and our estimated
expenses in connection with this offering, we expect the net
proceeds from this offering will be approximately
$
million.
Placement
Agent Warrants
In
addition, we have agreed to issue to the placement agent or its
designees warrants, or the placement agent warrants, to purchase up
to 7.5% of the aggregate number of shares of common stock sold in
this offering (including shares underlying any pre-funded
warrants), at an exercise price equal to 125% of the public
offering price per unit to be sold in this offering. The placement
agent warrants will be exercisable upon issuance and will expire
five years from the commencement of sales under this
offering.
If at
the time of exercise there is no effective registration statement
registering, or the prospectus contained therein is not available
for the resale of warrant shares by the holders of the placement
agent warrants, then the placement agent warrants may be exercised,
in whole or in part, at such time by means of a “cashless exercise”
in which the holders shall be entitled to receive a number of
warrant shares as calculated in the placement agent
warrants.
The
placement agent warrants provide for customary anti-dilution
provisions (for share dividends, splits and recapitalizations and
the like) consistent with FINRA Rule 5110.
Tail
Financing Payments
In
the event that any investors (other than Jackson or its affiliates)
that were contacted by the placement agent or were introduced to
the Company by the placement agent during the term of our
engagement agreement with the placement agent provide any capital
to us in a public or private offering or capital-raising
transaction within 12 months following the termination or
expiration of our engagement agreement with the placement agent, we
shall pay the placement agent the cash and warrant compensation
provided above on the gross proceeds from such
investors.
Lock-Up
Agreements
We
and each of our officers and directors have agreed, subject to
certain exceptions, not to offer, pledge, sell, contract to sell,
grant any option or contract to purchase, purchase any option or
contract to sell, hypothecate, pledge or otherwise dispose of (or
enter into any transaction which is designed to, or might
reasonably be expected to, result in the disposition (whether by
actual disposition or effective economic disposition due to cash
settlement or otherwise). directly or indirectly, or establish or
increase a put equivalent position or liquidate or decrease a call
equivalent position within the meaning of Section 16 of the
Exchange Act with respect to, any shares of common stock of the
Company or securities convertible, exchangeable or exercisable
into, shares of common stock of the Company beneficially owned,
held or hereafter acquired for a period of 90 days after the
date of the securities purchase agreement. The placement agent may,
in its sole discretion and without notice, waive the terms of any
of these lock-up agreements.
We
have also agreed for a period of one year following the closing
date of this offering not to (i) issue or agree to issue equity or
debt securities convertible into, or exercisable or exchangeable
for, common stock at a conversion price, exercise price or exchange
price which floats with the trading price of our common stock or
which may be adjusted after issuance upon the occurrence of certain
events or (ii) enter into any agreement, including an equity line
of credit, whereby we may issue securities at a future-determined
price. This agreement does not apply to the offer, issuance or sale
by us of our common stock pursuant to an at-the-market offering
facility we may enter with the placement agent following expiration
of the 90-day lock-up period.
Indemnification
We
have agreed to indemnify the placement agent against certain
liabilities, including civil liabilities under the Securities Act,
or to contribute to payments that the placement agent may be
required to make in respect of those liabilities.
In
addition, we will indemnify the purchasers of securities in this
offering against liabilities arising out of or relating to (i) any
breach of any of the representations, warranties, covenants or
agreements made by us in the securities purchase agreement or
related documents or (ii) any action instituted against a purchaser
by a third party (other than a third party who is affiliated with
such purchaser) with respect to the securities purchase agreement
or related documents and the transactions contemplated thereby,
subject to certain exceptions.
Other
Relationships
From
time to time, the placement agent and its affiliates have in the
past and may in the future provide various advisory, investment and
commercial banking and other services to us in the ordinary course
of business, for which they may receive customary fees and
commissions. The placement agent acted as our underwriter for our
December 2020 public offering, and as placement agent for our
December 2020 registered direct offering, February 2021 public
offering, April 2021 private placement, July 2021 registered direct
offering and concurrent private placement, each of the August 2021
registered direct offerings and concurrent private placements,
November 2021 private placement and July 2022 private placement.
for which it received compensation.
Transfer
Agent
The
transfer agent and registrar for our common stock is Securities
Transfer Corporation.
Nasdaq
listing
Our
shares of common stock are listed on Nasdaq under the symbol
“STAF”.
BUSINESS
General
Staffing
360 Solutions, Inc. (“we,” “us,” “our,” “Staffing 360,” or the
“Company”) was incorporated in the State of Nevada on December 22,
2009, as Golden Fork Corporation, which changed its name to
Staffing 360 Solutions, Inc., ticker symbol “STAF”, on March 16,
2012. On June 15, 2017, we changed our domicile to the State of
Delaware. As a rapidly growing public company in the international
staffing sector, our high-growth business model is based on finding
and acquiring, suitable, mature, profitable, operating, domestic
and international staffing companies. Our targeted consolidation
model is focused specifically on the accounting and finance,
information technology (“IT”), engineering, administration and
light industrial disciplines.
Business
Model and Acquisitions
We
are a high-growth international staffing company engaged in the
acquisition of U.S. and U.K. based staffing companies. As part of
our consolidation model, we pursue a broad spectrum of staffing
companies supporting primarily the Professional and Commercial
Business Streams. Our typical acquisition model is based on paying
consideration in the form of cash, stock, earn-outs and/or
promissory notes. In furthering our business model, we are
regularly in discussions and negotiations with various suitable,
mature acquisition targets. Since November 2013, we have completed
11 acquisitions.
Operating
History
We
generated revenue of $197,770,476 and $204,526,852 for the years
ended January 1, 2022 (“Fiscal 2021”) and January 2, 2021 (“Fiscal
2020”), respectively. This decrease was primarily caused by the
sale of firstPRO, as well as a slower than expected recovery
due to the ongoing impacts of the COVID-19 pandemic.
Headway
Acquisition
On
April 18, 2022, we entered into a Stock Purchase Agreement with
Headway and Chapel Hill Partners, LP, as the representatives of all
the stockholders of Headway, pursuant to which, among other things,
we agreed to purchase all of the issued and outstanding securities
of Headway in exchange for (i) a cash payment of $14,065, and (ii)
9,000,000 shares of our Series H Preferred Stock, with a value
equal to the Closing Payment, as defined in the Stock Purchase
Agreement. On May 18, 2022, the Headway Acquisition closed. The
purchase price in connection with the Headway Acquisition was
approximately $9,000,000.
Industry
Background
The
staffing industry is divided into three major segments: temporary
staffing services, professional employer organizations (“PEOs”) and
placement agencies. Temporary staffing services provide workers for
limited periods, often to substitute for absent permanent workers
or to help during periods of peak demand. These workers, who are
often employees of the temporary staffing agency, will generally
fill clerical, technical, or industrial positions. PEOs, sometimes
referred to as employee leasing agencies, contract to provide
workers to customers for specific functions, often related to human
resource management. In many cases, a customer’s employees are
hired by a PEO and then contracted back to the customer. Placement
agencies, sometimes referred to as executive recruiters or
headhunters, find workers to fill permanent positions at customer
companies. These agencies may specialize in placing senior
managers, mid-level managers, technical workers, or clerical and
other support workers.
We
consider ourselves a temporary staffing company within the broader
staffing industry. However, we provide permanent placements at the
request of existing clients and some consulting services
clients.
Staffing
companies identify potential candidates through online advertising
and referrals, and interview, test and counsel workers before
sending them to the customer for approval. Pre-employment screening
can include skills assessment, drug tests and criminal background
checks. The personnel staffing industry has been radically changed
by the internet. Many employers list available positions with one
or several internet personnel sites like www.monster.com or
www.careerbuilder.com, and on their own sites. Personnel agencies
operate their own sites and often still work as intermediaries by
helping employers accurately describe job openings and by screening
candidates who submit applications.
Major
end-use customers include businesses from a wide range of
industries such as manufacturing, construction, wholesale and
retail. Marketing involves direct sales presentations, referrals
from existing clients and advertising. Agencies compete both for
customers and workers. Depending on market supply and demand at any
given time, agencies may allocate more resources either to finding
potential employers or potential workers. Permanent placement
agencies work either on a retained or on a contingency basis.
Clients may retain an agency for a specific job search or on
contract for a specific period. Temporary staffing services charge
customers a fixed price per hour/day or a standard markup on
prevailing hourly/daily rates.
For
many staffing companies, demand is lower late in the fourth
calendar quarter and early in the first calendar quarter, partly
because of holidays, and higher during the rest of the year.
Staffing companies may have high receivables from customers.
Temporary staffing agencies and PEOs must manage a high cash flow
because they funnel payroll payments from employers. Cash flow
imbalances also occur because agencies must pay workers even though
they haven’t been paid by clients.
The
revenue of staffing companies depends on the number of jobs they
fill, which in turn can depend upon the economic environment.
During economic slowdowns, many client companies stop hiring
altogether. Internet employment sites expand a company’s ability to
find workers without the help of traditional agencies. Staffing
companies often work as intermediaries, helping employers
accurately describe job openings and screen candidates. Increasing
the use of sophisticated, automated job description and candidate
screening tools could make many traditional functions of personnel
agencies obsolete. Free social networking sites such as LinkedIn
and Facebook are also becoming a common way for recruiters and
employees to connect without the assistance of a staffing
agency.
To
avoid large placement agency fees, big companies may use in-house
personnel staff, current employee referrals, or human resources
consulting companies to find and hire new personnel. Because
placement agencies typically charge a fee based on a percentage of
the first year’s salary of a new worker, companies with many jobs
to fill have a financial incentive to avoid agencies.
Many
staffing companies are small and may depend heavily on a few big
customers for a large portion of revenue. Large customers may lead
to increased revenue, but also expose agencies to higher risks.
When major accounts experience financial hardships, and have less
need for temporary employment services, agencies stand to lose
large portions of revenue.
The
loss of a staff member who handles a large volume of business may
result in a large loss of revenue for a staffing company.
Individual staff members, rather than the staffing company itself,
often develop strong relationships with customers. Staff members
who move to another staffing company are often able to move
customers with them.
Some
of the best opportunities for temporary employment are in
industries traditionally active in seasonal cycles, such as
manufacturing, construction, wholesale and retail. However,
seasonal demand for workers creates cash flow fluctuations
throughout the year.
Staffing
companies are regulated by the U.S. Department of Labor and the
Equal Employment Opportunity Commission, and often by state
authorities. Many federal anti-discrimination rules regulate the
type of information that employment firms can request from
candidates or provide to customers about candidates. In addition,
the relationship between the agency and the temporary employees, or
employee candidates may not always be clear, resulting in legal and
regulatory uncertainty. PEOs are often considered co-employers
along with the client, but the PEO is responsible for employee
wages, taxes and benefits. State regulation aims to ensure that
PEOs provide the benefits they promise to workers.
Trends
in the Staffing Business
Start-up
costs for a staffing company are very low. Individual offices can
be profitable, but consolidation is driven mainly by the
opportunity for large agencies to develop national relationships
with big customers. Some agencies expand by starting new offices in
promising markets, but most prefer to buy existing independent
offices with proven staff and an existing customer
roster.
At
some companies, temporary workers have become such a large part of
the workforce that staffing company employees sometimes work at the
customer’s site to recruit, train, and manage temporary employees.
The Company has a number of onsite relationships with its
customers. Staffing companies try to match the best qualified
employees for the customer’s needs, but often provide additional
training specific to that company, such as instruction in the use
of proprietary software.
Some
personnel consulting firms and human resource departments are
increasingly using psychological tests to evaluate potential job
candidates. Psychological or liability testing has gained
popularity, in part, due to recent fraud scandals. In addition to
stiffer background checks, headhunters often check the credit
history of prospective employees.
We
believe the trends of outsourcing entire departments and dependence
on temporary and leased workers will expand opportunities for
staffing companies. Taking advantage of their expertise in
assessing worker capabilities, some staffing companies manage their
clients’ entire human resource functions. Human resources
outsourcing (“HRO”) may include management of payroll, tax filings,
and benefit administration services. HRO may also include
recruitment process outsourcing (“RPO”), whereby an agency manages
all recruitment activities for a client.
New
online technology is improving staffing efficiency. For example,
some online applications coordinate workflow for staffing agencies,
their clients and temporary workers, and allow agencies and
customers to share work order requests, submit and track
candidates, approve timesheets and expenses, and run reports.
Interaction between candidates and potential employers is
increasingly being handled online.
Initially
viewed as rivals, some Internet job-search companies and
traditional employment agencies are now collaborating. While some
Internet sites do not allow agencies to use their services to post
jobs or look through resumes, others find that agencies are their
biggest customers, earning the sites a large percentage of their
revenue. Some staffing companies contract to help client employers
find workers online.
Competition
Our
staffing divisions face competition in attracting clients as well
as temporary candidates. The staffing industry is highly
competitive, with a number of firms offering services similar to
those provided by us on a national, regional or local basis. In
many areas, the local staffing companies are our strongest
competitors. The most significant competitive factors in the
staffing business are price and reliability of service. We believe
its competitive advantage stems from its experience in niche
markets, and commitment to the specialized employment market, along
with its growing global presence.
The
staffing industry is characterized by a large number of competing
companies in a fragmented sector. Major competitors also exist
across the sector, but as the industry affords low barriers to
entry, new entrants are constantly introduced to the
marketplace.
The
top layer of competitors includes large corporate staffing and
employment companies which have yearly revenue of $75 million or
more. The next (middle) layer of the competition consists of
medium-sized entities with yearly revenue of $10 million or more.
The largest portion of the marketplace is the bottom layer of this
competitive landscape consisting of small, individual-sized or
family-run operations. As barriers to entry are low, sole
proprietors, partnerships and small entities routinely enter the
industry.
Employees
We
employ approximately 265 full-time employees as part of our
internal operations. Additionally, we employ approximately 6,000
individuals that are placed directly with our clients through our
various operating subsidiaries.
PROPERTIES
We
lease 6,960 square feet of space at 757 Third Avenue, 27th Floor,
New York, NY 10017, our headquarters and principal location. Our
lease for this space will expire in 2029. We currently have a total
of 16 facilities throughout the U.S. and the U.K. This includes
U.K. offices in London and Redhill, England, as well as offices in
the following states in the U.S.: New York, Connecticut,
Massachusetts, Rhode Island, and North Carolina.
All
offices are operated from leased space ranging from approximately
1,200 to 10,000 square feet, typically through operating leases
with terms that range from six months to ten years, and thus with
expirations from 2023 through 2032. We believe that our facilities
are adequate for our current requirements and that our leasing
strategies provide us with sufficient flexibility to accommodate
our business needs.
LEGAL PROCEEDINGS
Whitaker
v. Monroe Staffing Services, LLC & Staffing 360 Solutions,
Inc.
On
December 5, 2019, former owner of Key Resources, Inc. (“KRI”),
Pamela D. Whitaker (“Whitaker” or “Plaintiff”), filed a complaint
in Guilford County, North Carolina (the “North Carolina Action”)
asserting claims for breach of contract and declaratory judgment
against Monroe Staffing Services LLC (“Monroe”) and the Company
(collectively, the “Defendants”) arising out of the alleged
non-payment of certain earn-out payments and interest purportedly
due under a share purchase agreement (the “Whitaker Share Purchase
Agreement”) pursuant to which Whitaker sold all issued and
outstanding shares in her staffing agency, KRI, to Monroe in August
2018. Whitaker sought $4,054,395 in alleged damages.
Defendants
removed the action to the Middle District of North Carolina on
January 7, 2020, and Plaintiff moved to remand on February 4, 2020.
Briefing on the motion to remand concluded on February 24, 2020.
Separately, Defendants moved to dismiss the action on January 14,
2020, based on Plaintiff’s failure to state a claim, improper
venue, and lack of personal jurisdiction as to defendant Staffing
360 Solutions, Inc. Alternatively, Defendants sought a transfer of
the action to the Southern District of New York, based on the plain
language of the Whitaker Share Purchase Agreement’s forum selection
clause. Briefing on Defendants’ motion to dismiss concluded on
February 18, 2020. On February 28, 2020, Plaintiff moved for leave
to file an amended complaint. Defendants filed their opposition to
the motion for leave on March 19, 2020. Plaintiff thereafter filed
a reply.
On
June 29, 2020, Magistrate Judge Joe L. Webster issued a Report and
Recommendation on the pending motions, recommending that
Defendants’ motion to dismiss be granted with regard to Defendants’
request to transfer the matter to the Southern District of New
York, and denied in all other regards without prejudice to
Defendants raising those arguments again in the new forum.
Magistrate Judge Webster also recommended that Plaintiff’s motion
to remand be denied and motion to amend be left to the discretion
of the Southern District of New York.
Plaintiff
filed an objection to the Report and Recommendation on July 9,
2020. Defendants responded on July 23, 2020. On February 19, 2021,
the District Court issued a decision that reversed the Magistrate
Judge’s Order. The District Court granted Plaintiff’s motion to
remand and denied Defendants’ motion to dismiss as moot. Defendants
filed a Notice of Appeal to the Fourth Circuit on February 25,
2021, and filed their opening brief on April 21, 2021. Plaintiff
filed her response brief on May 21, 2021, and Defendants replied on
June 11, 2021. Oral argument was held on March 9, 2022. On July 22,
2022, the Fourth Circuit issued a decision to vacate the District
Court’s decision and ordered the North Carolina District Court to
transfer the North Carolina Action to the Southern District of New
York for adjudication there in accordance with the Whitaker Share
Purchase Agreement’s forum selection clause.
Monroe
Staffing Services, LLC & Staffing 360 Solutions, Inc. v.
Whitaker
Separately,
on February 26, 2020, the Company and Monroe filed an action
against Whitaker in the United States District Court for the
Southern District of New York (Case No. 1:20-cv-01716) (the “New
York Action”). The New York Action concerns claims for breach of
contract and fraudulent inducement arising from various
misrepresentations made by Whitaker to the Company and Monroe in
advance of, and included in, the Whitaker Share Purchase Agreement.
The Company and Monroe are seeking damages in an amount to be
determined at trial but in no event less than $6,000. On April 28,
2020, Whitaker filed a motion to dismiss the New York Action on
both procedural and substantive grounds. On June 11, 2020, Monroe
and the Company filed their opposition to Whitaker’s motion to
dismiss. On July 9, 2020 Whitaker filed reply papers in further
support of the motion.
On
October 13, 2020, the Court denied Whitaker’s motion to dismiss, in
part, and granted the motion, in part. The Court rejected
Whitaker’s procedural arguments but granted the motion on
substantive grounds. However, the Court ordered that Monroe and the
Company may seek leave to amend the complaint by letter application
by December 1, 2020. Monroe and the Company filed a letter of
motion for leave to amend and a proposed Amended Complaint on
December 1, 2020. On January 5, 2021, Whitaker filed an opposition
to the letter motion. On January 25, 2021, Monroe and the Company
filed a reply in further support of the letter motion. On March 9,
2021, the Court granted Monroe and the Company’s motion for leave
to amend, in part, and denied the motion, in part. The Court
rejected Monroe and the Company’s claim for fraudulent inducement
but granted the motion for leave to amend their breach of contract
claim. Monroe and the Company filed their amended complaint on
March 12, 2021.
On
April 9, 2021, Whitaker renewed her motion to dismiss on procedural
grounds, requesting dismissal of the action or, in the alternative,
a stay of the proceeding pending adjudication on the merits of the
North Carolina Action. On May 14, 2021, Monroe and the Company
filed an opposition to the motion to dismiss. On June 21, 2021,
Whitaker filed a reply in further support of the motion. The Court
referred the case to Magistrate Judge Barbara Moses, who held oral
argument on the motion on November 9, 2021. On March 8, 2022,
Magistrate Judge Moses stayed the action pending a decision by the
Fourth Circuit on the appeal filed by Monroe and the Company in the
North Carolina Action.
In
light of the Fourth Circuit’s issuance of its July 22, 2022,
decision and order transferring the North Carolina Action to the
Southern District of New York, on August 1, 2022, the parties to
the New York Action wrote to the Magistrate overseeing the matter
to request a conference to address, inter alia, the resumption of
discovery in light of the Fourth Circuit’s Order issued on July 22,
2022. On August 3, 2022, Magistrate Judge Moses lifted the stay
previously imposed in the matter and ordered the parties to appear
at a teleconference held on August 16, 2022. At the teleconference,
the parties agreed that the North Carolina Action would be
dismissed following its transfer to the Southern District of New
York without prejudice to Whitaker’s right to assert the same
causes of action, based on substantially similar allegations, as
counterclaims in the New York Action and that Whitaker would have
until September 30, 2022, to do so. The Court ordered the parties
to submit a stipulation to this effect by August 23, 2022. Per the
Court’s Order, on August 22, 2022, the parties filed a stipulation
and proposed order whereby the parties agreed that Whitaker would
voluntarily dismiss the North Carolina Action, and would reassert
the causes of action set forth in the Proposed Amended Complaint
filed in the North Carolina Action as counterclaims in the New York
Action; and set forth deadlines for the filing of Whitaker’s answer
and counterclaims Plaintiffs’ response to such counterclaims. The
Court so-ordered that stipulation on August 23, 2022.
On
September 30, 2022, Whitaker filed an answer and counterclaims,
including (1) a cause of action for breach of contract, which was
substantially similar to Whitaker’s breach of contract in the North
Carolina Action (the “Breach of Contract Counterclaim”), and (2) a
cause of action under New York and North Carolina consumer
protection statutes, asserting that that Plaintiffs exhibited a
pattern and practice in the purchase of businesses similar to KRI
by which they allegedly, “endeavor[ ] to acquire the
purchased company at a discount of the agreed-upon purchase price
by making an initial down payment, then reneging on payment of
deferred compensation or earnouts and fabricating a pretextual
reason for nonpayment at the time the deferred compensation or
earnouts become due” (the Consumer Protection Counterclaim”). For
the Consumer Protection Counterclaim, Defendant seeks to recover
the full amount of the Earnout Payments ($4,054,396)—the very same
damages sought by Defendant’s Contract Counterclaim—as well as
trebled damages pursuant to the North Carolina statute, and
interest.
On
October 12, 2022, the parties filed a joint pre-conference
statement pursuant to the court’s August 24, 2022, order scheduling
an initial case management conference. Pursuant to that order, on
October 19, 2022, the Court held an initial case management
conference. Later that day, the Court issued an initial case
management order which set forth relevant deadlines, including the
close of fact discovery on April 21, 2023, and the close of all
discovery (including expert discovery) on July 19, 2023.
On
November 11, 2022, Plaintiffs moved to dismiss the Consumer
Protection Counterclaim.
As of
the date of this filing, we are not aware of any other material
legal proceedings to which we or any of our subsidiaries is a party
or to which any of our property is subject, other than as disclosed
above.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
You
should read the following discussion and analysis of our financial
condition and results of operations in conjunction with the audited
and unaudited consolidated financial statements and related notes
included elsewhere in this prospectus. The following discussion
contains forward-looking statements that are subject to risks and
uncertainties. See “Special Note Regarding Forward-Looking
Statements” for a discussion of the uncertainties, risks, and
assumptions associated with those statements. Actual results could
differ materially from those discussed in or implied by
forward-looking statements as a result of various factors,
including those discussed below and elsewhere in this prospectus,
particularly in “Risk Factors.”
Overview
We
are incorporated in the state of Delaware. As a rapidly growing
public company in the international staffing sector, our
high-growth business model is based on finding and acquiring
suitable, mature, profitable, operating, U.S. and U.K. based
staffing companies. Our targeted consolidation model is focused
specifically on the Professional Business Stream and Commercial
Business Stream disciplines. All dollar amounts in this section are
expressed in thousands except for share and per share values,
unless otherwise indicated.
Business
Model, Operating History and Acquisitions
We
are a high-growth international staffing company engaged in the
acquisition of U.S. and U.K. based staffing companies. As part of
our consolidation model, we pursue a broad spectrum of staffing
companies supporting primarily the Professional and Commercial
Business Streams. Our typical acquisition model is based on paying
consideration in the form of cash, stock, earn-outs and/or
promissory notes. In furthering our business model, we are
regularly in discussions and negotiations with various suitable,
mature acquisition targets. Since November 2013, we have completed
11 acquisitions.
Recent
Developments
Amended Note Purchase Agreement and Warrant with
Jackson
On
October 27, 2022, we entered into the Third Amended and Restated
Note Purchase Agreement (the “Amended Note Purchase Agreement”)
with Jackson Investment Group, LLC (“Jackson”), which amended and
restated the Second Amended and Restated Note Purchase Agreement,
dated October 26, 2020, as amended, and issued to Jackson the Third
Amended and Restated Senior Secured 12% Promissory Note (the
“Jackson Note”), with a remaining outstanding principal balance of
approximately $9.0 million.
Under
the terms of the Amended Note Purchase Agreement and the Jackson
Note, we are required to pay interest on the Jackson Note at an
annual rate of 12% and in the event we have not repaid in cash at
least 50% of the outstanding principal balance of the Jackson Note
by October 27, 2023, then interest on the outstanding principal
balance of the Jackson Note shall continue to accrue at 16% per
year of the outstanding principal balance of the Jackson Note until
the Jackson Note is repaid in full. The Amended Note Purchase
Agreement also extended the maturity date of the Jackson Note from
October 28, 2022 to October 14, 2024. On October 27, 2022, in
connection with the Amended Note Purchase Agreement, we issued to
Jackson 100,000 shares of common stock and a warrant to purchase up
to 24,332 shares of common stock at an exercise price of $3.06 per
share, which is exercisable six months from October 27, 2022, and
expires on October 27, 2027.
On
October 27, 2022, in connection with the Amended Note Purchase
Agreement, the Jackson Note and Amendment No. 27 (as defined
below), we, Jackson and MidCap (as defined below) entered into the
Fifth Amendment to Intercreditor Agreement (the “Fifth Amendment”),
which amended the Intercreditor Agreement, dated September 15,
2017, by and between us, Jackson and MidCap, as amended. The Fifth
Amendment, among other things, permits the increase of the credit
commitments under the Credit and Security Agreement as amended by
Amendment No. 27 to $32.5 million. On October 27, 2022, in
connection with the Amended Note Purchase Agreement, we also
entered into an Omnibus Amendment and Reaffirmation Agreement with
Jackson, which, among other things, amended (i) the Amended and
Restated Security Agreement, dated as of September 15, 2017, as
amended, and (ii) the Amended and Restated Pledge Agreement, dated
as of September 15, 2017, as amended, to reflect certain of the
terms as updated and amended by the Amended Note Purchase
Agreement.
Amendment to Credit and Security Agreement with
MidCap
On
October 27, 2022, we entered into Amendment No. 27 with MidCap,
which amended the Credit and Security Agreement (“Amendment No.
27”) with MidCap Funding IV Trust as successor by assignment to
MidCap Funding X Trust, dated April 8, 2015 (“MidCap”), which
amended the Credit and Security Agreement, dated April 8, 2015 (as
amended, the “Credit and Security Agreement”). Amendment No. 27,
among other things, (i) increased the revolving loan commitment
amount from $25 million to $32.5 million; (ii) extended the
commitment expiry date from October 27, 2022 to September 6, 2024;
and (iii) modified certain of the financial covenants. Pursuant to
Amendment No. 27, as long as no default or event of default under
the Credit and Security Agreement as amended by Amendment No. 27
exists, upon our written request and with the prior written consent
of the agent and lenders, the Loan may be increased by up to $10
million in minimum amounts of $5 million tranches each, for an
aggregate loan commitment amount of $42.5 million.
July 2022 Private Placement
On
July 1, 2022, we entered into a securities purchase agreement with
certain institutional and accredited investors for the issuance and
sale of a private placement of 657,858 shares of common stock or
pre-funded warrants to purchase shares of common stock, and
warrants (the “July 2022 Warrants”) to purchase up to 657,858
shares of common stock, with an exercise price of $5.85 per share.
The July 2022 Warrants are exercisable immediately upon issuance
and have a term of exercise equal to five and one-half years from
the date of issuance. The combined purchase price for one share (or
pre-funded warrant) and one associated warrant to purchase one
share of common stock was $6.10.
In
connection with the private placement, each investor entered into a
warrant amendment agreement with us (collectively, the “Warrant
Amendment Agreements”) to amend the exercise prices of certain
existing warrants to purchase up to an aggregate of 657,858 shares
of our common stock that were previously issued to the investors,
with exercise prices ranging from $18.50 to $38.00 per share and
expiration dates ranging from July 22, 2026 to November 1, 2026.
The Warrant Amendment Agreements became effective upon the closing
of the private placement and pursuant to the Warrant Amendment
Agreements, the amended warrants have a reduced exercise price of
$5.85 per share and expire five and one-half years following the
closing of the private placement. We intend to use the net proceeds
received from the private placement for general working capital
purposes.
Headway Acquisition
On
April 18, 2022, we entered into a stock purchase agreement (the
“Stock Purchase Agreement”) with Headway Workforce Solutions
(“Headway”), and Chapel Hill Partners, LP, as the representatives
of all the stockholders (collectively, the “Sellers”) of Headway
(the “Seller’s Representative”), pursuant to which, among other
things, we agreed to purchase all of the issued and outstanding
securities of Headway in exchange for (i) a cash payment of $14,065
and (ii) 9,000,000 shares of our Series H Convertible Preferred
Stock (the “Series H Preferred Stock”), with a value equal to the
Closing Payment, as defined in the Stock Purchase Agreement (the
“Headway Acquisition”). On May 18, 2022, the Headway Acquisition
closed. The purchase price in connection with the Headway
Acquisition was approximately $9,000,000.
Pursuant
to certain covenants in the Stock Purchase Agreement, we may be
subject to a Contingent Payment of up to $5,000 based on the
Adjusted EBITDA (such term as defined in the Stock Purchase
Agreement) of Headway during the Contingent Period (such term as
defined in the Stock Purchase Agreement).
In
connection with the Headway Acquisition, the Sellers’
Representative and certain of the Sellers entered into voting
agreements whereby each will agree to, at every meeting of our
stockholders, and at every adjournment or postponement thereof, to
appear or issue a proxy to a third party to be present for purposes
of establishing a quorum, and to vote all applicable shares in
favor of each matter proposed and recommended for approval by our
Board either in person or by proxy, amongst other
provisions.
For the Nine Months Ended October 1, 2022 and October 2,
2021
|
|
Nine
Months Ended |
|
|
|
|
|
Nine
Months Ended |
|
|
|
|
|
|
|
|
|
October 1, 2022 |
|
|
% of Revenue |
|
|
October 2, 2021 |
|
|
% of Revenue |
|
|
Growth |
|
Revenue |
|
$ |
175,066 |
|
|
|
100.0 |
% |
|
$ |
146,982 |
|
|
|
100.0 |
% |
|
|
19.1 |
% |
Cost of revenue |
|
|
143,709 |
|
|
|
82.1 |
% |
|
|
120,324 |
|
|
|
81.9 |
% |
|
|
19.4 |
% |
Gross profit |
|
|
31,357 |
|
|
|
17.9 |
% |
|
|
26,658 |
|
|
|
18.1 |
% |
|
|
17.6 |
% |
Operating expenses |
|
|
32,556 |
|
|
|
18.6 |
% |
|
|
27,933 |
|
|
|
19.0 |
% |
|
|
16.6 |
% |
Loss from operations |
|
|
(1,199 |
) |
|
|
-0.7 |
% |
|
|
(1,275 |
) |
|
|
-0.9 |
% |
|
|
-6.0 |
% |
Other (expenses) income |
|
|
(2,292 |
) |
|
|
-1.3 |
% |
|
|
16,250 |
|
|
|
11.1 |
% |
|
|
-114.1 |
% |
Benefit (Provision) for income
taxes |
|
|
(65 |
) |
|
|
0.0 |
% |
|
|
(102 |
) |
|
|
-0.1 |
% |
|
|
-36.3 |
% |
Net (loss) income |
|
$ |
(3,556 |
) |
|
|
-2.0 |
% |
|
$ |
14,873 |
|
|
|
10.1 |
% |
|
|
-123.9 |
% |
Revenue
For
the nine months ended October 1, 2022, revenue increased by 19.1%
to $175,066 as compared with $146,982 for the nine months ended
October 2, 2021. Of that $28,084 increase, $33,074 was attributable
to the Headway acquisition, partially offset by $311 organic
revenue decline and $4,679 of unfavorable foreign currency
translation.
Revenue
for the nine months ended October 1, 2022 was comprised of $170,699
of temporary contractor revenue and $4,367 of permanent placement
revenue, compared with $143,274 of temporary contractor revenue and
$3,708 of permanent placement revenue for the nine months ended
October 2, 2021, respectively.
Cost
of revenue, Gross profit and Gross margin
Cost
of revenue, excluding depreciation and amortization, includes the
variable cost of labor and various non-variable costs (e.g.,
workers’ compensation insurance) relating to employees (temporary
and permanent) as well as sub-contractors and consultants. For the
nine months ended October 1, 2022, cost of revenue was $143,709, an
increase of 19.4% from $120,324 for the nine months ended October
2, 2021, compared with revenue growth of 19.1%. Of that $23,385
increase, $28,049 was attributable to the Headway acquisition
offset by a $778 decline in associated costs of our operations and
$3,886 of favorable foreign currency translation.
Gross
profit for the nine months ended October 1, 2022 was $31,357, an
increase of 17.9% from $26,658 for the nine months ended October 2,
2021, representing gross margin of 17.9% and 18.1% for each period,
respectively. The $4,699 increase was driven by $5,025 from the
Headway acquisition and $468 of organic growth and partially offset
by $794 of unfavorable foreign currency translation.
Operating
expenses
Total
operating expenses for the nine months ended October 1, 2022 were
$32,556, an increase of 16.6% from $27,933 for the nine months
ended October 2, 2021. The increase of $4,623 was driven primarily
by Headway operating expenses of $4,450 as well as higher
non-recurring costs, legal costs, and other costs associated with
acquisitions efforts.
Other
expenses
Total
other (expenses) income for the nine months ended October 1, 2022
were $(2,292), a decrease of 114.1% from $16,250 in the nine months
ended October 2, 2021. The decrease was driven by the following:
PPP forgiveness gain of $19,395 for the nine months ended October
2, 2021 compared to $0 for the nine months ended October 1, 2022,
$3,030 interest expense and amortization of debt discount and
deferred financing costs in the nine months ended October 1, 2022,
which includes interest expense and amortization of $299 from the
Headway acquisition, compared with the nine months ended October 2,
2021 of $(3,432), remeasuring our intercompany note for the nine
months ended October 1, 2022 of $0 compared with losses from
remeasuring our intercompany note in the nine months ended October
2, 2021 of $219. In addition, for the nine months ended October 1,
2022, we had other income of $738 compared to other income of $292
for the nine months ended October 2, 2021.
For the Three Months Ended October 1, 2022 and October 2,
2021
|
|
Three
Months Ended |
|
|
|
|
|
Three
Months Ended |
|
|
|
|
|
|
|
|
|
October 1, 2022 |
|
|
% of Revenue |
|
|
October 2, 2021 |
|
|
% of Revenue |
|
|
Growth |
|
Revenue |
|
$ |
66,120 |
|
|
|
100.0 |
% |
|
$ |
47,501 |
|
|
|
100.0 |
% |
|
|
39.2 |
% |
Cost of revenue |
|
|
53,795 |
|
|
|
81.4 |
% |
|
|
37,877 |
|
|
|
79.7 |
% |
|
|
42.0 |
% |
Gross profit |
|
|
12,325 |
|
|
|
18.6 |
% |
|
|
9,624 |
|
|
|
20.3 |
% |
|
|
28.1 |
% |
Operating expenses |
|
|
11,830 |
|
|
|
17.9 |
% |
|
|
9,151 |
|
|
|
19.3 |
% |
|
|
29.3 |
% |
Loss from operations |
|
|
495 |
|
|
|
0.7 |
% |
|
|
473 |
|
|
|
1.0 |
% |
|
|
4.7 |
% |
Other (expenses) income |
|
|
599 |
|
|
|
0.9 |
% |
|
|
8,371 |
|
|
|
17.6 |
% |
|
|
-92.8 |
% |
Benefit (expense) from income
taxes |
|
|
(62 |
) |
|
|
-0.1 |
% |
|
|
(131 |
) |
|
|
-0.3 |
% |
|
|
-52.7 |
% |
Net (loss) income |
|
$ |
1,032 |
|
|
|
1.6 |
% |
|
$ |
8,713 |
|
|
|
18.3 |
% |
|
|
-88.2 |
% |
Revenue
For
the three months ended October 1, 2022, revenue increased by 39.2%
to $66,120 as compared with $47,501 for the three months ended
October 2, 2021. Of that $18,619 increase, $21,822 was attributable
to the Headway acquisition which was partially offset by a $770
decrease in the Company’s other operations and $2,433 of
unfavorable foreign currency translation.
Revenue
for the three months ended October 1, 2022 was comprised of $64,733
of temporary contractor revenue and $1,387 of permanent placement
revenue, compared with $46,168 and $1,333 for the three months
ended October 2, 2021, respectively.
Cost
of revenue, Gross profit and Gross margin
Cost
of revenue, excluding depreciation and amortization, includes the
variable cost of labor and various non-variable costs (e.g.,
workers’ compensation insurance) relating to employees (temporary
and permanent) as well as sub-contractors and consultants. For the
three months ended October 1, 2022, cost of revenue was $53,795, an
increase of 42.0% from $37,877 in the three months ended October 2,
2021, compared with revenue growth of 39.2%. Of that $15,918
increase, $18,129 was attributable to the Headway acquisition which
was partially offset by a $209 decline in associated costs of the
Company’s other operations and $2,002 of favorable foreign currency
translation.
Gross
profit for the three months ended October 1, 2022 was $12,325, an
increase of 28.1% from $9,624 for the three months ended October 2,
2021, representing gross margin of 18.6% and 20.3% for each period,
respectively. The increase of $2,701 was driven by $3,693 from the
Headway acquisition and partially offset by $564 of loss from our
other operations and $428 of unfavorable foreign currency
translation.
Operating
expenses
Total
operating expenses for the three months ended October 1, 2022 were
$11,830, an increase of 29.3% from $9,151 for the three months
ended October 2, 2021. The increase of $2,679 was driven primarily
by Headway operating expenses of $2,856 which was offset by a
reduction in non-recurring costs, legal, and other costs associated
with acquisitions efforts.
Other
expenses
Total
other expenses for the three months ended October 1, 2022 was $410,
a decrease of 92.8% from other income of $8,371 in the three months
ended October 2, 2021. The decrease was driven by the following:
PPP forgiveness gain of $9,504 for the three months ended October
2, 2021 compared to $0 for the three months ended October 1, 2022,
$1,127 interest expense and amortization of debt discount and
deferred financing costs in the three months ended October 1, 2022,
which includes interest expense and amortization of $187 from the
Headway acquisition, compared with the three months ended October
2, 2021 of $1,006, gain from remeasuring our intercompany note in
the three months ended October 1, 2022 of $1,009 compared with loss
from remeasuring our intercompany note in the three months ended
October 2, 2021 of $315. In addition, in the three months ended
October 1, 2022, we had other income of $717 compared with other
loss of $188 for the three months ended October 2,
2021.
For the Years Ended January 1, 2022 and January 2,
2021
|
|
Fiscal
2021
|
|
|
% of Revenue |
|
|
Fiscal 2020 |
|
|
% of Revenue |
|
|
Growth
(decline)
|
|
Revenue |
|
$ |
197,770 |
|
|
|
100.0 |
% |
|
$ |
204,527 |
|
|
|
100.0 |
% |
|
|
(3.3 |
)% |
Cost of revenue |
|
|
163,903 |
|
|
|
82.9 |
% |
|
|
169,714 |
|
|
|
83.0 |
% |
|
|
(3.4 |
)% |
Gross profit |
|
|
33,867 |
|
|
|
17.1 |
% |
|
|
34,813 |
|
|
|
17.0 |
% |
|
|
(2.7 |
)% |
Operating expenses |
|
|
41,167 |
|
|
|
20.8 |
% |
|
|
43,593 |
|
|
|
21.3 |
% |
|
|
(5.6 |
)% |
(Loss) from operations |
|
|
(7,300 |
) |
|
|
(3.7 |
)% |
|
|
(8,780 |
) |
|
|
(4.3 |
)% |
|
|
16.9 |
% |
Other income (expenses) |
|
|
15,101 |
|
|
|
7.6 |
% |
|
|
(6,962 |
) |
|
|
(3.4 |
)% |
|
|
316.9 |
% |
Benefit for income taxes |
|
|
357 |
|
|
|
0.2 |
% |
|
|
100 |
|
|
|
(0.0 |
)% |
|
|
257.0 |
% |
Net income (loss) |
|
$ |
8,158 |
|
|
|
4.1 |
% |
|
$ |
(15,642 |
) |
|
|
(7.6 |
)% |
|
|
152.2 |
% |
Revenue
Fiscal
2021 revenue decreased by 3.3% to $197,770 as compared with
$204,527 for Fiscal 2020. Of that decline, $10,848 was attributable
to organic revenue decline, slightly offset by $4,091 of favorable
foreign currency translation. Within organic revenue, temporary
contractor revenue declined $9,175 and permanent placement declined
$1,673. The primary driver of temporary contractor revenue decline
was due to the sale of firstPRO and government-mandated
lockdowns in Fiscal 2021 due to the Covid-19 outbreaks.
Revenue
in Fiscal 2021 was comprised of $192,756 of temporary contractor
revenue and $5,014 of permanent placement revenue, compared with
$198,066 and $6,461 for Fiscal 2020, respectively.
Cost
of revenue, Gross profit and gross margin
Cost
of revenue includes the variable cost of labor and various
non-variable costs (e.g., workers’ compensation insurance) relating
to employees (temporary and permanent) as well as sub-contractors
and consultants. For Fiscal 2021, cost of revenue was $163,903, a
decrease of 3.4% from $169,714 in Fiscal 2020, compared with
revenue decline of 3.3%.
Gross
profit for Fiscal 2021 was $33,867, a decrease of 2.7% from $34,813
for Fiscal 2020, representing gross margin of 17.1% and 17.0% for
each period, respectively. The increase was driven by $674 of
favorable foreign currency translation and $1,620 of organic
decline.
Operating
expenses
Operating
expenses for Fiscal 2021 were $41,167, a decrease of 5.6% from
$43,593 for Fiscal 2020. The decrease in operating expenses was
driven by headcount reductions, lower variable costs, and cost
savings initiatives. Included in the 2021 total of $42,741 is
$3,104 for impairment of goodwill.
Other
Income and Expenses
Other
income (expenses) for Fiscal 2021 were $15,101, an increase of
316.9% from $(6,962) in Fiscal 2020. The increase was driven
primarily by the PPP forgiveness gain of $19,609. This was
partially offset by $4,215 interest expense and amortization of
debt discount and deferred financing costs in Fiscal 2021 compared
with $7,195 in Fiscal 2020; other loss of $33 in Fiscal 2021 versus
other gain of $125 in Fiscal 2020, and $260 loss in remeasuring the
intercompany note in Fiscal 2021 compared with a gain of $584 in
Fiscal 2020.
KPIs
and Non-GAAP Measures
To
supplement our consolidated financial statements presented in
accordance with GAAP, we also use non-GAAP financial measures and
Key Performance Indicators (“KPIs”) in addition to our GAAP
results. We believe non-GAAP financial measures and KPIs may
provide useful information for evaluating our cash operating
performance, ability to service debt, compliance with debt
covenants and measurement against competitors. This information
should be considered as supplemental in nature and should not be
considered in isolation or as a substitute for the related
financial information prepared in accordance with GAAP. In
addition, these non-GAAP financial measures may not be comparable
to similarly entitled measures reported by other
companies.
We
present the following non-GAAP financial measure and KPIs in this
report:
Revenue
and Gross Profit by Business Streams We use this KPI to measure
our mix of Revenue and respective Gross Profit between our two main
lines of business due to their differing margins. For clarity,
these lines of business are not our operating segments, as this
information is not currently regularly reviewed by the chief
operating decision maker to allocate capital and resources. Rather,
we use this KPI to benchmark us against the industry.
The
following table details Revenue and Gross Profit by
sector:
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
October 1, 2022 |
|
|
Mix |
|
|
October 2, 2021 |
|
|
Mix |
|
|
October 1, 2022 |
|
|
Mix |
|
|
October 2, 2021 |
|
|
Mix |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing –
US |
|
$ |
25,940 |
|
|
|
39 |
% |
|
$ |
29,601 |
|
|
|
62 |
% |
|
$ |
83,350 |
|
|
|
48 |
% |
|
$ |
88,240 |
|
|
|
60 |
% |
Professional Staffing – US |
|
|
25,756 |
|
|
|
39 |
% |
|
|
4,536 |
|
|
|
10 |
% |
|
|
45,292 |
|
|
|
26 |
% |
|
|
12,215 |
|
|
|
8 |
% |
Professional Staffing – UK |
|
|
14,424 |
|
|
|
22 |
% |
|
|
13,364 |
|
|
|
28 |
% |
|
|
46,424 |
|
|
|
27 |
% |
|
|
46,527 |
|
|
|
32 |
% |
Total Service Revenue |
|
$ |
66,120 |
|
|
|
|
|
|
$ |
47,501 |
|
|
|
|
|
|
$ |
175,066 |
|
|
|
|
|
|
$ |
146,982 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing – US |
|
$ |
5,034 |
|
|
|
41 |
% |
|
$ |
5,195 |
|
|
|
54 |
% |
|
$ |
15,197 |
|
|
|
48 |
% |
|
$ |
15,422 |
|
|
|
58 |
% |
Professional Staffing – US |
|
|
4,715 |
|
|
|
38 |
% |
|
|
1,200 |
|
|
|
12 |
% |
|
|
8,286 |
|
|
|
26 |
% |
|
|
3,146 |
|
|
|
12 |
% |
Professional Staffing – UK |
|
|
2,576 |
|
|
|
21 |
% |
|
|
3,229 |
|
|
|
34 |
% |
|
|
7,874 |
|
|
|
25 |
% |
|
|
8,090 |
|
|
|
30 |
% |
Total Gross Profit |
|
$ |
12,325 |
|
|
|
|
|
|
$ |
9,624 |
|
|
|
|
|
|
$ |
31,357 |
|
|
|
|
|
|
$ |
26,658 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing – US |
|
|
19.4 |
% |
|
|
|
|
|
|
17.6 |
% |
|
|
|
|
|
|
18.2 |
% |
|
|
|
|
|
|
17.5 |
% |
|
|
|
|
Professional Staffing – US |
|
|
18.3 |
% |
|
|
|
|
|
|
26.5 |
% |
|
|
|
|
|
|
18.3 |
% |
|
|
|
|
|
|
25.8 |
% |
|
|
|
|
Professional Staffing – UK |
|
|
17.9 |
% |
|
|
|
|
|
|
24.2 |
% |
|
|
|
|
|
|
17.0 |
% |
|
|
|
|
|
|
17.4 |
% |
|
|
|
|
Total Gross Margin |
|
|
18.6 |
% |
|
|
|
|
|
|
20.3 |
% |
|
|
|
|
|
|
17.9 |
% |
|
|
|
|
|
|
18.1 |
% |
|
|
|
|
|
|
Fiscal 2021 |
|
|
Mix |
|
|
Fiscal 2020 |
|
|
Mix |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing -
US |
|
$ |
118,879 |
|
|
|
60 |
% |
|
$ |
113,970 |
|
|
|
56 |
% |
Professional Staffing - US |
|
|
16,519 |
|
|
|
8 |
% |
|
|
23,477 |
|
|
|
11 |
% |
Professional Staffing - UK |
|
|
62,372 |
|
|
|
32 |
% |
|
|
67,080 |
|
|
|
33 |
% |
Total Service Revenue |
|
$ |
197,770 |
|
|
|
|
|
|
$ |
204,527 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing - US |
|
$ |
20,801 |
|
|
|
61 |
% |
|
$ |
17,845 |
|
|
|
51 |
% |
Professional Staffing - US |
|
|
4,476 |
|
|
|
13 |
% |
|
|
7,546 |
|
|
|
22 |
% |
Professional Staffing - UK |
|
|
8,590 |
|
|
|
26 |
% |
|
|
9,422 |
|
|
|
27 |
% |
Total Gross Profit |
|
$ |
33,867 |
|
|
|
|
|
|
$ |
34,813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial Staffing - US |
|
|
17.5 |
% |
|
|
|
|
|
|
15.7 |
% |
|
|
|
|
Professional Staffing - US |
|
|
27.1 |
% |
|
|
|
|
|
|
32.1 |
% |
|
|
|
|
Professional Staffing - UK |
|
|
13.8 |
% |
|
|
|
|
|
|
14.0 |
% |
|
|
|
|
Total Gross Margin |
|
|
17.1 |
% |
|
|
|
|
|
|
17.0 |
% |
|
|
|
|
Adjusted
EBITDA This measure is defined as net income (loss)
attributable to common stock before: interest expense, benefit from
income taxes; depreciation and amortization; acquisition, capital
raising and other non-recurring expenses; other non-cash charges;
impairment of goodwill; re-measurement gain on intercompany note;
restructuring charges; gain from sale of business; PPP Forgiveness
Gain; other income; and charges we consider to be non-recurring in
nature such as legal expenses associated with litigation,
professional fees associated potential and completed acquisitions.
We use this measure because we believe it provides a more
meaningful understanding of our profit and cash flow
generation.
|
|
Three Months
Ended
|
|
|
Nine Months
Ended
|
|
|
Trailing Twelve
Months
|
|
|
|
October 1, 2022 |
|
|
October 2, 2021 |
|
|
October 1, 2022 |
|
|
October 2, 2021 |
|
|
October 1, 2022 |
|
|
October 2, 2021 |
|
Net loss |
|
$ |
1,032 |
|
|
$ |
8,713 |
|
|
$ |
(3,556 |
) |
|
$ |
14,873 |
|
|
$ |
(10,200 |
) |
|
$ |
12,632 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
891 |
|
|
|
814 |
|
|
|
2,512 |
|
|
|
3,068 |
|
|
|
3,301 |
|
|
|
4,506 |
|
(Benefit) expense from income
taxes |
|
|
62 |
|
|
|
131 |
|
|
|
65 |
|
|
|
102 |
|
|
|
(392 |
) |
|
|
247 |
|
Depreciation and amortization |
|
|
1,023 |
|
|
|
880 |
|
|
|
2,658 |
|
|
|
2,486 |
|
|
|
3,289 |
|
|
|
3,330 |
|
EBITDA |
|
$ |
3,008 |
|
|
$ |
10,538 |
|
|
$ |
1,679 |
|
|
$ |
20,529 |
|
|
$ |
(4,073 |
) |
|
$ |
20,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition, capital raising and other
non-recurring expenses (1) |
|
|
1,788 |
|
|
|
321 |
|
|
|
4,375 |
|
|
|
2,802 |
|
|
|
4,847 |
|
|
|
5,024 |
|
Other non-cash charges (2) |
|
|
7 |
|
|
|
8 |
|
|
|
32 |
|
|
|
344 |
|
|
|
253 |
|
|
|
450 |
|
Impairment of Goodwill |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,104 |
|
|
|
- |
|
Re-measurement gain on intercompany
note |
|
|
(1,009 |
) |
|
|
315 |
|
|
|
- |
|
|
|
219 |
|
|
|
- |
|
|
|
(712 |
) |
Deferred consideration settlement |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
41 |
|
PPP Forgiveness Gain |
|
|
- |
|
|
|
(9,504 |
) |
|
|
- |
|
|
|
(19,609 |
) |
|
|
- |
|
|
|
(19,609 |
) |
Gain on sale of business |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
95 |
|
Other (income) loss |
|
|
(717 |
) |
|
|
(188 |
) |
|
|
(738 |
) |
|
|
(292 |
) |
|
|
(412 |
) |
|
|
(296 |
) |
Adjusted EBITDA |
|
$ |
3,077 |
|
|
$ |
1,490 |
|
|
$ |
5,348 |
|
|
$ |
3,993 |
|
|
$ |
3,719 |
|
|
$ |
5,708 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA of Divested Business
(3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
- |
|
|
$ |
101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro Forma Adjusted EBITDA (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,719 |
|
|
$ |
5,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Gross Profit (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
35,866 |
|
|
$ |
34,945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA as percentage of
Adjusted Gross Profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4 |
% |
|
|
16.6 |
% |
(1) |
Acquisition,
capital raising, and other non-recurring expenses primarily relate
to capital raising expenses, acquisition and integration expenses,
and legal expenses incurred in relation to matters outside the
ordinary course of business. Due to government mandated
restrictions, the Company had to temporarily close some of its
offices and, due to social distancing restrictions, could not make
full use of these facilities for significant periods of time during
2021. |
(2) |
Other
non-cash charges primarily relate to staff option and share
compensation expense, expense for shares issued to directors for
board services, and consideration paid for consulting
services. |
|
|
(3) |
Adjusted
EBITDA of Divested Business for the period prior to the divestment
date. |
|
|
(4) |
Pro
Forma Adjusted EBITDA excludes the Adjusted EBITDA of Divested
Business for the period prior to the divestment
date. |
|
|
(5) |
Adjusted Gross Profit excludes gross profit of business divested
in September 2020, for the period prior to divestment date.
|
|
|
Fiscal 2021 |
|
|
Fiscal 2020 |
|
Net Income (Loss) |
|
$ |
8,158 |
|
|
$ |
(15,642 |
) |
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
3,856 |
|
|
|
7,195 |
|
Benefit from income taxes |
|
|
(357 |
) |
|
|
(100 |
) |
Depreciation and amortization |
|
|
3,118 |
|
|
|
3,677 |
|
EBITDA |
|
$ |
14,775 |
|
|
$ |
(4,870 |
) |
|
|
|
|
|
|
|
|
|
Acquisition, capital raising and other
non-recurring expenses (1) |
|
|
3,510 |
|
|
|
6,714 |
|
Other non-cash charges (2) |
|
|
361 |
|
|
|
662 |
|
Impairment of Goodwill |
|
|
3,104 |
|
|
|
2,969 |
|
Re-measurement gain on intercompany
note |
|
|
260 |
|
|
|
(584 |
) |
Restructuring charges |
|
|
- |
|
|
|
21 |
|
Gain from sale of business |
|
|
- |
|
|
|
(124 |
) |
PPP Forgiveness Gain |
|
|
(19,609 |
) |
|
|
- |
|
Other loss (income) |
|
|
33 |
|
|
|
(125 |
) |
Adjusted EBITDA |
|
$ |
2,434 |
|
|
$ |
4,663 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA of Divested Business
(3) |
|
$ |
- |
|
|
$ |
(507 |
) |
|
|
|
|
|
|
|
|
|
Pro Forma Adjusted EBITDA (4) |
|
$ |
2,434 |
|
|
$ |
4,156 |
|
|
|
|
|
|
|
|
|
|
Adjusted Gross Profit (5) |
|
$ |
33,867 |
|
|
$ |
31,199 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA as percentage of
Adjusted Gross Profit |
|
|
7.2 |
% |
|
|
14.9 |
% |
(1) |
Acquisition, capital raising, and other non-recurring expenses
primarily relate to capital raising expenses, acquisition and
integration expenses, and legal expenses incurred in relation to
matters outside the ordinary course of business. Due to government
mandated restrictions, the Company had to temporarily close some of
its offices and, due to social distancing restrictions, could not
make full use of these facilities for significant periods of time
during the year. |
Operating
Leverage This measure is calculated by dividing the growth in
Adjusted EBITDA by the growth in Adjusted Gross Profit, on a
trailing 12-month basis. We use this KPI because we believe it
provides a measure of our efficiency for converting incremental
gross profit into Adjusted EBITDA.
|
|
October 1, 2022 |
|
|
October 2, 2021 |
|
|
|
|
|
|
|
|
Gross Profit - TTM
(Current Period) |
|
$ |
35,866 |
|
|
$ |
34,945 |
|
Gross Profit - TTM (Prior Period) |
|
|
34,945 |
|
|
|
32,479 |
|
Gross Profit - Growth (Decline) |
|
$ |
921 |
|
|
$ |
2,466 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA - TTM (Current
Period) |
|
$ |
3,719 |
|
|
$ |
5,708 |
|
Adjusted EBITDA - TTM (Prior
Period) |
|
|
5,708 |
|
|
|
5,442 |
|
Adjusted EBITDA - Growth
(Decline) |
|
$ |
(1,989 |
) |
|
$ |
266 |
|
|
|
|
|
|
|
|
|
|
Operating Leverage |
|
|
-216.0 |
% |
|
|
10.8 |
% |
|
|
Fiscal
2021 |
|
|
Fiscal
2020 |
|
|
|
|
|
|
|
|
Gross
Profit - TTM (Current Period) |
|
$ |
33,867 |
|
|
$ |
34,813 |
|
Gross
Profit - TTM (Prior Period) |
|
|
34,813 |
|
|
|
48,309 |
|
Gross
Profit - Growth (Decline) |
|
$ |
(946 |
) |
|
$ |
(13,496 |
) |
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA - TTM (Current Period) |
|
$ |
2,434 |
|
|
$ |
4,663 |
|
Adjusted
EBITDA - TTM (Prior Period) |
|
|
4,663 |
|
|
|
9,778 |
|
Adjusted
EBITDA - Growth (Decline) |
|
$ |
(2,229 |
) |
|
$ |
(5,115 |
) |
|
|
|
|
|
|
|
|
|
Operating
Leverage |
|
|
236 |
% |
|
|
38 |
% |
Leverage
Ratio Calculated as Total Debt, Net, gross of any Original
Issue Discount (includes Redeemable Series H Preferred Stock),
divided by Pro Forma Adjusted EBITDA for the trailing 12-months. We
use this KPI as an indicator of our ability to service debt
prospectively.
|
|
October
1, 2022 |
|
|
October
2, 2021 |
|
|
|
|
|
|
|
|
Total
Term Debt, Net |
|
$ |
17,701 |
|
|
$ |
14,357 |
|
Addback:
Total Debt Discount and Deferred Financing Costs |
|
|
660 |
|
|
|
235 |
|
Total
Debt |
|
$ |
18,361 |
|
|
$ |
14,592 |
|
|
|
|
|
|
|
|
|
|
TTM
Adjusted EBITDA |
|
$ |
3,759 |
|
|
$ |
5,708 |
|
|
|
|
|
|
|
|
|
|
Pro
Forma TTM Adjusted EBITDA |
|
$ |
3,759 |
|
|
$ |
5,809 |
|
|
|
|
|
|
|
|
|
|
Pro
Forma Leverage Ratio |
|
|
4.88 |
x |
|
|
2.5 |
x |
|
|
Fiscal
2021 |
|
|
Fiscal
2020 |
|
|
|
|
|
|
|
|
Total
Term Debt, Net |
|
$ |
9,502 |
|
|
$ |
54,810 |
|
Addback:
Total Debt Discount and Deferred Financing Costs |
|
|
256 |
|
|
|
559 |
|
Total
Debt |
|
$ |
9,758 |
|
|
$ |
55,369 |
|
|
|
|
|
|
|
|
|
|
TTM
Adjusted EBITDA |
|
$ |
2,434 |
|
|
$ |
4,663 |
|
|
|
|
|
|
|
|
|
|
Pro
Forma TTM Adjusted EBITDA |
|
$ |
2,434 |
|
|
$ |
4,156 |
|
|
|
|
|
|
|
|
|
|
Pro
Forma Leverage Ratio |
|
|
4.01 |
x |
|
|
13.32 |
x |
Operating
Cash Flow Including Proceeds from Accounts Receivable Financing
calculated as net cash (used in) provided by operating activities
plus net proceeds from accounts receivable financing. Because much
of our temporary payroll expense is paid weekly and in advance of
clients remitting payment for invoices, operating cash flow is
often weaker in staffing companies where revenue and accounts
receivable are growing. Accounts receivable financing is
essentially an advance on client remittances and is primarily used
to fund temporary payroll. As such, we believe this measure is
helpful to investors as an indicator of our underlying operating
cash flow.
On
February 8, 2018, CBS Butler Holdings Limited (“CBS Butler”),
Staffing 360 Solutions Limited and The JM Group, entered into a new
arrangement with HSBC Invoice Finance (UK) Ltd (“HSBC”) which
provides for HSBC to purchase the subsidiaries’ accounts receivable
up to an aggregate amount of £11,500 across all three subsidiaries.
The terms of the arrangement provide for HSBC to fund 90% of the
purchased accounts receivable upfront and a secured borrowing line
of 70% of unbilled receivables capped at £1,000 (within the overall
aggregate total facility of £11,500). The arrangement has an
initial term of 12 months, with an automatic rolling three-month
extension and carries a service charge of 1.80%. Under ASU 2016-16,
“Statement of Cash Flows (Topic 230, Classification of Certain
Cash Receipts and Cash Payments, a consensus of the FASB Emerging
Issues Task Force), the upfront portion of the sale of accounts
receivable is classified within operating activities, while the
deferred purchase price portion (or beneficial interest), once
collected, is classified within investing activities. On April 20,
2020, the terms of the loan with HSBC were amended whereby no
capital repayments will be made between April 2020 to September
2020, and only interest payments will be made during this time. On
May 15, 2020, we entered into a three-year term loan with HSBC in
the UK for £1,000.
|
|
Nine Months Ended |
|
|
|
October 1, 2022 |
|
|
October 2, 2021 |
|
|
|
|
|
|
|
|
Net cash flow used in
operating activities |
|
$ |
(8,282 |
) |
|
$ |
(9,774 |
) |
|
|
|
|
|
|
|
|
|
Collection of UK factoring facility
deferred purchase price |
|
|
5,282 |
|
|
|
5,349 |
|
|
|
|
|
|
|
|
|
|
Repayments on accounts receivable
financing |
|
|
(3,345 |
) |
|
|
(3,659 |
) |
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
including proceeds from accounts receivable financing |
|
$ |
(6,345 |
) |
|
$ |
(8,084 |
) |
|
|
Fiscal
2021 |
|
|
Fiscal
2020 |
|
|
|
|
|
|
|
|
Net
cash flow used in operating activities |
|
$ |
(14,634 |
) |
|
$ |
(14,256 |
) |
|
|
|
|
|
|
|
|
|
Collection
of UK factoring facility deferred purchase price |
|
|
7,311 |
|
|
|
8,654 |
|
|
|
|
|
|
|
|
|
|
Repayments
on accounts receivable financing |
|
|
(1,779 |
) |
|
|
(2,426 |
) |
|
|
|
|
|
|
|
|
|
Net
cash used in operating activities including proceeds from accounts
receivable financing |
|
$ |
(9,102 |
) |
|
$ |
(8,028 |
) |
The
Leverage Ratio and Operating Cash Flow Including Proceeds from
Accounts Receivable Financing should be considered together with
the information in the “Liquidity and Capital Resources” section,
immediately below.
Liquidity
and Capital Resources
Liquidity
is the ability of a company to generate funds to support its
current and future operations, satisfy its obligations, and
otherwise operate on an ongoing basis. Historically, we have funded
our operations through term loans, promissory notes, bonds,
convertible notes, private placement offerings and sales of
equity.
Our
primary uses of cash have been for debt repayments, repayment of
deferred consideration from acquisitions, professional fees related
to our operations and financial reporting requirements and for the
payment of compensation, benefits and consulting fees. The
following trends may occur as we continue to execute on our
strategy:
|
● |
an
increase in working capital requirements to finance organic
growth; |
|
● |
addition
of administrative and sales personnel as the business
grows; |
|
● |
increases
in advertising, public relations and sales promotions for existing
and new brands as we expand within existing markets or enter new
markets; |
|
● |
a
continuation of the costs associated with being a public company;
and |
|
● |
capital
expenditures to add technologies. |
As of
and for the nine months ended October 1, 2022, we had a working
capital deficiency of $13,761, accumulated deficit of $87,506, and
a net loss of $3,485.
The
accompanying financial statements have been prepared in conformity
with GAAP, which contemplate our continuation as a going concern.
We have unsecured payments due in the next 12 months associated
with a historical acquisition and secured current debt arrangements
representing approximately $4,795 which are in excess of cash and
cash equivalents on hand as of October 1, 2022, in addition to
funding operational growth requirements. Historically, we have
funded such payments either through cash flow from operations or
the raising of capital through additional debt or equity. If we are
unable to obtain additional capital, such payments may not be made
on time. These factors raise substantial doubt about our ability to
continue as a going concern. The accompanying financial statements
do not include any adjustments or classifications that may result
from our possible inability to continue as a going
concern.
In
addition, beginning in January 2023, we will have numerous
contractual lease obligations representing an aggregate of
approximately $8,693 related to current lease agreements. We intend
to fund the majority of this by a combination of cash flow from
operations, as well as the raising of capital through additional
debt or equity.
The
financial statements included in this prospectus have been prepared
assuming that we will continue as a going concern, which
contemplates the recoverability of assets and the satisfaction of
liabilities in the normal course of business. Significant
assumptions underlie this belief, including, among other things,
that there will be no material adverse developments in our
business, liquidity, capital requirements and that our credit
facilities with our lenders will remain available to us.
Operating
activities for the nine months ended October 1, 2022 and October 2,
2021
For the nine months ended October 1, 2022, net cash used in
operating activities of $8,282 was primarily attributable to net
loss of $3,556 and changes in operating assets and liabilities
totaling $8,473, offset by non-cash adjustments of $3,747. Changes
in operating assets and liabilities primarily relate to a decrease
in accounts receivable of $6,114, decrease in prepaid expenses and
other current assets of $1,854, decrease in other assets of $944,
increase in other current liabilities of $357, increase in other
long-term liabilities of $1,040 and a decrease in accounts payable
and accrued expense of $1,083. Total non-cash adjustments of $3,747
primarily include depreciation and amortization of intangible
assets of $2,140, stock-based compensation of $325, amortization of
debt discounts and deferred financing of $518, right of use assets
amortization of $1,066 and bad debt expense of $302.
For the nine months ended October 2, 2021, net cash used in
operations of $9,774 was primarily attributable to net income of
$14,873 and changes in operating assets and liabilities totaling
$(9,206), offset by non-cash adjustments of $(15,441). Changes in
operating assets and liabilities primarily relate to a decrease in
accounts receivable of $5,343, decrease in prepaid expenses and
other current assets of $289, decrease in other assets of $438,
decrease in current liabilities of $105, decrease in long term
liabilities of $349, decrease in accounts payable and accrued
expense of $2,356 and decrease in payables to related parties of
$326. Total non-cash adjustments of $(15,441) primarily include
forgiveness of PPP loan and related accrued interest of $19,609,
offset by foreign currency re-measurement loss on intercompany loan
of $219, depreciation and amortization of intangible assets of
$2,122, stock-based compensation of $350, amortization of debt
discounts and deferred financing of $365, right of use assets
amortization of $852 and bad debt expense of $260.
Investing
activities for the nine months ended October 1, 2022 and October 2,
2021
For
the nine months ended October 1, 2022, net cash flows provided by
investing activities totaled $5,958 primarily due to the
acquisition of Headway, net of cash acquired, totaling $1,395 and
$5,282 related to collection of UK factoring facility deferred
purchase price, partially offset by purchase of property and
equipment of $719.
For the nine months ended October 2, 2021, net cash flows provided
by investing activities was $5,249, of which $5,349 was related to
collection of the beneficial interest from HSBC and partially
offset by purchase of property and equipment of $100.
Financing
activities for the nine months ended October 1, 2022 and October 2,
2021
For
the nine months ended October 1, 2022, net cash flows used in
financing activities totaled $358 primarily due to proceeds from sale of common stock of
$4,013, and proceeds from term loan of $67, offset by
repayments of $3,345 on accounts receivable financing, net,
repayment of term loan of $379, payment of $160 towards the Headway
earnout, and third party
financing costs of $554.
For the nine months ended October 2, 2021, net cash flows used in
financing activities totaled $3,574 primarily due to proceeds from
sale of common stock of $33,769, proceeds from related party note
of $130, and proceeds from sale of Series F Preferred Stock of
$4,698, offset by repayments of $3,659 on accounts receivable
financing, net, repayment of term loan of $29,244, dividends paid
to Jackson of $591, redemption of Series E preferred stock of
$4,908 and third party financing costs of $3,769.
Operating
activities for the years ended January 1, 2022 and January 2,
2021
For
Fiscal 2021, net cash used in operations of $14,634 was primarily
attributable to changes in operating assets and liabilities
totaling $11,601 and net income of $8,158, offset by non-cash
adjustments of $11,191. Changes in operating assets and liabilities
primarily relates to a decrease in accounts receivable of $3,765,
decrease in accounts payable and accrued expenses of $2,479,
decrease in interest payable - related party of $733, decrease in
other current liabilities of $197, decrease in other assets of $50,
and decrease in other long-term liabilities of $4,636, offset by
increase in prepaid expenses of $260. Non-cash add backs of $11,191
primarily relates to PPP loan forgiveness of $19,609, offset by
amortization of intangible assets and depreciation of $2,758,
impairment of goodwill of $3,104, right of use assets amortization
of $1,299, amortization of debt discount and deferred financing of
$359, stock-based compensation of $377, bad debt expense of $260,
and remeasurement gain on intercompany note of $260.
For
Fiscal 2020, net cash used in operations of $14,256 was primarily
attributable to changes in operating assets and liabilities
totaling $7,800 and a net loss of $15,642, offset by non-cash
adjustments of $9,186. Changes in operating assets and liabilities
primarily relates to a decrease in accounts receivable of $7,314,
decrease in other assets of $941, increase in accounts payable and
accrued expenses of $1,659, decrease in other current liabilities
of $2,058, and decrease in other long-term liabilities of $1,657,
offset by increase in accounts payable - related party of $1,598,
increase in prepaid expenses of $427, and increase in other of
$424. Non-cash add backs of $9,186 primarily relates to
amortization of intangible assets and depreciation of $3,275, right
of use assets amortization of $1,521, amortization of debt discount
and deferred financing of $559, stock-based compensation of $637,
bad debt expense of $933, and write-off of goodwill of $2,969,
offset by remeasurement gain on intercompany note of $584 and gain
on sale of subsidiary of $124.
Investing
activities for the years ended January 1, 2022 and January 2,
2021
For
Fiscal 2021, net cash flows provided by investing activities was
$7,062, of which $7,311 was related to the collection of the UK
factoring facility deferred purchase price, partially offset by
purchase of property and equipment of $249.
For
Fiscal 2020, net cash flows provided by investing activities was
$11,697, of which $8,654 was from the collection of UK factoring
facility deferred purchase price and $3,300 was attributable to
proceeds from the sale of a subsidiary, partially offset by
purchase of property and equipment of $257.
Financing
activities for the years ended January 1, 2022 and January 2,
2021
For
Fiscal 2021, net cash flows used in financing activities totaled
$1,799, of which $43,019 related to proceeds from common stock,
$4,698 related to proceeds from Series F Preferred Stock, and $130
related to proceeds from related party note, offset by $34,076 of
repayments on term loan, $4,908 of redemption of Series E Preferred
Stock-related party, $1,778 of repayments on accounts receivable
financing, net, payment of third-party financing costs of $4,695,
and dividends paid to related parties of $591.
For
Fiscal 2020, net cash flows provided by financing activities
totaled $11,553, of which $2,426 relates to repayments on accounts
receivable financing, net, payment of third-party financing costs
of $795, dividends paid to related parties of $3,333, redemption of
Series E Preferred Stock of $1,920, repayment of term loans of
$4,734; and financing costs - related party of $488; offset by
proceeds from equity raise of $4,634, proceeds from PPP Loans of
$19,395 and proceeds from term loans of $1,220.
Off-Balance
Sheet Arrangements
We
have no off-balance sheet arrangements.
Critical
Accounting Policies and Estimates
Use
of Estimates
The
preparation of consolidated financial statements in accordance with
GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities at the date
of the financial statements and the reported amounts of revenue and
expenses in the reporting period. We base our estimates and
assumptions on current facts, historical experience and various
other factors that it believes to be reasonable under the
circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities and
the accrual of costs and expenses that are not readily apparent
from other sources. The actual results experienced by us may differ
materially and adversely from its estimates. To the extent there
are material differences between estimates and the actual results,
future results of operations will be affected. Significant
estimates for Fiscal 2021 and Fiscal 2020 include the valuation of
intangible assets, including goodwill, liabilities associated with
earn-out obligations, testing long-lived assets for impairment and
valuation reserves against deferred tax assets.
Legal
Contingencies and Expenses
From
time to time, we may become involved in various claims, disputes
and legal or regulatory proceedings that arise in the ordinary
course of business and relate to contractual and other obligations.
We assess our potential contingent and other liabilities by
analyzing its claims, disputes and legal and regulatory matters
using all available information and developing its views on
estimated losses in consultation with its legal and other advisors.
We determine whether a loss from a contingency should be accrued by
assessing whether a loss is deemed probable and can be reasonably
estimated. If the contingency is not probable or cannot be
reasonably estimated, disclosure of the contingency shall be made
when there is at least a reasonable possibility that a loss may be
incurred. Expenses associated with legal contingencies are expensed
as incurred.
Income
Taxes
We
utilize Accounting Standards Codification (“ASC”) Topic 740,
“Accounting for Income Taxes,” which requires the recognition of
deferred tax assets and liabilities for the expected future tax
consequences of events that have been included in the financial
statements or tax returns. Under this method, deferred income taxes
are recognized for the tax consequences in future years of
differences between the tax bases of assets and liabilities and
their financial reporting amounts at each period end based on
enacted tax laws and statutory tax rates applicable to the periods
in which the differences are expected to affect taxable income.
Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be
realized.
We
apply the provisions of ASC 740-10-50, “Accounting for Uncertainty
in Income Taxes,” which provides clarification related to the
process associated with accounting for uncertain tax positions
recognized in the financial statements. Audit periods remain open
for review until the statute of limitations has passed. The
completion of review or the expiration of the statute of
limitations for a given audit period could result in an adjustment
to our liability for income taxes. Any such adjustment could be
material to our results of operations for any given quarterly or
annual period based, in part, upon the results of operations for
the given period. As of the date of this filing, we are current on
all corporate, federal and state tax returns. Our policy is to
record interest and penalties related to unrecognized tax benefits
as income tax expense.
Business
Combinations
In
accordance with ASC 805, “Business Combinations,” we record
acquisitions under the purchase method of accounting, under which
the acquisition purchase price is allocated to the assets acquired
and liabilities assumed based upon their respective fair values. We
utilize management estimates and, in some instances, may retain the
services of an independent third-party valuation firm to assist in
determining the fair values of assets acquired, liabilities assumed
and contingent consideration granted. Such estimates and valuations
require us to make significant assumptions, including projections
of future events and operating performance.
Goodwill
Goodwill
relates to amounts that arose in connection with various
acquisitions and represents the difference between the purchase
price and the fair value of the identifiable intangible and
tangible net assets when accounted for using the purchase method of
accounting. Goodwill is not amortized, but it is subject to
periodic review for impairment. Events that would indicate
impairment and trigger an interim impairment assessment include,
but are not limited to, current economic and market conditions, a
decline in the equity value of the business, a significant adverse
change in certain agreements that would materially affect reported
operating results, business climate or operational performance of
the business and an adverse action or assessment by a
regulator.
In
accordance with ASU No. 2011-08, Intangibles-Goodwill and Other
(Topic 350) Testing Goodwill for Impairment, or ASU 2011-08, we are
required to review goodwill by reporting unit for impairment at
least annually or more often if there are indicators of impairment
present. During the year ended January 2, 2021, we changed our
annual measurement date from the first day of the fiscal fourth
quarter to the last day of the fiscal year end. A reporting unit is
either the equivalent of, or one level below, an operating segment.
We early adopted the provisions in ASU 2017-04, which eliminates
the second step of the goodwill impairment test. As a result, our
goodwill impairment tests include only one step, which is a
comparison of the carrying value of each reporting unit to its fair
value, and any excess carrying value, up to the amount of goodwill
allocated to that reporting unit, is impaired.
The
carrying value of each reporting unit is based on the assignment of
the appropriate assets and liabilities to each reporting unit.
Assets and liabilities were assigned to each reporting unit if the
assets or liabilities are employed in the operations of the
reporting unit and the asset and liability is considered in the
determination of the reporting unit fair value.
Recent
Accounting Pronouncements
In
August 2020, the FASB issued ASU 2020-06, which simplifies the
guidance on the issuer’s accounting for convertible debt
instruments by removing the separation models for (1) convertible
debt with a cash conversion feature and (2) convertible instruments
with a beneficial conversion feature. As a result, entities will
not separately present in equity an embedded conversion feature in
such debt and will account for a convertible debt instrument wholly
as debt, unless certain other conditions are met. The elimination
of these models will reduce reported interest expense and increase
reported net income for entities that have issued a convertible
instrument that is within the scope of ASU 2020-06. Also, ASU
2020-06 requires the application of the if-converted method for
calculating diluted earnings per share and treasury stock method
will be no longer available. ASU 2020-06 is applicable for fiscal
years beginning after December 15, 2021, with early adoption
permitted no earlier than fiscal years beginning after December 15,
2020. We adopted this ASU in Fiscal 2022. This standard did not
have an impact on our financial statements.
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
On
August 26, 2022, the Audit Committee (the “Audit Committee”) of our
Board dismissed BDO USA LLP (“BDO”) as our independent registered
public accounting firm, as of the same date.
The
reports of BDO on our consolidated financial statements for the
fiscal years ended January 1, 2022 and January 2, 2021, did not
contain an adverse opinion or a disclaimer of opinion, and were not
qualified or modified as to uncertainty, audit scope, or accounting
principles, except that BDO’s reports dated April 16, 2021 and June
24, 2022 each contained an explanatory paragraph stating there was
substantial doubt about our ability to continue as a going
concern.
During
the fiscal years ended January 1, 2022 and January 2, 2021, and the
subsequent interim period through August 26, 2022, there were no
disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K
and the related instructions to Item 304 of Regulation S-K) with
BDO on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of BDO, would
have caused BDO to make reference to the subject matter of the
disagreements in connection with its reports on our consolidated
financial statements for such years. Also during this time, there
were no “reportable events,” as defined in Item 304(a)(1)(v) of
Regulation S-K, except to note, for the years ended January 1, 2022
and January 2, 2021 and for each of the quarters ended April 2,
2022 and July 2, 2022, that management identified a material
weakness in our internal control over financial reporting related
to the number of competent finance personnel to appropriately
account for, review and disclose the completeness and accuracy of
transactions entered into by us, and for the year ended January 1,
2022 and for each of the quarters ended April 2, 2022 and July 2,
2022, that management identified a material weakness related to the
design and operating effectiveness over forecasts used in our
annual goodwill impairment evaluation.
We
provided BDO with a copy of the foregoing disclosures and requested
that BDO furnish us with a letter addressed to the SEC stating
whether it agrees with the statements made by us set forth above. A
copy of BDO’s letter, dated November 7, 2022, is filed as Exhibit
16.1 to the registration statement of which this prospectus forms a
part.
On
August 26, 2022, the Audit Committee engaged Baker Tilly US, LLP
(“Baker Tilly”) as our independent registered public accounting
firm for the fiscal year ending December 31, 2022, effective
immediately. During the fiscal years ended January 1, 2022 and
January 2, 2021, and the subsequent interim period through August
26, 2022, neither us nor anyone on our behalf consulted with Baker
Tilly regarding (i) the application of accounting principles to any
specified transaction, either completed or proposed or the type of
audit opinion that might be rendered on our consolidated financial
statements, and neither a written report nor oral advice was
provided to us that Baker Tilly concluded was an important factor
considered by us in reaching a decision as to any accounting,
auditing, or financial reporting issue, or (ii) any matter that was
either the subject of a “disagreement,” as defined in Item
304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as
defined in Item 304(a)(1)(v) of Regulation S-K.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE
GOVERNANCE.
Board
Composition
Our
Board consists of six directors as follows:
Class
I: Dimitri Villard, Nicholas Florio and Vincent Cebula;
Class
II: Jeff Grout and Alicia Barker; and
Non-Classified:
Brendan Flood.
Under
our Amended and Restated Certificate of Incorporation and Bylaws,
the Board is divided into Class I and Class II directors, and any
directors not classified are non-classified directors. Each Class I
director seat is up for election at the annual meeting of
stockholders occurring in calendar year 2021 and every two years
thereafter, each Class II director seat is up for election at the
annual meeting of stockholders occurring in calendar year 2020 and
every two years thereafter, and any non-classified directors are up
for election at every annual meeting of stockholders and, in each
case, until his or her successor shall be elected and qualified,
unless sooner displaced. Our shareholders approved the appointment
of our two Class II and one non-classified director at our annual
shareholder meeting on December 30, 2022.
Executive
Officers and Directors
The
name, age and position of our executive officers and directors are
set forth below.
Name
and Address |
|
Age |
|
Positions |
Brendan
Flood |
|
58 |
|
Chairman,
Chief Executive Officer, President and Director |
Joe
Yelenic |
|
61 |
|
Senior
Vice President, Corporate Finance (Principal Financial
Officer) |
Nick
Koutsivitis |
|
48 |
|
Senior
Vice President, Corporate Controller (Principal Accounting
Officer) |
Alicia
Barker |
|
52 |
|
Chief
Operating Officer, Executive Vice President and
Director |
Dimitri
Villard |
|
79 |
|
Director |
Jeff
Grout |
|
70 |
|
Director |
Nicholas
Florio |
|
59 |
|
Director |
Vincent
Cebula |
|
59 |
|
Director |
Brendan
Flood, Chairman, Chief Executive Officer, President and
Director. Mr. Flood has been the Chairman or Executive
Chairman and a Director of the Company since January 7, 2014. He
assumed the role of Chairman and Chief Executive Officer (“CEO”) on
December 19, 2017 and has been in the staffing industry for over 20
years. Mr. Flood joined the Company upon the sale to us of his
business, Initio International Holdings Limited (“Initio”), on
January 3, 2014, where he was the chairman and chief executive
officer. He had previously acquired Initio as part of a management
buy-out, which he led, in January 2010. Prior to Initio, Mr. Flood
worked in several staffing companies, including Hudson Global
Resources Inc. (“Hudson Global Resources”), which he brought to the
Nasdaq National Market on April 1, 2003 as a spin-off from
Monsterworldwide Inc. (“Monsterworldwide”). His experience while at
Monsterworldwide included numerous M&A transactions,
operational management in both London and New York, and various
senior financial roles. Mr. Flood graduated from Dublin City
University in Ireland with a Bachelor of Arts Degree in Accounting
and Finance. Mr. Flood’s strong financial background and years of
experience at major staffing firms like Monsterworldwide and Hudson
Global Resources qualifies him to be the President and Chief
Executive Officer and Chairman of the Board of Directors given our
core business in the staffing industry.
Joe Yelenic, Senior Vice President, Corporate Finance. Mr.
Yelenic joined us as a result of the acquisition of Headway
Workforce Solutions (“Headway”) on May 18, 2022. During his 18
years with Headway, he served in senior financial roles, including
Director of Internal Audit and Chief Financial Officer. Mr. Yelenic
was instrumental in overseeing Headway’s growth in revenues during
this time. Mr. Yelenic assumed the role of President, Chief
Operating Officer for Headway in January 2019. As a licensed CPA
with over thirty-eight years of financial management experience,
primarily in HR outsourcing and temporary staffing industries, Mr.
Yelenic provides strategic financial and operational leadership in
his role involving financial planning and analysis for the Company.
His experience includes several M&A transactions beginning with
the buyout of SPEC Group Holdings in 1994, where he helped
facilitate six years of accelerated growth before its acquisition
by TMP Worldwide. Mr. Yelenic graduated from Duquesne University in
Pittsburgh Pennsylvania with a Bachelor of Science degree in
accounting. Mr. Yelenic has served as the Company’s Senior Vice
President, Corporate Finance since May 2022.
Nick Koutsivitis, Senior Vice President, Corporate
Controller. Mr. Koutsivitis brings to us more than 20 years
of experience in accounting and leadership roles. From 2014 to
2017, he was our Corporate Controller. From 2017 to 2019, he was
the CFO of a privately owned staffing company before returning to
us in 2020. Mr. Koutsivitis has served as our Senior Vice
President, Corporate Controller since 2020.
Alicia
Barker, Chief Operating Officer, Executive Vice President and
Director. Alicia Barker has served as a director on the
Board since April 2018 and as Executive Vice President and Chief
Operating Officer since July 2018. Ms. Barker brings over two
decades of extensive human resources, communication and operational
expertise to her role. From July 2016 to July 2018, she served as
principal and owner of Act II Consulting, providing human resources
consulting and professional coaching services to individuals and
corporations. From May 2014 to May 2016, Ms. Barker served as
senior vice president, Human Resources at Barker, a full-service
advertising agency where she led talent procurement and executive
development. She also previously served on the executive team as
vice president, Human Resources at Hudson North America, a global
talent solutions company, as vice president, Human Resources, at
Grey Group, a global advertising and marketing agency, and before
that, as Human Resources Director at Icon/Nicholson, which designs,
develops, and produces prepackaged computer software. Over the past
several years, Ms. Barker has held positions on not-for-profit
boards in her local community. Ms. Barker was also solicited to be
the Campaign Manager for the Mayoral Campaign in the town of
Westfield, New Jersey during the 2018 election. Ms. Barker’s
educational background includes a major in Communications, a
SHRM-CP Certification in HR and a Professional Coaching
Certification. Ms. Barker’s extensive human resources expertise
qualifies her to be a director on the Board.
Dimitri
Villard, Director. Dimitri Villard has been a
director on the Board since July 2012. Mr. Villard was chairman and
chief executive officer of Peer Media Technologies, Inc., a public
company Internet technology business, from February 2009 to
December 2012. Peer Media Technologies, Inc. changed its name from
ARTISTdirect, Inc. in May 2010. Prior to that, Mr. Villard served
as interim chief executive officer from March 6, 2008 and as a
director from January 2005 until 2012. Mr. Villard has also served
as president and a director of Pivotal BioSciences, Inc., a
biotechnology company, from September 1998 to August 2018. In
addition, since January 1982, he has served as president and
director of Byzantine Productions, Inc. Previously, Mr. Villard was
a director at the investment banking firm, SG Cowen and affiliated
entities, a position held from January 1997 to July 1999. From 2004
to 2008, Mr. Villard served as chairman of the board of directors
of Dax Solutions, Inc., an entertainment industry digital asset
management venture, and from July 2012 until September 2013, he was
a member of the board of directors of The Grilled Cheese Truck
Company, a public company. He is also a member of the executive
committee of the Los Angeles chapter of the Tech Coast Angels, a
private venture capital group. Mr. Villard received a Bachelor of
Arts from Harvard University and a Master of Science degree from
China International Medical University. He serves on the Nominating
and Corporate Governance Committee, the Compensation and Human
Resources Committee and the Audit Committee. Mr. Villard’s
experience as an officer and/or director of several public
companies, as well as an investment banker, qualifies him to be a
director on the Board.
Jeff
Grout, Director. Jeff Grout has been a director on the
Board since February 2014. He is a successful business speaker,
consultant and coach. From 1980 to 2001, he served as U.K. managing
director of Robert Half International, a leading international
recruitment consultancy, and business manager to Sir Clive
Woodward, head coach of the England Rugby Team. From 2001, Mr.
Grout has been an independent business consultant specializing in
leadership, people management, team building, peak performance,
recruitment and retention issues. He has spoken at Henley Business
School, Ashridge Management College, Cardiff Business School and
the Danish Centre for Leadership, and his clients include Amazon,
Deloitte, LinkedIn, British Airways, Barclays, Ernst & Young
and Virgin. He holds several corporate advisory and executive
coaching appointments and is also a successful business author. Mr.
Grout has written books on leadership, recruitment, career success,
the psychology of peak performance and his police detective
father’s first murder case. His eighth book entitled What You
Need to Know about Leadership was published in May 2011. Mr.
Grout holds a Bachelor of Science in Economics from the London
School of Economics and Political Science. Mr. Grout brings
valuable operational experience within the staffing industry having
grown the U.K. business of Robert Half International from $1
million to $100 million in sales and from 12 to 365 employees. He
also identified and integrated several acquisitions of staffing
businesses in the U.K. and continental Europe. He is the Chairman
of our Compensation and Human Resources Committee and serves on the
Nominating and Corporate Governance Committee and the Audit
Committee. Mr. Grout’s extensive staffing industry experience,
including his role as former Managing Director of Robert Half
International, qualifies him to be a director on the
Board.
Nicholas
Florio, Director. Nicholas Florio has been a director on
the Board since May 2014. Mr. Florio provides business consulting
and financial advice to a variety of closely held private
businesses. He is a retired audit and accounting partner for Citrin
Cooperman & Company, LLP (“Citrin Cooperman”). Mr. Florio has
been with Citrin Cooperman for over 25 years. He currently serves
as a consultant with Citrin Cooperman. With over 30 years of
experience in the staffing and employment arena, Mr. Florio served
as the practice leader of Citrin Cooperman’s employment and
staffing area. Mr. Florio’s experience in this area included
providing advice on corporate structuring; design of stock
incentive and deferred compensation plans; merger and acquisition
due diligence and consulting; among general business and tax
advice. He was also a member of the board of directors of both the
New York Staffing Association (“NYSA”) and New Jersey Staffing
Association and was the president of the Industry Partner Group of
NYSA for over 20 years. Prior to his retirement Mr. Florio was also
a long-standing member of the Citrin Cooperman’s executive
committee. A graduate of Pace University, Mr. Florio is a member of
the New York State Society of Certified Public Accountants as well
as the American Institute of CPAs. He is the Chairman of our
Nominating and Corporate Governance Committee as of August 2022 and
serves on the Audit Committee and the Compensation and Human
Resources Committee. Mr. Florio’s acute knowledge of financial and
accounting matters, with an emphasis in the staffing industry
through his role as audit and accounting partner for Citrin
Cooperman, qualifies him to be a director on the Board.
Vincent
Cebula, Director. Vincent Cebula has been a director on
the Board since July 2021. Mr. Cebula has a decades-long and
successful history as an independent director in a number of both
public and private companies, operating advisor and investor in
special situations, including 35 years of experience in private
equity, investment banking and operational restructurings. From
2013 through 2021, Mr. Cebula was Chief Operating Officer,
Co-Founder and Operating Advisor of Solace Capital Partners, L.P.
an alternative asset manager focused on distressed debt and special
situation investment opportunities in middle-market companies.
Earlier in his career, he was Managing Director at Oaktree Capital
Management, LLC and its predecessor, Trust Company of the West, and
later at Jefferies Capital Partners where he was active in
investing on behalf of funds representing more than $4 billion in
combined capital commitments. He began his career as an investment
banker at Drexel Burnham Lambert. Mr. Cebula graduated from Wharton
School, University of Pennsylvania summa cum laude earning a B.S.
Economics degree with concentrations in Finance and Decision
Science. He currently serves as an Independent Director on the
board of Independence Contract Drilling, Inc., a publicly traded
oil field services company, and on the board of another private
company. Mr. Cebula is the Chairman of the Audit Committee as of
August 2022 and serves on the Compensation and Human Resources
Committee and the Nominating and Corporate Governance Committee.
Mr. Cebula’s extensive skills and experience in business and
finance, including corporate governance, capital markets and tax
planning, qualifies him to be a director on the Board.
EXECUTIVE AND DIRECTOR COMPENSATION
Executive
Compensation Overview
The
compensation program for our executive officers, as presented in
the summary compensation table below, is administered by our Board
and our Compensation and Human Resources Committee. The intent of
our compensation program is to align our executives’ interests with
those of our stockholders, while providing reasonable and
competitive compensation.
The
purpose of this executive compensation discussion is to provide
information about the material elements of compensation that we pay
or award to, or that is earned by: (i) the individual who served as
our principal executive officer during Fiscal 2022; (ii) our two
most highly compensated executive officers, other than the
individual who served as our principal executive officer, who were
serving as executive officers, as determined in accordance with the
rules and regulations promulgated by the SEC, as of December 31,
2022, with compensation during Fiscal 2022 of $100,000 or more; and
(iii) if applicable, up to two additional individuals for whom
disclosure would have been provided pursuant to clause (ii) but for
the fact that such individuals were not serving as executive
officers on December 31, 2022. We refer to these individuals as our
“named executive officers.” For Fiscal 2022, our named executive
officers and the positions in which they served are:
|
● |
Brendan
Flood, our Chairman and Chief Executive Officer; |
|
|
|
|
● |
Joe
Yelenic, our Senior Vice President of Corporate Finance;
and |
|
|
|
|
● |
Alicia
Barker, our Chief Operating Officer. |
The
named executive officers, including our Chief Executive Officer, do
not participate in any part of the process of reviewing and setting
their own compensation levels. The Chief Executive Officer acts in
an advisory capacity in setting compensation for executives other
than himself and defers to the decisions of the Compensation and
Human Resources Committee.
For
Fiscal 2022, the compensation of our named executive officers
consisted of salary, an annual cash bonus and equity awards, as
well as benefits such as medical coverage, life insurance and
401(k) contributions.
All
amounts presented in this section are in whole dollar amounts. All
compensation amounts presented in British pounds have been
translated using the foreign currency average exchange rates,
unless otherwise indicated.
Compensation
of Executive Officers
Summary
Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All |
|
|
|
|
|
|
Fiscal |
|
|
Salary |
|
|
Bonus |
|
|
Stock
Awards
(1) (2)
|
|
|
Option
Awards
(3)
|
|
|
Other
Compensation
(4)
|
|
|
Total |
|
Name and Principal Position |
|
Year |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
($) |
|
|
($) |
|
Brendan
Flood |
|
|
Fiscal
2022 |
|
|
|
503,000 |
|
|
|
300,000 |
|
|
|
30,192 |
|
|
|
327,669 |
|
|
|
29,345 |
|
|
|
1,190,206 |
|
Chairman and Chief Executive
Officer |
|
|
Fiscal
2021 |
|
|
|
646,468 |
|
|
|
— |
|
|
|
421,915 |
|
|
|
— |
|
|
|
38,930 |
|
|
|
1,107,313 |
|
Alicia Barker |
|
|
Fiscal
2022 |
|
|
|
275,018 |
|
|
|
217,513 |
|
|
|
34,206 |
|
|
|
— |
|
|
|
28,385 |
|
|
|
555,122 |
|
Chief Operating
Officer
|
|
|
Fiscal
2021 |
|
|
|
257,821 |
|
|
|
— |
|
|
|
17,736 |
|
|
|
— |
|
|
|
26,000 |
|
|
|
301,557 |
|
Joe
Yelenic (4) |
|
|
Fiscal
2022 |
|
|
|
200,000 |
|
|
|
99,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
299,000 |
|
Senior Vice President of Corporate
Finance |
|
|
Fiscal
2021 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
(1) |
Represents
the amount recognized for financial statement reporting purposes in
accordance with ASC Topic 718. Stock awards vest in full on the
third anniversary of the grant date, and the value of stock award
is based upon the fair value of the award at issuance over the
vesting term on a straight-line basis. The fair value of the award
is calculated by multiplying the number of restricted shares by the
Company’s stock price on the date of issuance. |
(2) |
On
January 27, 2022, Mr. Flood was granted 50,000 options expiring in
5 years. On December 28, 2022, Mr. Flood was issued 10,000 shares
for board services at $3.02 per share. On January 11, 2022, April
12, 2022 and December 28, 2022, Ms. Barker was issued 200 shares at
$9.65, 200 shares at $7.40 and 10,200 shares at $3.02,
respectively. On October 21, 2021, Mr. Flood and Ms. Barker
were issued 8,334 and 667 shares, respectively at $18.10 per share.
On January 8, 2021, and October 21, 2021, Ms. Barker was issued 24
shares at $51.52 per share and 247 shares at $18.10 per share,
respectively. |
|
|
(3) |
In accordance with SEC rules, this column reflects the aggregate
fair value of the five (5) year option awards totaling $327,669
granted January 22, 2022 in accordance with Financial Accounting
Standard Board Accounting Standards Codification Topic 718 for
share-based compensation transactions.
|
|
|
(4) |
Includes
vacation pay, car allowance, 401(k) match, pensions and life
insurance premiums. |
|
|
(5) |
On
November 4, 2022, the Board appointed Mr. Joe Yelenic, Senior Vice
President, Corporate Finance, as our principal financial
officer. |
Employment
Agreements
The
Flood Employment Agreement
On
January 3, 2014, in connection with our acquisition of Initio, we
entered into a services agreement (the “Flood Employment
Agreement”) with Brendan Flood. Pursuant to the Flood Employment
Agreement, Mr. Flood initially served as Executive Chairman of the
Board. Mr. Flood was initially paid a salary of £192,000 per year,
less statutory deductions, plus other benefits including
reimbursement for reasonable expenses, paid vacation and insurance
coverage for his roles with both us and our U.K. subsidiary. Under
the Flood Employment Agreement, Mr. Flood’s salary is required to
be adjusted (but not decreased) annually in connection with the CPI
Adjustment (as defined in the Flood Employment Agreement). Mr.
Flood is also entitled to an annual bonus of up to 50% of his
annual base salary based on reaching certain financial milestones.
Additionally, Mr. Flood was entitled to a gross profit appreciation
participation, which entitled the participants to 10% of Initio’s
“Excess Gross Profit,” which is defined as the increase in Initio
gross profits in excess of 120% of the base year’s gross profit, up
to $400,000. Mr. Flood’s participating level was 62.5%. On May 29,
2015, the Gross Profit Appreciation Bonus associated with this
employment agreement was converted into 1,039,380 shares of Series
A Preferred Stock. On January 8, 2021, all of his Series A
Preferred Stock were converted into 45,100 shares of our common
stock.
The
Flood Employment Agreement had an initial term of five years and
automatically renews thereafter unless 12 months’ written notice is
provided by either party. It also includes customary
non-compete/solicitation language for a period of 12 months after
termination of employment, and in the event of a change in control,
we may request that Mr. Flood continue employment with the new
control entity. In December 2017, upon the reorganization of the
Company and departure of Mr. Briand, Mr. Flood’s title was changed
to Chairman and he assumed the roles of our Chief Executive Officer
and President. On January 1, 2018, the Company increased his salary
by the CPI Adjustment. On January 1, 2019 and on January 1, 2020,
Mr. Flood was eligible for a CPI salary adjustment and chose to
waive this adjustment. Effective January 1, 2020, Mr. Flood’s
salary changed to $503,000 and bonus changed to up to 75% of his
annual base salary.
The
Barker Employment Agreement
We
entered into an employment agreement with Alicia Barker that
appointed her as our Chief Operating Officer effective July 1, 2018
(the “Barker Employment Agreement”). Ms. Barker also serves as a
director on the Board and receives stock compensation for her
service as a director on the Board.
Under
the terms of the Barker Employment Agreement, Ms. Barker currently
receives an annual base salary of $250,000 and is entitled to
receive an annual performance bonus of up to 75% of her base salary
based on the achievement of certain performance metrics. Ms.
Barker’s base salary is required to be reviewed by the Board on an
annual basis and may be increased, but not decreased, in its sole
discretion. Ms. Barker is also entitled to reimbursement of certain
out-of-pocket expenses incurred in connection with her services to
the Company and to participate in the benefit plans generally made
available to other executives of the Company. Effective January 1,
2021, Ms. Barker’s salary changed to $275,000.
In
the event Ms. Barker is terminated without cause or for good reason
(as such terms are defined in the Barker Employment Agreement), she
is entitled to receive (subject to certain requirements, including
signing a general release of claims): (i) any earned but unpaid
base salary and vacation time, as well as unreimbursed expenses,
through her termination date; (ii) severance pay in an amount equal
to 12 months’ base salary; and (iii) any earned but unpaid
performance bonus. In the event Ms. Barker is terminated for cause
or without good reason, she is only entitled to receive any earned
but unpaid base salary and vacation time, as well as unreimbursed
expenses, through her termination date.
The
Barker Employment Agreement also contains customary
confidentiality, non-solicitation and non-disparagement
clauses.
The
Yelenic Employment Agreement
We
entered into an employment agreement with Joe Yelenic that
appointed him as our Senior Vice President, Corporate Finance
effective April 18, 2022 (the “Yelenic Employment
Agreement”).
Under
the terms of the Yelenic Employment Agreement, Mr. Yelenic
currently receives an annual base salary of $320,000 and is
entitled to receive an annual performance bonus of up to $140,000
based on the achievement of certain performance metrics. The
Yelenic Employment Agreement will continue in effect unless
terminated by either party upon written notice provided of not less
than six months. Mr. Yelenic is also entitled to reimbursement of
certain out-of-pocket expenses incurred in connection with his
services to the Company and to participate in the benefit plans
generally made available to other executives of the
Company.
In
the event Mr. Yelenic is terminated without cause or for good
reason (as such terms are defined in the Yelenic Employment
Agreement), he is entitled to receive (subject to certain
requirements, including signing a general release of claims) (i)
any earned but unpaid base salary and vacation time, as well as
unreimbursed expenses, through his termination date and (ii) any
earned but unpaid performance bonus. In the event Mr. Yelenic is
terminated for cause or without good reason, he is only entitled to
receive any earned but unpaid base salary and vacation time, as
well as unreimbursed expenses, through his termination
date.
The
Yelenic Employment Agreement also contains customary
confidentiality, non-solicitation and non-disparagement
clauses.
Outstanding
Equity Awards at December 31, 2022
The
following table sets forth information concerning the outstanding
equity awards that have been previously awarded to each of the
named executive officers for Fiscal 2022.
|
|
Number
of securities underlying unexercised options (#)
exercisable
|
|
|
Number
of securities underlying unexercised options (#)
unexercisable
|
|
|
Equity
incentive plan awards: Number of securities underlying unexercised
unearned
options
(#)
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
Name |
|
Option awards |
|
Brendan
Flood(1) |
|
|
110 |
(1) |
|
|
— |
|
|
|
110 |
|
|
$ |
6,000 |
|
|
|
01/07/2024 |
|
|
|
|
50 |
(2) |
|
|
— |
|
|
|
50 |
|
|
|
3,000 |
|
|
|
03/01/2025 |
|
|
|
|
160 |
(3) |
|
|
— |
|
|
|
160 |
|
|
|
405 |
|
|
|
02/28/2027 |
|
|
|
|
50,000 |
(4) |
|
|
— |
|
|
|
50,000 |
|
|
|
7.80 |
|
|
|
01/27/2027 |
|
(1) |
These
options are fully vested, were issued pursuant to the 2014 Equity
Incentive Plan and are exercisable for a period of 10 years from
the date of grant. |
|
|
(2) |
These
options are fully vested, were issued pursuant to the 2015 Equity
Incentive Plan and are exercisable for a period of 10 years from
the date of grant. |
|
|
(3) |
These
options are fully vested, were issued pursuant to the 2016 Equity
Incentive Plan and are exercisable for a period of 10 years from
the date of grant. |
|
|
(4) |
These
options are fully vested, were issued pursuant to the 2021 Equity
Incentive Plan and are exercisable for a period of 5 years from the
date of grant. |
Compensation
of Directors
The
following table provides compensation information for Fiscal 2022
for each member of our Board during Fiscal 2022:
|
|
Fees
Earned |
|
|
|
|
|
|
|
|
|
or
Paid in |
|
|
Stock |
|
|
|
|
|
|
Cash ($) |
|
|
Awards
($) (1) |
|
|
Total ($) |
|
Brendan
Flood(2) |
|
|
— |
|
|
|
30,200 |
|
|
|
30,200 |
|
Dimitri
Villard(3) |
|
|
100,000 |
|
|
|
34,214 |
|
|
|
134,214 |
|
Jeff
Grout(4) |
|
|
100,000 |
|
|
|
34,214 |
|
|
|
134,214 |
|
Nicholas
Florio(5) |
|
|
100,000 |
|
|
|
34,214 |
|
|
|
134,214 |
|
Alicia
Barker(6) |
|
|
— |
|
|
|
34,214 |
|
|
|
34,214 |
|
Vincent
Cebula(7) |
|
|
100,000 |
|
|
|
34,214 |
|
|
|
134,214 |
|
(1) |
We
account for stock-based instruments issued to employees in
accordance with ASC Topic 718. Stock awards vest in full on the
third anniversary of the grant date, and the value of stock award
is based upon the fair value of the award at issuance over the
vesting term on a straight-line basis. The fair value of the award
is calculated by multiplying the number of restricted shares by our
stock price on the date of issuance. We issued these shares under
our 2021 Omnibus Incentive Plan, whereby these shares vest on the
third anniversary of the date of grant. A nonemployee who sits on
the Board and is compensated by us solely for the individual’s role
as a director will be treated as an employee under ASC
718. |
|
|
|
On
January 11, 2022, April 12, 2022 and December 28, 2022, Mr.
Villard, Mr. Grout, Mr. Florio, Ms. Barker and Mr. Cebula were
issued 200 shares at $9.65, 2,000 shares at $7.40 and 10,200 shares
at $3.02, respectively. On December 28, 2022, Mr. Flood was issued
10,000 shares at $3.02 per share. |
|
|
(2) |
Mr.
Flood does not receive any cash compensation for his service as a
director. Beginning in the fourth quarter of 2022, Mr. Flood
received 10,000 shares per quarter for his service as a director.
For information concerning Mr. Flood’s compensation as our
President and Chief Executive Officer, please see “Compensation of
Executive Officers—Summary Compensation Table”. |
|
|
(3) |
In
August 2022, Mr. Villard was named the lead independent director.
Mr. Villard formerly served as Chairman of the Nominating and
Corporate Governance Committee from May 2014 to July 2022. Mr.
Villard has been a member of the Audit Committee and of the
Compensation and Human Resources Committee since May 2014. As a
member of our Board, Mr. Villard receives an annual payment of
$100,000, effective July 1, 2021, payable in monthly installments
of $8,333. In addition, for his services as a Board and committee
member, Mr. Villard received 200 shares of restricted common stock
per quarter for the first three quarters of 2022. Effective October
1, 2022, the shares of restricted stock per quarter increased to
10,000 shares. During Fiscal 2022, Mr. Villard received 10,600
shares of restricted common stock valued at $34,214 for his
services as a Board and committee member. As of December 31, 2022,
Mr. Villard held 11,561 shares of common stock from stock awards
and options representing the right to purchase 17 shares of common
stock. |
|
|
(4) |
In
February 2014, Mr. Grout was named the Chairman of the Compensation
and Human Resources Committee and was also named as a member of the
Nominating and Corporate Governance Committee. In June 2015, Mr.
Grout was also named as a member of the Audit Committee. As a
member of our Board, Mr. Grout receives an annual payment of
$100,000, effective July 1, 2021, payable in monthly installments
of $8,333. In addition, for his services as a Board and committee
member, Mr. Grout received 200 shares of restricted common stock
per quarter for the first three quarters of 2022. Effective October
1, 2022, the shares of restricted stock per quarter increased to
10,000 shares. During Fiscal 2022, Mr. Grout received 10,600 shares
of restricted common stock valued at $34,214 for his services as a
Board and committee member. As of December 31, 2022, Mr. Grout held
11,581 shares of common stock from stock awards and options
representing the right to purchase 17 shares of common
stock. |
(5) |
In
August 2022, Mr. Florio was named the Chairman of the Nominating
and Corporate Governance Committee Mr. Florio formerly served as
Chairman of the Audit Committee from May 2014 to July 2022. Mr.
Florio has been a member of each of the Audit and Corporate
Governance Committee and of the Compensation and Human Resources
Committee since May 2014. As a member of our Board, Mr. Florio
receives an annual payment of $100,000, effective July 1, 2021,
payable in monthly installments of $8,333. In addition, for his
services as a Board and committee member, Mr. Florio received 200
shares of restricted common stock per quarter for the first three
quarters of 2022. Effective October 1, 2022, the shares of
restricted stock per quarter increased to 10,000 shares. During
Fiscal 2022, Mr. Florio received 10,600 shares of restricted common
stock valued at $34,214 for his services as a Board and committee
member. As of December 31, 2022, Mr. Florio held 11,624 shares of
common stock from stock awards and options representing the right
to purchase 17 shares of common stock. At the request of Mr.
Florio, all cash payments, common stock issuances and stock option
issuances have been made in the name of Citrin Cooperman &
Company, LLP. As of December 31, 2022, Mr. Florio, in the name of
Citrin Cooperman, held 11,624 shares of common stock from stock
awards and options representing the right to purchase 17 shares of
common stock. |
(6) |
As a
non-independent director, Ms. Barker receives equity compensation
but is not entitled to cash compensation for services as a
director. For her services as a director, Ms. Barker received 200
shares of restricted common stock per quarter for the first three
quarters of 2022. Effective October 1, 2022, the shares of
restricted stock per quarter increased to 10,000 shares. During
Fiscal 2022, Mr. Barker received 10,600 shares of restricted common
stock valued at $34,214 for his services as a Board and committee
member. As of December 31, 2022, Mr. Barker held 12,795 shares of
common stock from stock awards and options representing the right
to purchase 17 shares of common stock. For information concerning
Ms. Barker’s compensation as our Chief Operating Officer, please
see “Executive and Director Compensation—Summary Compensation
Table”. |
|
|
(7) |
On
July 29, 2021, Mr. Cebula was appointed to the Board as a Class I
director, to fill a vacancy as a result of the increase in the size
of the Board from five to six persons. In August 2022, Mr. Cebula
was named Chairman of the Audit Committee. As a member of our
Board, Mr. Cebula receives an annual payment of $100,000, effective
July 1, 2021, payable in monthly installments of $8,333. In
addition, for his services as a Board and committee member, Mr.
Cebula received 200 shares of restricted common stock per quarter
for the first three quarters of 2022. Effective October 1, 2022,
the shares of restricted stock per quarter increased to 10,000
shares. During Fiscal 2022, Mr. Cebula received 10,600 shares of
restricted common stock valued at $34,214 for his services as a
Board and committee member. As of December 31, 2022, Mr. Cebula
held 10,800 shares of common stock from stock awards. |
Securities
Authorized for Issuance under Equity Compensation
Plans
The
following table provides information as of December 31, 2022 about
the common stock that may be issued upon the exercise of
outstanding options, warrants and rights under our equity
compensation plans:
Plan Category |
|
Number of securities to be issued upon exercising outstanding
options, warrants and rights |
|
|
Weighted-average exercise price of outstanding options, warrants
and rights |
|
|
Number of securities remaining available for future issuance under
equity compensation plans |
|
Equity compensation plans
approved by security holders |
|
|
148,727 |
|
|
$ |
10.38 |
|
|
|
351,273 |
|
Equity
compensation plans not approved by security
holders(1) |
|
|
566 |
|
|
$ |
3,318 |
|
|
|
- |
|
(1)
At December 31, 2022, we had two equity compensation plans, the
2014 Equity Incentive Plan and the 2015 Omnibus Incentive Plan, not
approved by security holders, which are more fully described
below.
2014
Equity Incentive Plan
On
January 28, 2014, the Board adopted the 2014 Equity Incentive Plan
(the “2014 Plan”). Under the 2014 Plan, we may grant options to
employees, directors, senior management and, under certain
circumstances, consultants. The purpose of the 2014 Plan is to
secure and retain the services of the group of persons eligible to
receive option awards, to secure and retain the services of new
members of this group and to provide incentives for such persons to
exert maximum efforts for the success of the Company and its
affiliates. A maximum of 834 shares of common stock has been
reserved for issuance under the 2014 Plan (adjusted for the Reverse
Stock Splits). The 2014 Plan expires on January 28, 2024. As of
December 31, 2022, we had issued 834 options and shares of common
stock pursuant to the 2014 Plan and therefore there are no
remaining shares eligible to be issued under the 2014
Plan.
The
authority to administer the 2014 Plan currently resides with the
Compensation and Human Resources Committee.
Transferability
Option
awards are not transferable other than by will or by the laws of
descent and distribution unless otherwise provided in the
individual option agreement.
Change
of Control Event
In
the event of a change in control, then, without the consent or
action required of any holder of an option award (in such holder’s
capacity as such):
(i)
Any surviving corporation or acquiring corporation or any parent or
affiliate thereof, as determined by the Board in its discretion,
will assume or continue any option awards outstanding under the
plan in all or in part or shall substitute to similar stock awards
in all or in part; or
(ii)
In the event any surviving corporation or acquiring corporation
does not assume or continue any option awards or substitute to
similar stock awards, for those outstanding under the plan, then:
(a) all unvested option awards will expire (b) vested options will
terminate if not exercised at or prior to such change in control;
or
(iii)
Upon change in control, the Board may, in its sole discretion,
accelerate the vesting, partially or in full, in the sole
discretion of the Board and on a case-by-case basis of one or more
option awards as the board of directors may determine to be
appropriate prior to such events.
Notwithstanding
the above, in case of change in control, in the event all or
substantially all of the shares of our common stock of are to be
exchanged for securities of another company, then each holder of an
option award shall be obliged to sell or exchange, as the case may
be, any shares such holder holds or purchased under the plan, in
accordance with the instructions issued by the Board, whose
determination shall be final.
Termination
of Employment/Relationship
In
the event of termination of the option holder’s employment with us
or any of our affiliates, or if applicable, the termination of
services given to us or any of our affiliates by consultants of the
Company or any of its affiliates for cause (as defined in the
plan), all outstanding option awards granted to such option holder
(whether vested or not) will immediately expire and terminate on
the date of such termination and the holder of option awards will
not have any right in connection to such outstanding option awards,
unless otherwise determined by the Board. The shares of common
stock covered by such option awards will revert to the 2014
Plan.
2015
Omnibus Incentive Plan
On
September 23, 2015, the Board adopted the 2015 Omnibus Incentive
Plan (the “2015 Plan”). Under the 2015 Plan, we may grant options
to our employees, directors, senior management and, under certain
circumstances, consultants. The purpose of the 2015 Plan is to
retain the services of the group of persons eligible to receive
option awards, to secure and retain the services of new members of
this group and to provide incentives for such persons to exert
maximum efforts for the success of the Company and its
affiliates.
The
2015 Plan provides for an aggregate of 1,500 shares of common stock
to be available for awards (adjusted for the Reverse Stock Splits).
The number of shares available for grant pursuant to awards under
the 2015 Plan is referred to as the “Available Shares”. If an award
is forfeited, canceled, or if any option terminates, expires or
lapses without being exercised, the common stock subject to such
award will again be made available for future grant. However,
shares that are used to pay the exercise price of an option or that
are withheld to satisfy the participant’s tax withholding
obligation will not be available for re-grant under the 2015
Plan.
The
2015 Plan has a term of ten years and no further awards may be
granted under the 2015 Plan after that date. As of December 31,
2022, we had issued 1,500 in options and shares of common stock
pursuant to the 2015 Plan and had 0 unissued securities remaining
under the 2015 Plan.
Awards
Available for Grant
The
Compensation and Human Resources Committee may grant awards of
Non-Qualified Stock Options, Incentive Stock Options, Stock
Appreciation Rights, Restricted Stock Awards, Restricted Stock
Units, Stock Bonus Awards, Performance Compensation Awards
(including cash bonus awards) or any combination of the foregoing.
Notwithstanding, the Compensation and Human Resources Committee may
not grant to any one person in any one calendar year awards (i) for
more than 500 common shares in the aggregate or (ii) payable in
cash in an amount exceeding $3,600 in the aggregate.
Transferability
Each
award may be exercised during the participant’s lifetime only by
the participant or, if permissible under applicable law, by the
participant’s guardian or legal representative and may not be
otherwise transferred or encumbered by a participant other than by
will or by the laws of descent and distribution. The Compensation
and Human Resources Committee, however, may permit awards (other
than Incentive Stock Options) to be transferred to family members,
a trust for the benefit of such family members, a partnership or
limited liability company whose partners or stockholders are the
participant and his or her family members or anyone else approved
by it.
Change
in Control
Except
to the extent otherwise provided in an award, in the event of a
change in control, all outstanding options and equity awards (other
than performance compensation awards) issued under the Plan will
become fully vested and performance compensation awards will vest,
as determined by the Compensation and Human Resources Committee,
based on the level of attainment of the specified performance
goals. In general, the Compensation and Human Resources Committee
may, in its discretion, cancel outstanding awards and pay the value
of such awards to the participants in connection with a change in
control. The Compensation and Human Resources Committee can also
provide otherwise in an award under the 2015 Plan.
2016
Omnibus Incentive Plan
On
October 25, 2016, our Board adopted the 2016 Omnibus Incentive Plan
(the “2016 Plan”) to, among other things, attract and retain the
best available personnel, to provide additional incentive to
employees, directors and consultants and to promote the success of
our business. On January 26, 2017, our stockholders approved the
2016 Plan, pursuant to which 8,334 shares of our common stock were
reserved for issuance under stock and stock option awards (adjusted
for the Reverse Stock Splits). On May 30, 2018, our stockholders
approved an amendment to the 2016 Plan to increase the total number
of shares reserved for issuance under the 2016 Plan to 20,834
shares of our common stock. As of December 31, 2022, we had issued
20,834 shares and options to purchase shares of common stock
pursuant to the 2016 Plan, leaving 0 shares remaining under the
2016 Plan. The Compensation and Human Resources Committee
administers the 2016 Plan.
The
Compensation and Human Resources Committee administers the 2016
Plan. The Compensation and Human Resources Committee will have the
authority, without limitation to (i) designate participants; (ii)
determine the type or types of awards to be granted to a
participant; (iii) determine the number of common shares to be
covered by, or with respect to which payments, rights, or other
matters are to be calculated in connection with, awards; (iv)
determine the terms and conditions of any award; (v) determine
whether, to what extent, and under what circumstances awards may be
settled or exercised in cash, common shares, other securities,
other awards or other property, or canceled, forfeited, or
suspended and the method or methods by which awards may be settled,
exercised, canceled, forfeited, or suspended; (vi) determine
whether, to what extent, and under what circumstances the delivery
of cash, common shares, other securities, other awards or other
property and other amounts payable with respect to an award; (vii)
interpret, administer, reconcile any inconsistency in, settle any
controversy regarding, correct any defect in and/or complete any
omission in the 2016 Plan and any instrument or agreement relating
to, or award granted under, the 2016 Plan; (viii) establish, amend,
suspend, or waive any rules and regulations and appoint such agents
as the Compensation and Human Resources Committee shall deem
appropriate for the proper administration of the 2016 Plan; (ix)
accelerate the vesting or exercisability of, payment for or lapse
of restrictions on, awards; and (x) make any other determination
and take any other action that the Compensation and Human Resources
Committee deems necessary or desirable for the administration of
the 2016 Plan. The Compensation and Human Resources Committee will
have full discretion to administer and interpret the 2016 Plan and
to adopt such rules, regulations and procedures as it deems
necessary or advisable and to determine, among other things, the
time or times at which the awards may be exercised and whether and
under what circumstances an award may be exercised.
Eligibility
Employees,
directors, officers, advisors and consultants of the Company or its
affiliates are eligible to participate in the 2016 Plan. The
Compensation and Human Resources Committee has the sole and
complete authority to determine who will be granted an award under
the 2016 Plan, however, it may delegate such authority to one or
more officers of the Company under the circumstances set forth in
the 2016 Plan.
Number
of Shares Authorized
The
2016 Plan provides for an aggregate of 20,834 shares of common
stock to be available for awards. The 2016 Plan has a term of ten
years and no further awards may be granted under the 2016 Plan
after that date.
Awards
Available for Grant
The
Compensation and Human Resources Committee may grant awards of
Non-Qualified Stock Options, Incentive Stock Options, Stock
Appreciation Rights, Restricted Stock Awards, Restricted Stock
Units, Stock Bonus Awards, Performance Compensation Awards
(including cash bonus awards) (each defined under the 2016 Plan) or
any combination of the foregoing subject to the number of available
shares. Notwithstanding anything to the contrary in the 2016 Plan,
the Compensation and Human Resources Committee may not grant to any
one participant under the plan in any one calendar year awards (i)
for more than 1,334 common shares in the aggregate or (ii) payable
in cash in an amount exceeding $750,000 in the
aggregate.
Options
Under
the terms of the 2016 Plan, unless the Compensation and Human
Resources Committee determines otherwise in the case of an option
substituted for another option in connection with a corporate
transaction, the exercise price of the options will not be less
than the fair market value (as determined under the 2016 Plan) of
the shares of common stock on the date of grant. Options granted
under the 2016 Plan will be subject to such terms, including the
exercise price and the conditions and timing of exercise, as may be
determined by the Compensation and Human Resources Committee and
specified in the applicable award agreement. The maximum term of an
option granted under the 2016 Plan will be ten years from the date
of grant (or five years in the case of an Incentive Stock Option
granted to a 10% stockholder.)
Stock
Appreciation Rights
The
Compensation and Human Resources Committee is authorized to award
Stock Appreciation Rights (“SARs”) under the 2016 Plan. SARs will
be subject to such terms and conditions as established by the
Compensation and Human Resources Committee. A SAR is a contractual
right that allows a participant to receive, either in the form of
cash, shares or any combination of cash and shares, the
appreciation, if any, in the value of a share over a certain period
of time. A SAR granted under the 2016 Plan may be granted in tandem
with an option and SARs may also be awarded to a participant
independent of the grant of an option. SARs granted in connection
with an option shall be subject to terms similar to the option
which corresponds to such SARs. SARs shall be subject to terms
established by the Compensation and Human Resources Committee and
reflected in the award agreement.
Restricted
Stock
The
Compensation and Human Resources Committee is authorized to award
restricted stock under the 2016 Plan. Unless otherwise provided by
the Compensation and Human Resources Committee and specified in an
award agreement, restrictions on restricted stock will lapse after
three years of service with the Company. The Compensation and Human
Resources Committee will determine the terms of such restricted
stock awards. Shares of restricted stock are shares of common stock
that generally are non-transferable and subject to other
restrictions determined by the Compensation and Human Resources
Committee for a specified period. Unless the Compensation and Human
Resources Committee determines otherwise or specifies otherwise in
an award agreement, if the participant terminates employment or
services during the restricted period, then any unvested restricted
stock will be forfeited.
Restricted
Stock Unit Awards
The
Compensation and Human Resources Committee is authorized to award
restricted stock unit awards under the 2016 Plan. Unless otherwise
provided by the Compensation and Human Resources Committee and
specified in an award agreement, restricted stock units vest after
three years of service with the Company. The Compensation and Human
Resources Committee determines the terms of such restricted stock
units. Unless the Compensation and Human Resources Committee
determines otherwise or specifies otherwise in an award agreement,
if the participant terminates employment or services during the
period of time over which all or a portion of the units are to be
earned, then any unvested units will be forfeited. At the election
of the Compensation and Human Resources Committee, the participant
will receive a number of shares of common stock equal to the number
of units earned or an amount in cash equal to the fair market value
of that number of shares at the expiration of the period over which
the units are to be earned or at a later date selected by the
Compensation and Human Resources Committee.
Stock
Bonus Awards
The
Compensation and Human Resources Committee is authorized to grant
awards of unrestricted shares of common stock or other awards
denominated in shares of common stock, either alone or in tandem
with other awards, under such terms and conditions as the
Compensation and Human Resources Committee may
determine.
Performance
Compensation Awards
The
Compensation and Human Resources Committee is authorized to grant
any award under the 2016 Plan in the form of a performance
compensation awards. The Compensation and Human Resources Committee
will select the performance criteria based on one or more of the
following factors: (i) revenue; (ii) sales; (iii) profit (net
profit, gross profit, operating profit, economic profit, profit
margins or other corporate profit measures); (iv) earnings (EBIT,
EBITDA, earnings per share, or other corporate earnings measures);
(v) net income (before or after taxes, operating income or other
income measures); (vi) cash (cash flow, cash generation or other
cash measures); (vii) stock price or performance; (viii) total
stockholder return (stock price appreciation plus reinvested
dividends divided by beginning share price); (ix) economic value
added; (x) return measures (including, but not limited to, return
on assets, capital, equity, investments or sales, and cash flow
return on assets, capital, equity, or sales); (xi) market share;
(xii) improvements in capital structure; (xiii) expenses (expense
management, expense ratio, expense efficiency ratios or other
expense measures); (xiv) business expansion or consolidation
(acquisitions and divestitures); (xv) internal rate of return or
increase in net present value; (xvi) working capital targets
relating to inventory and/or accounts receivable; (xvii) inventory
management; (xviii) service or product delivery or quality; (xix)
customer satisfaction; (xx) employee retention; (xxi) safety
standards; (xxii) productivity measures; (xxiii) cost reduction
measures; and/or (xxiv) strategic plan development and
implementation.
Transferability
Each
award may be exercised during the participant’s lifetime only by
the participant or, if permissible under applicable law, by the
participant’s guardian or legal representative. No award may be
assigned, alienated, pledged, attached, sold or otherwise
transferred or encumbered by a participant other than by will or by
the laws of descent and distribution and any such purported
assignment, alienation, pledge, attachment, sale, transfer or
encumbrance shall be void and unenforceable against the Company;
provided that the designation of a beneficiary shall not constitute
an assignment, alienation, pledge, attachment, sale, transfer or
encumbrance. The Compensation and Human Resources Committee,
however, may permit awards (other than incentive stock options) to
be transferred to family members, a trust for the benefit of such
family members, a partnership or limited liability company whose
partners or stockholders are the participant and his or her family
members or anyone else approved by it.
Amendment
The
2016 Plan has a term of ten years from the effective date of the
2016 Plan. The Board may amend, suspend or terminate the 2016 Plan
at any time; however, shareholder approval to amend the 2016 Plan
may be necessary if applicable law or listing rule so requires. No
amendment, suspension or termination will impair the rights of any
participant or recipient of any award without the consent of the
participant or recipient.
Change
in Control
Except
to the extent otherwise provided in an award, in the event of a
change in control, all outstanding options and equity awards (other
than performance compensation awards) issued under the 2016 Plan
will become fully vested or the period of restriction will expire
and performance compensation awards vest, as determined by the
Compensation and Human Resources Committee, based on the level of
attainment of the specified performance goals or assuming that that
the applicable “target” levels of performance have been obtained or
on such other basis as determined by the Compensation and Human
Resources Committee.
2020
Omnibus Incentive Plan
On
June 30, 2020, the Board approved the 2020 Omnibus Incentive Plan
(the “2020 Plan”) pursuant to which we may grant equity incentive
awards to key employees, key contractors, and non-employee
directors of the Company. The 2020 Plan provides for the granting
of incentive stock options, nonqualified stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance awards, dividend equivalent rights, and other awards,
which may be granted singly or in combination, and that may be paid
in cash, shares of our common stock, or a combination of cash and
common stock. A total of 12,500 shares of common stock are reserved
for grant under the 2020 Plan, plus any awards reserved under the
Company’s prior equity incentive plans, subject to adjustment in
certain circumstances to prevent dilution or enlargement. On
September 29, 2020, our stockholders approved the 2020 Plan. As of
December 31, 2022, we had issued 12,500 shares and options to
purchase shares of common stock pursuant to the 2020 Plan,
therefore leaving 274 shares remaining under the 2020 Plan. The
Compensation and Human Resources Committee administers the 2020
Plan. The 2020 Plan will terminate on June 30, 2030.
2021
Omnibus Incentive Plan
On
August 17, 2021, the Board approved the 2021 Omnibus Incentive Plan
(the “2021 Plan”) pursuant to which we may grant equity incentive
awards to key employees, key contractors, and non-employee
directors of the Company. The 2021 Plan provides for the granting
of incentive stock options, nonqualified stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance awards, dividend equivalent rights, and other awards,
which may be granted singly or in combination, and that may be paid
in cash, shares of our common stock, or a combination of cash and
common stock. A total of 200,000 shares of common stock are
reserved for grant under the 2021 Plan, plus any awards reserved
under the Company’s prior equity incentive plans, subject to
adjustment in certain circumstances to prevent dilution or
enlargement. On October 14, 2021, our stockholders approved the
2021 Plan. On December 27, 2021, we held a special meeting of the
stockholders, at which meeting the stockholders approved an
amendment to the 2021 Plan to increase the number of shares of
common stock available for issuance pursuant to awards under the
2021 Plan by an additional 300,000 shares, to a total of 500,000
shares of our common stock. As of December 31, 2022, we had issued
148,727 shares and options to purchase shares of common stock
pursuant to the 2021 Plan, therefore leaving 351,273 shares
remaining under the 2021 Plan. The Compensation and Human Resources
Committee administers the 2021 Plan. The 2021 Plan will terminate
on August 17, 2031.
Purpose.
The purpose of the 2021 Plan is to enable us to remain competitive
and innovative in our ability to attract and retain the services of
key employees, key contractors, and non-employee directors of the
Company and our subsidiaries. The 2021 Plan provides for the
granting of incentive stock options, nonqualified stock options,
stock appreciation rights (“SARs”), restricted stock, restricted
stock units, performance awards, dividend equivalent rights, and
other awards, which may be granted singly or in combination, and
that may be paid in cash, shares of our common stock, or a
combination of cash and common stock. The 2021 Plan is expected to
provide flexibility to our compensation methods in order to adapt
the compensation of our key employees, key contractors, and
non-employee directors to a changing business environment, after
giving due consideration to competitive conditions and the impact
of applicable tax laws.
Effective
Date and Expiration. The 2021 Plan was approved by our Board on
August 17, 2021 and approved by our stockholders on October 14,
2021. The 2021 Plan will terminate on August 17, 2031, unless
earlier terminated by our Board. No award may be granted under the
2021 Plan after its termination date, but awards made prior to the
termination date may extend beyond that date in accordance with
their terms.
Shares
Available. The 2021 Plan, as amended, provides that the
aggregate number of shares of our common stock that may be subject
to awards under the 2021 Plan cannot exceed 500,000 shares, subject
to adjustment in certain circumstances to prevent dilution or
enlargement. All of the shares available for issuance as an award
under the 2021 Plan may be delivered pursuant to incentive stock
options.
Administration.
Under the terms of the 2021 Plan, the 2021 Plan will be
administered by our Board or such committee of our Board as is
designated by it to administer the 2021 Plan (the “Committee”),
which, to the extent necessary to satisfy the requirements of Rule
16b-3 under the Exchange Act, shall consist entirely of two or more
“non-employee directors” as defined in Rule 16b-3 under the
Exchange Act. At any time there is no Committee to administer the
2021 Plan, any reference to the Committee is a reference to our
Board. The Committee will determine the persons to whom awards are
to be made; determine the type, size, and terms of awards;
interpret the 2021 Plan; establish and revise rules and regulations
relating to the 2021 Plan and any sub-plans (including sub-plans
for awards made to participants who do not reside in the United
States); establish performance goals applicable to awards and
certify the extent of their achievement; and make any other
determinations that it believes are necessary for the
administration of the 2021 Plan. The Committee may delegate certain
of its duties to one or more of our officers as provided in the
2021 Plan.
Shares
to be issued under the 2021 Plan may be made available from
authorized but unissued shares of our common stock, common stock
held in our treasury, or shares purchased by us on the open market
or otherwise. During the term of the 2021 Plan, we will at all
times reserve and keep enough shares available to satisfy the
requirements of the 2021 Plan. Shares underlying awards granted
under the 2021 Plan, the 2020 Plan or the 2016 Plan that expire or
are forfeited or terminated without being exercised, or awards that
are settled for cash, will again be available for the grant of
additional awards within the limits provided by the 2021 Plan.
Shares withheld by or delivered to us to satisfy the exercise price
of stock options or tax withholding obligations with respect to any
award granted under the 2021 Plan will nonetheless be deemed to
have been issued under the 2021 Plan and will not again be
available for grant under the 2021 Plan. Awards that may be
satisfied either by the issuance of common stock or by cash or
other consideration shall be counted against the maximum number of
shares that may be issued under the 2021 Plan only during the
period that the award is outstanding or to the extent the award is
ultimately satisfied by the issuance of shares. An award will not
reduce the number of shares that may be issued pursuant to the 2021
Plan if the settlement of the award will not require the issuance
of shares, such as, for example, SARs that can only be satisfied by
the payment of cash. Only shares forfeited back to us or shares
cancelled on account of termination, expiration, or lapse of an
award shall again be available for grant as incentive stock options
under the 2021 Plan, but shall not increase the maximum number of
shares that may be delivered pursuant to incentive stock
options.
Eligibility.
The 2021 Plan provides for awards to the non-employee directors,
officers, employees, and contractors of the Company and our
subsidiaries and prospective non-employee directors, officers,
employees, and contractors who have accepted offers of employment
or service from the Company or our subsidiaries, with such awards
being effective upon such individual’s commencement of employment
with or service to the Company or our subsidiaries, as applicable.
As of the date of this proxy statement, there were four
non-employee directors, three Section 16 officers, and
approximately 205 other employees eligible to participate in the
2021 Plan. The Company’s current Section 16 executive officers and
each member of our Board are among the individuals eligible to
receive awards under the 2021 Plan.
Stock
Options. Subject to the terms and provisions of the 2021 Plan,
options to purchase shares of our common stock may be granted to
eligible individuals at any time and from time to time as
determined by the Committee. Stock options may be granted as
incentive stock options, which are intended to qualify for
favorable treatment to the recipient under federal tax law, or as
nonqualified stock options, which do not qualify for such favorable
tax treatment. Subject to the limits provided in the 2021 Plan, the
Committee determines the number of stock options granted to each
recipient. Each stock option grant will be evidenced by a stock
option agreement that specifies the stock option’s exercise price,
whether the stock options are intended to be incentive stock
options or nonqualified stock options, the duration of the stock
options, the number of shares to which the stock options pertain,
and such additional limitations, terms, and conditions as the
Committee may determine.
The
Committee determines the exercise price for each stock option
granted, except that the exercise price may not be less than 100%
of the fair market value of a share of our common stock on the date
of grant; provided, however, that if an incentive stock option is
granted to an employee who owns or is deemed to own more than 10%
of the combined voting power of all classes of our common stock (or
of any parent or subsidiary), the exercise price must be at least
110% of the fair market value of a share of our common stock on the
date of grant. As of August 20, 2021, the fair market value (as
that term is defined in the 2021 Plan) of a share of our common
stock was $20.35. All stock options granted under the 2021 Plan
will expire no later than ten years (or, in the case of an
incentive stock option granted to an employee who owns or is deemed
to own more than 10% of the combined voting power of all classes of
our common stock (or of any parent or subsidiary), five years) from
the date of grant. Stock options are nontransferable except by will
or by the laws of descent and distribution or, in the case of
nonqualified stock options, as otherwise expressly permitted by the
Committee. The granting of a stock option does not accord the
recipient the rights of a stockholder, and such rights accrue only
after the exercise of a stock option and the registration of shares
of our common stock in the recipient’s name. No dividend or
dividend equivalent rights may be paid or granted with respect to
any stock options granted under the 2021 Plan.
Stock
Appreciation Rights. The 2021 Plan authorizes the Committee to
grant SARs, either as a separate award or in connection with a
stock option. A SAR entitles the holder to receive from us, upon
exercise, an amount equal to the excess, if any, of the aggregate
fair market value of a specified number of shares of our common
stock to which such SAR pertains over the aggregate exercise price
for the underlying shares. The exercise price of a SAR shall not be
less than 100% of the fair market value of a share of our common
stock on the date of grant.
Each
SAR will be evidenced by an award agreement that specifies the
exercise price, the number of shares to which the SAR pertains, and
such additional limitations, terms, and conditions as the Committee
may determine. We may make payment of the amount to which the
participant exercising SARs is entitled by delivering shares of our
common stock, cash, or a combination of stock and cash as set forth
in the award agreement relating to the SARs. SARs are not
transferable except as expressly permitted by the Committee. No
dividend or dividend equivalent rights may be paid or granted with
respect to any SARs granted under the 2021 Plan.
Restricted
Stock. The 2021 Plan provides for the award of shares of our
common stock that are subject to forfeiture and restrictions on
transferability as set forth in the 2021 Plan, the applicable award
agreement, and as may be otherwise determined by the Committee.
Except for these restrictions and any others imposed by the
Committee, upon the grant of restricted stock, the recipient will
have rights of a stockholder with respect to the restricted stock,
including the right to vote the restricted stock and to receive all
dividends and other distributions paid or made with respect to the
restricted stock on such terms as will be set forth in the
applicable award agreement; provided, however, such dividends or
distributions may be withheld by us for a participant’s account
until the restrictions lapse with respect to such restricted stock.
During the restriction period set by the Committee, the recipient
may not sell, transfer, pledge, exchange, or otherwise encumber the
restricted stock.
Restricted
Stock Units. The 2021 Plan authorizes the Committee to grant
restricted stock units. Restricted stock units are not shares of
our common stock and do not entitle the recipients to the rights of
a stockholder, although the award agreement may provide for rights
with respect to dividends or dividend equivalents. The recipient
may not sell, transfer, pledge, or otherwise encumber restricted
stock units granted under the 2021 Plan prior to their vesting.
Restricted stock units will be settled in shares of our common
stock, in an amount based on the fair market value of our common
stock on the settlement date. If the right to receive dividends on
restricted stock units is awarded, then such dividends may be
withheld by us for a participant’s account until the restrictions
lapse with respect to such restricted stock units.
Dividend
Equivalent Rights. The Committee may grant a dividend
equivalent right either as a component of another award or as a
separate award. The terms and conditions of the dividend equivalent
right will be specified by the grant and, when granted as a
component of another award, may have terms and conditions different
from such other award; provided, however, that (i) any dividend
equivalent rights with respect to such other award may be withheld
by us for a participant’s account until such other award is vested,
subject to such terms as determined by the Committee; and (ii) such
dividend equivalent rights so withheld and attributable to another
award will be distributed to such participant in cash or, at the
discretion of the Committee, in common stock having a fair market
value equal to the amount of such dividend equivalent rights, if
applicable, upon vesting of the other award and, if such other
award is forfeited, the right to dividend equivalent rights
attributable to such forfeited award also will be forfeited. No
dividend equivalent rights may be paid or granted with respect to
any stock option or SAR. Dividend equivalent rights granted as a
separate award also may be paid currently or may be deemed to be
reinvested in additional common stock. Any such reinvestment will
be at the fair market value at the time thereof. Dividend
equivalent rights may be settled in cash or common
stock.
Performance
Awards. The Committee may grant performance awards payable at
the end of a specified performance period in cash, shares of common
stock, or other rights based upon, payable in, or otherwise related
to our common stock. Payment will be contingent upon achieving
pre-established performance goals (as described below) by the end
of the applicable performance period. The Committee will determine
the length of the performance period, the maximum payment value of
an award, and the minimum performance goals required before payment
will be made, so long as such provisions are not inconsistent with
the terms of the 2021 Plan, and to the extent an award is subject
to Section 409A of the Internal Revenue Code of 1986, as amended
(the “Code”), are in compliance with the applicable requirements of
Section 409A of the Code and any applicable regulations or
authoritative guidance issued thereunder. In certain circumstances,
the Committee may, in its discretion, determine that the amount
payable with respect to certain performance awards will be reduced
from the maximum amount of any potential awards. If the Committee
determines, in its sole discretion, that the established
performance measures or objectives are no longer suitable because
of a change in our business, operations, corporate structure, or
for other reasons that the Committee deems satisfactory, the
Committee may modify the performance measures or objectives and/or
the performance period.
Performance
Goals. The 2021 Plan provides that performance goals may be
established by the Committee in connection with the grant of any
award under the 2021 Plan. Such goals shall be based on the
attainment of specified levels of one or more business criteria,
which may include, without limitation: cash flow; cost; revenues;
sales; ratio of debt to debt plus equity; net borrowing, credit
quality or debt ratings; profit before tax; economic profit;
earnings before interest and taxes; earnings before interest,
taxes, depreciation and amortization; gross margin; earnings per
share (whether on a pre-tax, after-tax, operational or other
basis); operating earnings; capital expenditures; expenses or
expense levels; economic value added; ratio of operating earnings
to capital spending or any other operating ratios; free cash flow;
net profit; net sales; net asset value per share; the
accomplishment of mergers, acquisitions, dispositions, public
offerings or similar extraordinary business transactions; sales
growth; price of our common stock; return on assets, equity or
stockholders’ equity; market share; inventory management, inventory
turn or shrinkage; employee retention; safety standards; service or
product delivery or quality; or total return to stockholders, in
each case with respect to the Company or any one or more of our
subsidiaries, divisions, business units, or business segments,
either in absolute terms or relative to the performance of one or
more other companies (including an index covering multiple
companies).
Other
Awards. The Committee may grant other forms of awards, based
upon, payable in, or that otherwise relate to, in whole or in part,
shares of our common stock, if the Committee determines that such
other form of award is consistent with the purpose and restrictions
of the 2021 Plan. The terms and conditions of such other form of
award shall be specified in the grant. Such other awards may be
granted for no cash consideration, for such minimum consideration
as may be required by applicable law, or for such other
consideration as may be specified in the grant.
Vesting
of Awards; Forfeiture; Assignment. Except as otherwise provided
below, the Committee, in its sole discretion, may determine that an
award will be immediately vested, in whole or in part, or that all
or any portion may not be vested until a date, or dates, subsequent
to its date of grant, or until the occurrence of one or more
specified events, subject in any case to the terms of the 2021
Plan.
The
Committee may impose on any award, at the time of grant or
thereafter, such additional terms and conditions as the Committee
determines, including terms requiring forfeiture of awards in the
event of a participant’s termination of service. The Committee will
specify the circumstances under which performance awards may be
forfeited in the event of a termination of service by a participant
prior to the end of a performance period or settlement of awards.
Except as otherwise determined by the Committee, restricted stock
will be forfeited upon a participant’s termination of service
during the applicable restriction period.
Awards
granted under the 2021 Plan generally are not assignable or
transferable except by will or by the laws of descent and
distribution, except that the Committee may, in its discretion and
pursuant to the terms of an award agreement, permit transfers of
nonqualified stock options or SARs to: (i) the spouse (or former
spouse), children, or grandchildren of the participant (“Immediate
Family Members”); (ii) a trust or trusts for the exclusive benefit
of such Immediate Family Members; (iii) a partnership in which the
only partners are (a) such Immediate Family Members and/or (b)
entities that are controlled by the participant and/or his or her
Immediate Family Members; (iv) an entity exempt from federal income
tax pursuant to Section 501(c)(3) of the Code or any successor
provision; or (v) a split interest trust or pooled income fund
described in Section 2522(c)(2) of the Code or any successor
provision, provided that (x) there shall be no consideration for
any such transfer, (y) the applicable award agreement pursuant to
which such nonqualified stock options or SARs are granted must be
approved by the Committee and must expressly provide for such
transferability, and (z) subsequent transfers of transferred
nonqualified stock options or SARs shall be prohibited except those
by will or the laws of descent and distribution.
Change
in Control. In connection with a change in control, outstanding
awards may be converted into new awards, exchanged or substituted
for with new awards, or canceled for no consideration, provided
participants were given notice and an opportunity to purchase or
exercise such awards, or cancelled and cashed out based on the
positive difference between the per share amount to be received in
connection with the transaction and the purchase/exercise price per
share of the award, if any.
Recoupment
for Restatements. To the extent set forth in the award
agreement, the Company may recoup all or any portion of any shares
of our common stock or cash paid to a participant in connection
with an award, in the event of a restatement of our financial
statements as set forth in our clawback policy as may be in effect
from time to time.
Adjustments
Upon Changes in Capitalization. In the event that any dividend
or other distribution (whether in the form of cash, shares of our
common stock, other securities, or other property),
recapitalization, stock split, reverse stock split, rights
offering, reorganization, merger, consolidation, split-up,
spin-off, split-off, combination, subdivision, repurchase, or
exchange of shares of our common stock or other securities,
issuance of warrants or other rights to purchase shares of our
common stock or other securities, or other similar corporate
transaction or event affects the fair market value of an award, the
Committee shall adjust any or all of the following so that the fair
market value of the award immediately after the transaction or
event is equal to the fair market value of the award immediately
prior to the transaction or event: (i) the number of shares and
type of common stock (or other securities or property) that
thereafter may be made the subject of awards; (ii) the number of
shares and type of common stock (or other securities or property)
subject to outstanding awards; (iii) the exercise price of each
outstanding stock option; (iv) the amount, if any, we pay for
forfeited shares in accordance with the terms of the 2021 Plan; and
(v) the number of or exercise price of shares then subject to
outstanding SARs previously granted and unexercised under the 2021
Plan, to the extent that the same proportion of our issued and
outstanding shares of common stock in each instance shall remain
subject to exercise at the same aggregate exercise price; provided,
however, that the number of shares of common stock (or other
securities or property) subject to any award shall always be a
whole number. Notwithstanding the foregoing, no such adjustment
shall be made or authorized to the extent that such adjustment
would cause the 2021 Plan or any stock option to violate Section
422 of the Code or Section 409A of the Code. All such adjustments
must be made in accordance with the rules of any securities
exchange, stock market, or stock quotation system to which we are
subject.
Repricing
of Stock Options or SARs. The Committee may “reprice” any stock
option or SAR; provided, however, that the repricing of any Stock
Option or SAR shall not be permitted without stockholder approval
to the extent stockholder approval is required either by (i) any
securities exchange or inter-dealer quotation system on which the
Common Stock is listed or traded or (ii) applicable law. For
purposes of the 2021 Plan, “reprice” means any of the following or
any other action that has the same effect: (a) amending a stock
option or SAR to reduce its exercise price; (b) canceling a stock
option or SAR at a time when its exercise price exceeds the fair
market value of a share of our common stock in exchange for cash or
a stock option, SAR, award of restricted stock, or other equity
award; or (c) taking any other action that is treated as a
repricing under generally accepted accounting principles, provided
that nothing will prevent the Committee from (x) making adjustments
to awards upon changes in capitalization, (y) exchanging or
cancelling awards upon a merger, consolidation, or
recapitalization, or (z) substituting awards for awards granted by
other entities, to the extent permitted by the 2021
Plan.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
The
following table sets forth certain information with respect to the
beneficial ownership of our common stock as of the Record Date for:
(i) each of our directors; (ii) each of our named executive
officers; (iii) all of our directors and executive